var title_f11_52_12096="Nevus multi-component pattern";
var content_f11_52_12096=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F58486&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F58486&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Dermoscopic image of a nevus with a symmetric multi-component pattern",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Nevi with a multi-component pattern should be considered suspicious, since melanoma may present with a similar pattern.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Drs. Ashfaq Marghoob and Natalia Jaimes.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_52_12096=[""].join("\n");
var outline_f11_52_12096=null;
var title_f11_52_12097="Sonogram abn ut bleeding1";
var content_f11_52_12097=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F55785&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F55785&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Transvaginal pelvic sonogram of a perimenopausal patient with abnormal uterine bleeding",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 384px; height: 266px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The central uterine echo measures 14mm (calipers).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Steven Goldstein, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_52_12097=[""].join("\n");
var outline_f11_52_12097=null;
var title_f11_52_12098="Rheumatoid arthritis and pregnancy";
var content_f11_52_12098=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Rheumatoid arthritis and pregnancy (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?11/52/12098/contributors\">",
"       Author",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/52/12098/contributors\" id=\"au7370\">",
"       Bonnie L Bermas, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?11/52/12098/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/52/12098/contributors\" id=\"se5073\">",
"       RN Maini, BA, MB BChir, FRCP, FMedSci, FRS",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?11/52/12098/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/52/12098/contributors\" id=\"de4792\">",
"       Jerry M Greene, MD",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"UTD.htm?11/52/12098?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      INTRODUCTION",
"     </span>",
"    </p>",
"    <p>",
"     Rheumatoid arthritis (RA) affects 1 percent of the adults in the United States, with more women affected than men. Many women with RA are of childbearing age, which highlights the importance of careful family planning especially in patients who are taking medications or who have active disease.",
"    </p>",
"    <p>",
"     In many women with RA, disease activity improves substantially during pregnancy. However, some women's RA flares up or remains active during pregnancy. Thus, it is often necessary to change or modify treatment of RA during pregnancy to control flares while minimizing the risks of RA treatments to the developing fetus.",
"    </p>",
"    <p>",
"     A number of other topics about rheumatoid arthritis are available separately. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?20/61/21463?source=see_link\">",
"      \"Patient information: Rheumatoid arthritis symptoms and diagnosis (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?23/44/24264?source=see_link\">",
"      \"Patient information: Rheumatoid arthritis treatment (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?26/40/27266?source=see_link\">",
"      \"Patient information: Disease-modifying antirheumatic drugs (DMARDs) (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      CHANGES IN RHEUMATOID ARTHRITIS DURING PREGNANCY",
"     </span>",
"    </p>",
"    <p>",
"     Many changes to the immune system occur normally during pregnancy. These changes enable a fetus to grow and develop. Some of these changes contribute to the improvement of RA symptoms during pregnancy.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H3\">",
"     <span class=\"h2\">",
"      Disease activity during pregnancy",
"     </span>",
"     &nbsp;&mdash;&nbsp;Approximately 50 to 60 percent of women with RA notice improvement of RA signs and symptoms during pregnancy. The decrease in disease activity generally starts in the first trimester and lasts through delivery. Unfortunately, we cannot predict which patients will get better during pregnancy.",
"    </p>",
"    <p>",
"     It is sometimes difficult to distinguish between the common discomforts of pregnancy and the symptoms of RA. Pregnancy discomforts that are similar to those of RA include the following:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Fatigue",
"      </li>",
"      <li>",
"       Swelling of the hands, feet, or ankles",
"      </li>",
"      <li>",
"       Joint pain, especially in the low back",
"      </li>",
"      <li>",
"       Shortness of breath",
"      </li>",
"      <li>",
"       Numbness or pain in one or both hands (caused by carpal tunnel syndrome of pregnancy)",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H4\">",
"     <span class=\"h2\">",
"      Pregnancy outcome",
"     </span>",
"     &nbsp;&mdash;&nbsp;Most reports show that there is no increase in stillbirth or miscarriage in women who have RA. However, some medications, particularly high-dose steroids, may increase the risk of having a smaller than normal infant and may increase the risk of premature rupture of the membranes.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H5\">",
"     <span class=\"h1\">",
"      CARE BEFORE PREGNANCY",
"     </span>",
"    </p>",
"    <p>",
"     Women with RA should discuss their desire to become pregnant with an arthritis specialist (rheumatologist) and an obstetrical care provider before trying to become pregnant.",
"    </p>",
"    <p>",
"     General recommendations that apply to all women who are considering pregnancy can be found separately. In addition:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       If a woman takes prescription or non-prescription medications for rheumatoid arthritis, these should be reviewed with a healthcare provider. Some medications are safe during pregnancy while others are not. In some cases, an alternate medication can be substituted for an unsafe drug.",
"      </li>",
"      <li>",
"       Women who take methotrexate should stop it at least one month before trying to conceive although it is best to allow one to three full menstrual cycles to pass before attempting pregnancy. Men who take methotrexate should stop it for at least three months. This waiting period is necessary to allow the effects of methotrexate on the body to pass so that it will be safe to become pregnant.",
"      </li>",
"      <li>",
"       Women who take leflunomide must stop it for at least two years before trying to conceive unless a course of treatments to eliminate the drug from the body is used. Thus, women of child-bearing potential should discuss use of this medication with their arthritis specialist.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H7\">",
"     <span class=\"h2\">",
"      Am I ready for pregnancy?",
"     </span>",
"     &nbsp;&mdash;&nbsp;It is common for women with long-term medical problems to be worried about how their health will be affected by pregnancy and parenting. Women with RA often have an improvement in symptoms of pain and fatigue during pregnancy but then may have a worsening of these problems after delivery. Thus, it is important to be prepared for the changes that a new child may bring, including interrupted sleep, fatigue, stress, and anxiety. Close communication with an obstetric and a rheumatologic care provider and support from family and friends can help to ease the additional challenges of being pregnant and raising a child.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H8\">",
"     <span class=\"h1\">",
"      RHEUMATOID ARTHRITIS TREATMENT DURING PREGNANCY",
"     </span>",
"    </p>",
"    <p>",
"     Some women with RA flare during pregnancy and require treatment. However, some medications used in the treatment of RA can be harmful to the fetus. The benefit of any medication must be balanced with the potential risk.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H9\">",
"     <span class=\"h2\">",
"      Care during pregnancy",
"     </span>",
"     &nbsp;&mdash;&nbsp;During pregnancy, care of women with RA is usually shared between a rheumatologist and an obstetrical provider.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H10\">",
"     <span class=\"h2\">",
"      Medications during pregnancy",
"     </span>",
"     &nbsp;&mdash;&nbsp;The safety of RA medications during pregnancy has not been studied well, so the effects on the fetus are not always clearly known. For each patient, the decision about which drugs to use will depend upon their response to treatment, the activity of their disease, their overall medical status, and other individual factors.",
"    </p>",
"    <p>",
"     Methotrexate and leflunomide should be avoided completely during pregnancy due to a significant risk of fetal harm. If a woman takes one of these medications during pregnancy, she should speak to her clinician immediately. (See",
"     <a class=\"local\" href=\"#H5\">",
"      'Care before pregnancy'",
"     </a>",
"     above.) Other medications may be taken more safely during one part of the pregnancy but not another, such as aspirin and nonsteroidal antiinflammatory drugs which can be taken early during pregnancy but not later on.",
"    </p>",
"    <p>",
"     For some patients, the benefits of the drug in controlling disease and in maintaining function may outweigh the possible risks to the mother or to the fetus. The use of any medication for arthritis during pregnancy is, thus, a matter that a patient and her rheumatologist should discuss, so that potentially dangerous medications can be avoided and the individual risks and benefits of any other drug can be carefully weighed. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/59/38842?source=see_link\">",
"      \"Use of antiinflammatory and immunosuppressive drugs in rheumatic diseases during pregnancy and lactation\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H14\">",
"     <span class=\"h1\">",
"      RHEUMATOID ARTHRITIS AFTER DELIVERY",
"     </span>",
"    </p>",
"    <p>",
"     Approximately 90 percent of women with RA experience a flare during the postpartum period, usually within the first three months and particularly after a woman's first pregnancy [",
"     <a class=\"abstract\" href=\"UTD.htm?11/52/12098/abstract/1\">",
"      1",
"     </a>",
"     ]. Many experts recommend restarting RA medications in the first few weeks after delivery.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H15\">",
"     <span class=\"h2\">",
"      Breastfeeding and rheumatoid arthritis activity",
"     </span>",
"     &nbsp;&mdash;&nbsp;It is not clear if breastfeeding increases the risk of an RA flare. The postpartum period is a common time for women with RA to have a flare of the disease, so it is difficult to know if breastfeeding further increases this risk. However, there are numerous benefits of breastfeeding for both women and their infants. For these reasons, women with RA who want to breastfeed are encouraged to do so. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?33/63/34805?source=see_link\">",
"      \"Patient information: Deciding to breastfeed (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H16\">",
"     <span class=\"h2\">",
"      Medications and breastfeeding",
"     </span>",
"     &nbsp;&mdash;&nbsp;Many of the same restrictions on medication use during pregnancy apply also to breastfeeding mothers [",
"     <a class=\"abstract\" href=\"UTD.htm?11/52/12098/abstract/2\">",
"      2",
"     </a>",
"     ]:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       NSAIDs can be used, but aspirin should be avoided.",
"      </li>",
"      <li>",
"       Prednisone can be taken in low doses.",
"      </li>",
"      <li>",
"       Methotrexate, azathioprine, and cyclosporine should be avoided during breastfeeding. There is insufficient information available regarding the safety of TNF inhibitors, such as etanercept, infliximab, or adalimumab, during breastfeeding although many experts agree that minimal amount, if any, of these medications will be absorbed by the stomach of a nursing infant. The quality of information regarding medication safety in breastfeeding varies. A reliable source of up-to-date information is LactMed, which is available from the National Library of Medicine",
"       <span class=\"nowrap\">",
"        (file://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT).",
"       </span>",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Several topic reviews about breastfeeding are available separately. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?33/63/34805?source=see_link\">",
"      \"Patient information: Deciding to breastfeed (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?36/61/37845?source=see_link\">",
"      \"Patient information: Common breastfeeding problems (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?17/25/17813?source=see_link\">",
"      \"Patient information: Breast pumps (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?30/54/31588?source=see_link\">",
"      \"Patient information: Maternal health and nutrition during breastfeeding (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H17\">",
"     <span class=\"h2\">",
"      Birth control and rheumatoid arthritis",
"     </span>",
"     &nbsp;&mdash;&nbsp;Within a few weeks after delivering an infant, it is important to start thinking about birth control. A number of birth control options are available, most of which are safe and effective for women with RA. In most cases, RA should not affect which birth control method a woman chooses.",
"    </p>",
"    <p>",
"     A full discussion of birth control options is available separately. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?8/60/9157?source=see_link\">",
"      \"Patient information: Birth control; which method is right for me? (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H18\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H181\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H1943412\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?38/14/39138?source=see_link\">",
"      Patient information: Rheumatoid arthritis and pregnancy (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?16/31/16883?source=see_link\">",
"      Patient information: Rheumatoid arthritis (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H1943429\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?20/61/21463?source=see_link\">",
"      Patient information: Rheumatoid arthritis symptoms and diagnosis (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?23/44/24264?source=see_link\">",
"      Patient information: Rheumatoid arthritis treatment (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?26/40/27266?source=see_link\">",
"      Patient information: Disease-modifying antirheumatic drugs (DMARDs) (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?33/63/34805?source=see_link\">",
"      Patient information: Deciding to breastfeed (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?36/61/37845?source=see_link\">",
"      Patient information: Common breastfeeding problems (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?17/25/17813?source=see_link\">",
"      Patient information: Breast pumps (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?30/54/31588?source=see_link\">",
"      Patient information: Maternal health and nutrition during breastfeeding (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?8/60/9157?source=see_link\">",
"      Patient information: Birth control; which method is right for me? (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H20\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/53/40791?source=see_link\">",
"      Rheumatoid arthritis and pregnancy",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/59/38842?source=see_link\">",
"      Use of antiinflammatory and immunosuppressive drugs in rheumatic diseases during pregnancy and lactation",
"     </a>",
"     <br/>",
"    </p>",
"    <p>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/healthtopics.html\">",
"        www.nlm.nih.gov/medlineplus/healthtopics.html",
"       </a>",
"       )",
"      </li>",
"      <li>",
"       National Institute of Arthritis and Musculoskeletal and Skin Diseases",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.niams.nih.gov/\">",
"        www.niams.nih.gov",
"       </a>",
"       )",
"      </li>",
"      <li>",
"       The Arthritis Foundation",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.arthritis.org/\">",
"        www.arthritis.org",
"       </a>",
"       )",
"      </li>",
"      <li>",
"       American College of Rheumatology",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.rheumatology.org/\">",
"        www.rheumatology.org",
"       </a>",
"       )",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"UTD.htm?11/52/12098/abstract/1-7\">",
"      1-7",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 8, 2012.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"UTD.htm?11/52/12098?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12098/abstract/1\">",
"      Silman A, Kay A, Brennan P. Timing of pregnancy in relation to the onset of rheumatoid arthritis. Arthritis Rheum 1992; 35:152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12098/abstract/2\">",
"      Guidelines for monitoring drug therapy in rheumatoid arthritis. American College of Rheumatology Ad Hoc Committee on Clinical Guidelines. Arthritis Rheum 1996; 39:723.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12098/abstract/3\">",
"      N&oslash;rg&aring;rd B, Pedersen L, Christensen LA, S&oslash;rensen HT. Therapeutic drug use in women with Crohn's disease and birth outcomes: a Danish nationwide cohort study. Am J Gastroenterol 2007; 102:1406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12098/abstract/4\">",
"      &Oslash;stensen M, F&ouml;rger F, Nelson JL, et al. Pregnancy in patients with rheumatic disease: anti-inflammatory cytokines increase in pregnancy and decrease post partum. Ann Rheum Dis 2005; 64:839.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12098/abstract/5\">",
"      Straub RH, Buttgereit F, Cutolo M. Benefit of pregnancy in inflammatory arthritis. Ann Rheum Dis 2005; 64:801.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12098/abstract/6\">",
"      Barrett JH, Brennan P, Fiddler M, Silman AJ. Does rheumatoid arthritis remit during pregnancy and relapse postpartum? Results from a nationwide study in the United Kingdom performed prospectively from late pregnancy. Arthritis Rheum 1999; 42:1219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12098/abstract/7\">",
"      Soscia PN, Zurier RB. Drug therapy of rheumatic diseases during pregnancy. Bull Rheum Dis 1992; 41:1.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f11_52_12098=[""].join("\n");
var outline_f11_52_12098=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           INTRODUCTION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           CHANGES IN RHEUMATOID ARTHRITIS DURING PREGNANCY",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H5\">",
"           CARE BEFORE PREGNANCY",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H8\">",
"           RHEUMATOID ARTHRITIS TREATMENT DURING PREGNANCY",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H14\">",
"           RHEUMATOID ARTHRITIS AFTER DELIVERY",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H18\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f11_52_12099="Keratoderma blennorrhagicum 2";
var content_f11_52_12099=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F50133&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F50133&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Keratoderma blennorrhagicum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 434px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This close-up photograph shows the erythematous, scaly plaques of keratoderma blennorrhagicum in a patient with reactive arthritis (formerly Reiter's Syndrome).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Filip de Keyser.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_52_12099=[""].join("\n");
var outline_f11_52_12099=null;
var title_f11_52_12100="Heart attack recovery";
var content_f11_52_12100=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Heart attack recovery (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?11/52/12100/contributors\">",
"       Authors",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/52/12100/contributors\" id=\"au6237\">",
"       Julian M Aroesty, MD",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/52/12100/contributors\" id=\"au4742\">",
"       Joseph P Kannam, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?11/52/12100/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/52/12100/contributors\" id=\"se4323\">",
"       Bernard J Gersh, MB, ChB, DPhil, FRCP, MACC",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?11/52/12100/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/52/12100/contributors\" id=\"de1101\">",
"       Gordon M Saperia, MD, FACC",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"UTD.htm?11/52/12100?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      HEART ATTACK OVERVIEW",
"     </span>",
"    </p>",
"    <p>",
"     Recovering from a heart attack can be a long process, requiring you to make big changes in your life. You may need to change how you eat, begin a new exercise program, take new medicines, and visit your doctor on a regular basis. However, these treatments can help to lower your risk of having another heart attack, reduce your risk of death from heart disease, and often increase your ability to exercise and be active.",
"    </p>",
"    <p>",
"     This article will review the steps involved in recovering from a heart attack. An overview of heart attack treatment is available separately. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?39/16/40195?source=see_link\">",
"      \"Patient information: Heart attack (Beyond the Basics)\"",
"     </a>",
"     .) More detailed information about cardiac rehabilitation is available by subscription. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/18/17705?source=see_link\">",
"      \"Cardiac rehabilitation: Exercise training and secondary prevention of coronary heart disease in older adults\"",
"     </a>",
"     and",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/41/13977?source=see_link\">",
"      \"Efficacy of cardiac rehabilitation in patients with coronary heart disease\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      CARE AT HOME AFTER A HEART ATTACK",
"     </span>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H3\">",
"     <span class=\"h2\">",
"      Discharge from the hospital",
"     </span>",
"     &nbsp;&mdash;&nbsp;Most people can go home after about three to five days in the hospital. In some cases, the hospital stay could be longer (for example, if you have surgery). If you develop complications, you will not go home until your condition is stable.",
"    </p>",
"    <p>",
"     Before leaving the hospital, it is important for you and your family to understand the discharge plan. Make sure all your questions are answered and get written directions for taking all medicines (new and old). After a heart attack, it is common to start new medicines and stop or adjust the doses of old medicines.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H4\">",
"     <span class=\"h2\">",
"      Medications",
"     </span>",
"     &nbsp;&mdash;&nbsp;Most people who have had a heart attack are sent home with prescriptions for several medications. It is important to take each of these drugs exactly as directed. Some of these medications can help you to live longer while others help to prevent or treat recurrent symptoms, such as chest pain.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Aspirin helps prevent future blood clots and decreases the risk of death after a heart attack. (See",
"       <a class=\"medical medical_patient\" href=\"UTD.htm?39/54/40803?source=see_link\">",
"        \"Patient information: Aspirin and cardiovascular disease (Beyond the Basics)\"",
"       </a>",
"       .)",
"      </li>",
"      <li>",
"       Clopidogrel (brand name: Plavix) and similar medications such as ticagrelor (brand name: Brilinta) or prasugrel (brand name: Effient) are given to people who have had a stent placed or received clot-busting drugs to open a blocked artery. These drugs are given with aspirin to prevent platelets from clumping inside arteries that feed the heart and can prevent re-blockage. DO NOT STOP THIS KIND OF MEDICINE WITHOUT FIRST CHECKING WITH YOUR HEART DOCTOR.",
"      </li>",
"      <li>",
"       A beta-blocker (example: metoprolol [brand names: Lopressor, Toprol-XL]) is a medication that protects your heart from stress and can prevent future heart attacks. It can slow your heart rate. It can take weeks for your body to get used to a beta-blocker. The dose may need to be changed a few times as your body adjusts.",
"      </li>",
"      <li>",
"       Nitrates (examples: isosorbide dinitrate [brand name: Isordil], nitroglycerin patch or pills) are medicines that widen (dilate) coronary blood vessels, bringing more blood to the heart muscle, and are used to treat or prevent chest pain. Nitrates should be taken exactly as prescribed by the doctor. (See",
"       <a class=\"medical medical_patient\" href=\"UTD.htm?31/1/31766?source=see_link\">",
"        \"Patient information: Angina treatment &mdash; medical therapy (Beyond the Basics)\"",
"       </a>",
"       .)",
"      </li>",
"      <li>",
"       An ACE inhibitor (example: lisinopril [brand name: Zestril) can help your heart work better after a heart attack and decrease the amount of damage from a heart attack; it may also help prevent heart failure and future heart attacks. ACE inhibitors also lower blood pressure.",
"      </li>",
"      <li>",
"       A statin (examples: atorvastatin [brand name: Lipitor], pravastatin [brand name: Pravachol]) is a medication that helps to lower bad cholesterol levels and can help prevent another heart attack or stroke. Because statins help stabilize fatty deposits inside the arteries that can cause heart attacks, they are often given in high doses after a heart attack, even if your cholesterol levels are normal or low. (See",
"       <a class=\"medical medical_patient\" href=\"UTD.htm?6/4/6212?source=see_link\">",
"        \"Patient information: High cholesterol and lipids (hyperlipidemia) (Beyond the Basics)\"",
"       </a>",
"       .)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Medicines after a heart attack are important. To help you take them correctly, keep a current list of their names and how many times per day you take them. An example of such a list can be found at",
"     <a class=\"external\" href=\"file://www.fda.gov/drugs/resourcesforyou/ucm079489.htm\">",
"      file://www.fda.gov/Drugs/ResourcesForYou/ucm079489.htm",
"     </a>",
"     .",
"    </p>",
"    <p>",
"     Some people have difficulty taking medicines several times per day. If this becomes a problem, ask your doctor or pharmacist if there are ways to reduce the number of times per day you take pills. The cost of medicines can also be a problem. There may be ways to lower costs. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?31/61/32726?source=see_link\">",
"      \"Patient information: Reducing the costs of medicines (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     For more detailed information about your medicines, ask your doctor or nurse for information from Lexicomp, available through UpToDate. The Lexicomp hand-outs explain how to use and store your medicines. They also list possible side effects and warn you if your medicines should not be taken with certain other medicines or foods.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H5\">",
"     <span class=\"h1\">",
"      CARDIAC REHABILITATION AFTER HEART ATTACK",
"     </span>",
"    </p>",
"    <p>",
"     People who have had a heart attack are encouraged to participate in a structured cardiac rehabilitation (cardiac rehab) program. The program can improve your heart's ability to function, lower your heart rate, and reduce your risk of dying or developing complications from heart disease.",
"    </p>",
"    <p>",
"     There are three parts to cardiac rehabilitation:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Exercise",
"      </li>",
"      <li>",
"       Reduce risk factors",
"      </li>",
"      <li>",
"       Deal with stress, anxiety, and depression",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     You are most likely to benefit if you participate in all three parts of rehabilitation. However, if you cannot participate in all, you can still benefit by participating in one or two components.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H6\">",
"     <span class=\"h2\">",
"      Exercise",
"     </span>",
"     &nbsp;&mdash;&nbsp;Exercise is known to improve cardiovascular health. Although nearly everyone can exercise safely after a heart attack, the intensity and duration of exercise depends upon the severity of your heart disease. Therefore, the first step in an exercise program is to determine your risk of complications from exercise. This is usually done by performing an exercise test on a treadmill.",
"    </p>",
"    <p>",
"     During cardiac rehabilitation, a trained clinician will work with you and your doctor to develop an exercise program that is safe; this program will consider your fitness level, heart health, any physical limitations, the amount, intensity and duration of exercise needed to improve heart health, and the need for supervision. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/43/31417?source=see_link\">",
"      \"Components of cardiac rehabilitation and exercise prescription\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     The exercise should use large muscle groups and include aerobic exercise. Walking, jogging, swimming, cycling, rowing, and stair climbing are some examples. You can also build exercise into your daily routine by taking a brisk walk or playing with children or grandchildren. Over time, most people can gradually increase the intensity of exercise in their workout.",
"    </p>",
"    <p>",
"     The recommended frequency of exercise is three to five times a week. Each session should include the following:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       5- to 10-minute warm-up phase",
"      </li>",
"      <li>",
"       Conditioning phase of at least 20 minutes",
"      </li>",
"      <li>",
"       5- to 10-minute cool-down phase",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Eliminating the warm-up or cool-down phase can increase your risk of heart-related complications.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H7\">",
"     <span class=\"h2\">",
"      Reduce risk factors",
"     </span>",
"     &nbsp;&mdash;&nbsp;A number of factors increase your risk of developing heart disease and having a heart attack. Reducing or eliminating these risk factors can be helpful, even if you already have heart disease or had a heart attack.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H9\">",
"     <span class=\"h3\">",
"      Stop smoking",
"     </span>",
"     &nbsp;&mdash;&nbsp;Cigarette smoking markedly increases your risk of coronary heart disease and heart attack, and stopping smoking can rapidly reduce these risks. One year after stopping smoking, the risk of dying from coronary heart disease is reduced by about one-half, and the risk continues to decline with time. In some studies, the risk of heart attack was reduced to the rate of nonsmokers within two years of quitting smoking.",
"    </p>",
"    <p>",
"     Cardiac rehabilitation programs can recommend a treatment to help stop smoking, such as group programs, nicotine patches, gum, or nasal spray, or a prescription medication such as bupropion (brand names: Zyban&reg;, Wellbutrin&reg;). (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?19/13/19670?source=see_link\">",
"      \"Patient information: Quitting smoking (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H10\">",
"     <span class=\"h3\">",
"      Treat high blood pressure",
"     </span>",
"     &nbsp;&mdash;&nbsp;Medicines to control high blood pressure are often recommended after a heart attack. It is important to take these medications exactly as prescribed. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?36/32/37380?source=see_link\">",
"      \"Patient information: High blood pressure treatment in adults (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11\">",
"     <span class=\"h3\">",
"      Treat high cholesterol",
"     </span>",
"     &nbsp;&mdash;&nbsp;Medicine to lower blood cholesterol levels is also recommended after a heart attack. (See",
"     <a class=\"local\" href=\"#H4\">",
"      'Medications'",
"     </a>",
"     above and",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?6/4/6212?source=see_link\">",
"      \"Patient information: High cholesterol and lipids (hyperlipidemia) (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12\">",
"     <span class=\"h3\">",
"      Manage diabetes",
"     </span>",
"     &nbsp;&mdash;&nbsp;People with diabetes are at an increased risk of developing complications after a heart attack. Tight control of your blood sugar can help to reduce the risk of these and other types of complications. Tight control can be achieved by losing weight, managing your diet, exercising, monitoring blood sugar levels regularly, and taking oral medications (for people with type 2 diabetes) or insulin (for people with type 1 and sometimes type 2 diabetes). (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?40/1/40980?source=see_link\">",
"      \"Patient information: Preventing complications in diabetes mellitus (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H96176045\">",
"     <span class=\"h2\">",
"      Dietary counseling",
"     </span>",
"     &nbsp;&mdash;&nbsp;Diet counseling is helpful for people who need to lose weight or reduce cholesterol levels. A registered dietitian is the best person to consult about foods that are helpful, appropriate portion sizes, total calorie recommendations, and realistic ways to change bad eating habits. Most cardiac rehab programs have a dietitian who is knowledgeable and experienced in advising people who are recovering from a heart attack. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?27/62/28642?source=see_link\">",
"      \"Patient information: Diet and health (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H13\">",
"     <span class=\"h2\">",
"      Psychosocial treatment",
"     </span>",
"     &nbsp;&mdash;&nbsp;Feelings of depression, anxiety, and denial are common after a heart attack, occurring in up to 20 percent of people. Depression can make it hard to exercise, decrease energy levels, cause fatigue, and reduce your quality of life and sense of well being. Women, and in particular younger women, are at an especially high risk for depression after heart attack.",
"    </p>",
"    <p>",
"     These symptoms often translate into problems within the family, marriage, and the workplace. Individual or group therapy, and sometimes treatment with an antidepressant medication, can be beneficial. Many cardiac rehabilitation programs have trained personnel, including psychologists, psychiatrists, and social workers to help manage these issues. Getting treatment for depression and anxiety can improve your long term outlook and general sense of well being. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?21/24/21894?source=see_link\">",
"      \"Patient information: Depression treatment options for adults (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H14\">",
"     <span class=\"h1\">",
"      WHEN IS SEX SAFE?",
"     </span>",
"    </p>",
"    <p>",
"     An important issue for many people who have had a heart attack is knowing when it is safe to have sex. In the first two weeks after an",
"     <strong>",
"      uncomplicated",
"     </strong>",
"     heart attack, most people are at high risk of heart-related problems during sex. However, this risk becomes much smaller at six weeks after the heart attack.",
"    </p>",
"    <p>",
"     If you had complications with your heart attack, such as recurrent chest pain, abnormal heart rhythms (arrhythmias), or heart failure, you are at intermediate to high risk of heart-related problems during sex. People in these risk groups need further evaluation",
"     <span class=\"nowrap\">",
"      and/or",
"     </span>",
"     treatment before attempting to have sex. A cardiologist or internal medicine specialist can help to determine when sex is safe.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H15\">",
"     <span class=\"h2\">",
"      Sexual problems",
"     </span>",
"     &nbsp;&mdash;&nbsp;Sexual problems after a heart attack are common, occurring in one-half to three-quarters of patients. Both men and women may have less sex or feel less satisfied with sexual activity after heart attack. A variety of factors may contribute, including side effects of drugs (such as beta blockers), depression, and fears about triggering a new heart attack or dying. Since sexual activity is a type of physical activity, exercise testing can be used to determine if you are at risk of heart problems related to sex.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H16\">",
"     <span class=\"h3\">",
"      Treatment for men",
"     </span>",
"     &nbsp;&mdash;&nbsp;For many men with erectile dysfunction, medications such as sildenafil (brand name: Viagra), tadalafil (brand name: Cialis) or vardenafil (brand name: Levitra) are highly effective. If used appropriately, these drugs appear to be well tolerated and safe, even after a heart attack. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?28/33/29205?source=see_link\">",
"      \"Patient information: Sexual problems in men (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     There is one important exception: none of the medications for erectile dysfunction should be used if you take nitrates (such as nitroglycerin or isosorbide) on a regular basis or even occasionally for chest pain. This combination of medications can cause a life-threatening drop in blood pressure.",
"    </p>",
"    <p>",
"     Thus, if you develop chest pain after taking Viagra, Cialis or Levitra, you should not take nitrates. Instead, you should call for emergency medical services (available in the United States and Canada by calling 911).",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H17\">",
"     <span class=\"h3\">",
"      Treatment for women",
"     </span>",
"     &nbsp;&mdash;&nbsp;Unfortunately, medications for erectile dysfunction are not usually helpful for women who develop sexual problems after a heart attack. Other treatments are available for women. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?12/4/12357?source=see_link\">",
"      \"Patient information: Sexual problems in women (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H18\">",
"     <span class=\"h1\">",
"      FOLLOW-UP CARE AFTER HEART ATTACK",
"     </span>",
"    </p>",
"    <p>",
"     Following your healthcare provider's advice and participating in a cardiac rehabilitation program are the best ways to recover from a heart attack. In addition, it is important to schedule and attend periodic visits with your internal medicine provider",
"     <span class=\"nowrap\">",
"      and/or",
"     </span>",
"     cardiac specialist (cardiologist).",
"    </p>",
"    <p>",
"     Follow-up care is very important; people who have had one heart attack have a significantly increased risk of more cardiac events, including chest pain, another heart attack, heart failure, and an increased risk of dying. The risk of these problems can be reduced by following recommendations for rehabilitation, follow up visits, and treatments. Over time, the treatment plan may change as your heart health improves or other medical problems develop.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H19\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H1804633887\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H112838943\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?9/53/10068?source=see_link\">",
"      Patient information: Heart attack (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?37/6/37987?source=see_link\">",
"      Patient information: Heart attack recovery (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?16/20/16706?source=see_link\">",
"      Patient information: Sex as you get older (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H112838958\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?39/16/40195?source=see_link\">",
"      Patient information: Heart attack (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?39/54/40803?source=see_link\">",
"      Patient information: Aspirin and cardiovascular disease (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?31/1/31766?source=see_link\">",
"      Patient information: Angina treatment &mdash; medical therapy (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?6/4/6212?source=see_link\">",
"      Patient information: High cholesterol and lipids (hyperlipidemia) (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?27/62/28642?source=see_link\">",
"      Patient information: Diet and health (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?19/13/19670?source=see_link\">",
"      Patient information: Quitting smoking (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?36/32/37380?source=see_link\">",
"      Patient information: High blood pressure treatment in adults (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?40/1/40980?source=see_link\">",
"      Patient information: Preventing complications in diabetes mellitus (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?21/24/21894?source=see_link\">",
"      Patient information: Depression treatment options for adults (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?28/33/29205?source=see_link\">",
"      Patient information: Sexual problems in men (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?12/4/12357?source=see_link\">",
"      Patient information: Sexual problems in women (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H20\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/18/17705?source=see_link\">",
"      Cardiac rehabilitation: Exercise training and secondary prevention of coronary heart disease in older adults",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/43/31417?source=see_link\">",
"      Components of cardiac rehabilitation and exercise prescription",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/41/13977?source=see_link\">",
"      Efficacy of cardiac rehabilitation in patients with coronary heart disease",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/38/3687?source=see_link\">",
"      Exercise assessment and measurement of exercise capacity in patients with coronary heart disease",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/38/7783?source=see_link\">",
"      Rehabilitation after cardiac transplantation",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/60/40906?source=see_link\">",
"      Secondary prevention of cardiovascular disease",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/15/8442?source=see_link\">",
"      Sexual activity in patients with heart disease",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/healthtopics.html\">",
"      www.nlm.nih.gov/medlineplus/healthtopics.html",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Heart, Lung, and Blood Institute",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nhlbi.nih.gov/\">",
"      www.nhlbi.nih.gov",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       American Heart Association",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.americanheart.org/\">",
"      www.americanheart.org",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"UTD.htm?11/52/12100/abstract/1-3\">",
"      1-3",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 20, 2012.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"UTD.htm?11/52/12100?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12100/abstract/1\">",
"      Ades PA. Cardiac rehabilitation and secondary prevention of coronary heart disease. N Engl J Med 2001; 345:892.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12100/abstract/2\">",
"      Balady GJ, Williams MA, Ades PA, et al. Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Prevention, and Nutrition, Physical Activity, and Metabolism; and the American Association of Cardiovascular and Pulmonary Rehabilitation. Circulation 2007; 115:2675.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12100/abstract/3\">",
"      Wenger NK. Current status of cardiac rehabilitation. J Am Coll Cardiol 2008; 51:1619.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f11_52_12100=[""].join("\n");
var outline_f11_52_12100=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           HEART ATTACK OVERVIEW",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           CARE AT HOME AFTER A HEART ATTACK",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H5\">",
"           CARDIAC REHABILITATION AFTER HEART ATTACK",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H14\">",
"           WHEN IS SEX SAFE?",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H18\">",
"           FOLLOW-UP CARE AFTER HEART ATTACK",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H19\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f11_52_12101="Commotio cordis";
var content_f11_52_12101=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Commotio cordis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/52/12101/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/52/12101/contributors\">",
"     Mark S Link, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/52/12101/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/52/12101/contributors\">",
"     Peter J Zimetbaum, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/52/12101/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/52/12101/contributors\">",
"     Brian C Downey, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?11/52/12101/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 11, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H4609674\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Commotio cordis, which translates from a Latin origin as \"agitation of the heart\", is defined as the combination of ventricular fibrillation and sudden cardiac death secondary to relatively innocent chest wall impact. As one of the more common causes of sudden cardiac death in young athletes (along with hypertrophic cardiomyopathy and congenital anomalies of the coronary arteries), commotio cordis has received significant media attention because of the increased awareness of sudden cardiac death that occurs during sports [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12101/abstract/1-6\">",
"     1-6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The epidemiology, potential mechanisms, treatment, and primary prevention of commotio cordis will be discussed here. Other common causes of sudden cardiac death are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/55/890?source=see_link\">",
"     \"Overview of sudden cardiac arrest and sudden cardiac death\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/36/13898?source=see_link\">",
"     \"Risk of sudden cardiac death in athletes\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/12/15559?source=see_link\">",
"     \"Sudden cardiac arrest in the absence of apparent structural heart disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/3/22586?source=see_link&amp;anchor=H9#H9\">",
"     \"Ventricular arrhythmias and sudden cardiac arrest in hypertrophic cardiomyopathy\", section on 'Sudden cardiac death'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16873458\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reports of sudden cardiac death following chest trauma have appeared in the medical literature since the 1700s [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12101/abstract/7\">",
"     7",
"    </a>",
"    ]. However, the exact incidence of commotio cordis remains unknown, mostly due to a lack of systematic reporting of cases. In the mid-1990s, the National Commotio Cordis Registry was established in the United States as a means of collecting data systematically on cases of commotio cordis.",
"   </p>",
"   <p>",
"    Since the National Commotio Cordis Registry was established, data on over 200 confirmed cases of commotio cordis have been published [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12101/abstract/3,8\">",
"     3,8",
"    </a>",
"    ]. Some notable findings from the registry include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Young persons are most commonly affected (mean age of registry cases was 15 years); only nine percent of reported cases occurred in someone older than 25 years of age.",
"     </li>",
"     <li>",
"      95 percent of reported cases have been in males.",
"     </li>",
"     <li>",
"      75 percent of cases have occurred during athletics (50 percent during competitive sports, 25 percent during recreational sports).",
"     </li>",
"     <li>",
"      Most cases have been reported in sports with blunt projectiles (eg, baseball, lacrosse, hockey)",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      more physical contact (eg, football, hockey).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    While the National Commotio Cordis Registry receives reports of cases primarily from the US, 60 cases from outside the US have been reported to the registry [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12101/abstract/9\">",
"     9",
"    </a>",
"    ]. Patient demographics and survival between victims in the US and outside the US were fairly similar, though non-US victims were somewhat older (mean 19 versus 15 years of age), and a significantly greater number of non-US cases occurred during soccer (20 percent versus 3 percent of US cases).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16873792\">",
"    <span class=\"h1\">",
"     MECHANISM",
"    </span>",
"    &nbsp;&mdash;&nbsp;Despite its traumatic appearance, sudden death due to commotio cordis appears to be a primary electrical event, with ventricular fibrillation (VF) occurring immediately upon chest wall impact [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12101/abstract/8,10\">",
"     8,10",
"    </a>",
"    ]. In experimental models, several critical variables appear to influence the likelihood of commotio cordis occurring, including the timing of impact during the cardiac cycle, location of impact, and perhaps the velocity of impact (",
"    <a class=\"graphic graphic_figure graphicRef52268 \" href=\"UTD.htm?6/24/6536\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Timing of impact &ndash; The most important variable in the development of VF in cases of commotio cordis appears to be the timing of blunt chest trauma within the cardiac cycle. Only impacts occurring during a 20 to 40 millisecond window on the upslope of the T-wave (early ventricular repolarization) will cause VF (",
"      <a class=\"graphic graphic_figure graphicRef64133 \" href=\"UTD.htm?26/24/27023\">",
"       figure 2",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?11/52/12101/abstract/2,10\">",
"       2,10",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Location of impact &ndash; Only impacts occurring directly over the cardiac silhouette result in VF [",
"      <a class=\"abstract\" href=\"UTD.htm?11/52/12101/abstract/11\">",
"       11",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Velocity of impact &ndash; While there is no defined force of chest trauma which results in commotio cordis, the velocity of the projectile at impact appears to be important. As projectile velocity increases up to 40 miles per hour (mph), the incidence of VF increases to 70 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?11/52/12101/abstract/12\">",
"       12",
"      </a>",
"      ]. However, at impact velocities greater than 40 mph, the probability of VF decreases, while the frequency of structural damage including myocardial rupture and cardiac contusion increases.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Increased dispersion of ventricular repolarization caused by the blow appears to underlie VF in commotio cordis [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12101/abstract/13\">",
"     13",
"    </a>",
"    ]. The ATP-sensitive potassium channel is likely activated by the chest blow and contributes to the development of VF [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12101/abstract/14\">",
"     14",
"    </a>",
"    ]. Conversely, stretch-activated calcium channels and the autonomic nervous system are not involved [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12101/abstract/15,16\">",
"     15,16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4609681\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS, DIAGNOSIS, AND OUTCOMES",
"    </span>",
"    &nbsp;&mdash;&nbsp;While commotio cordis has been reported from a large variety of blunt chest blows, the most common scenario leading to commotio cordis occurs in sports in which a hard dense object becomes a projectile, such as baseball, lacrosse and hockey. Smaller spherical objects are more likely to induce ventricular arrhythmias than larger spheres and non-spherical objects [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12101/abstract/17\">",
"     17",
"    </a>",
"    ]. Commotio cordis is almost never caused by pneumatic objects such as soccer balls and tennis balls. Of the victims who were participating in competitive sports, approximately one-third suffered commotio cordis despite wearing the standard chest protection for that sport [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12101/abstract/18\">",
"     18",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H4609695\">",
"     'Prevention'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The diagnosis of commotio cordis is presumptively made based upon the clinical scenario (ie, blunt chest trauma followed by collapse), available electrocardiographic data demonstrating ventricular fibrillation, and the absence of structural heart damage on imaging studies (ie, echocardiogram, computed tomography of the chest) or autopsy. Evidence of ventricular fibrillation at the time of insult is often not available and is not necessary to make the presumptive diagnosis, but supports the diagnosis if documented.",
"   </p>",
"   <p>",
"    While blunt chest trauma is required as the trigger for ventricular arrhythmias in victims of commotio cordis, any structural damage to the body from this trauma is confined to the chest wall. This is an important point in distinguishing sudden cardiac death due to commotio cordis from more severe trauma, which may lead to a cardiac contusion or myocardial rupture, both of which are associated with high rates of death. (See",
"    <a class=\"local\" href=\"#H16873792\">",
"     'Mechanism'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/39/34426?source=see_link&amp;anchor=H18#H18\">",
"     \"Initial evaluation and management of blunt thoracic trauma in adults\", section on 'Cardiac injury'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Commotio cordis appears to be a primary electrical event, with ventricular fibrillation (VF) being the initial documented arrhythmia in most victims. Survival in commotio cordis remains poor, with a reported survival of only 25 percent in all patients in the National Commotio Cordis Registry [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12101/abstract/3\">",
"     3",
"    </a>",
"    ]. However, over time survival appears to be improving, with registry data showing improvements in survival from 10 percent (for reported cases between 1970 and 1993) to 58 percent (for cases reported between 2006 and 2012) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12101/abstract/19\">",
"     19",
"    </a>",
"    ]. These improvements in survival are presumably due to earlier activation of emergency medical services and earlier defibrillation, often by lay bystanders using an automated external defibrillator. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/39/25208?source=see_link\">",
"     \"Automated external defibrillators\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Following the identification of sudden cardiac arrest, the management of persons with commotio cordis follows the standard basic and advanced life support algorithms. Management should include chest compressions with early defibrillation, as indicated. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/25/36248?source=see_link\">",
"     \"Basic life support (BLS) in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/43/7864?source=see_link\">",
"     \"Basic life support in infants and children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/33/13850?source=see_link\">",
"     \"Advanced cardiac life support (ACLS) in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/16/20746?source=see_link\">",
"     \"Guidelines for pediatric advanced life support\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4609695\">",
"    <span class=\"h1\">",
"     PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because of its reported occurrence in a vast array of situations, there is no universal means available to prevent commotio cordis. However, due to its association with sports involving hard, dense projectiles",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    physical contact, one means of preventing commotio cordis is to avoid involvement in higher-risk (in relative terms) activities. For participants who choose to continue with activities where commotio cordis is seen more frequently, a combination of safety measures including coaching and protective equipment may decrease the associated risks [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12101/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Coaching measures should encourage athletes to turn away from oncoming projectiles (ie, baseballs, lacrosse balls) whenever possible to avoid contact to the chest.",
"     </li>",
"     <li>",
"      Softer and less dense balls should be used whenever possible without changing the nature of the game. As an example, age-appropriate safety baseballs have been shown to decrease the risk of commotio cordis (",
"      <a class=\"graphic graphic_figure graphicRef61105 \" href=\"UTD.htm?26/49/27421\">",
"       figure 3",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?11/52/12101/abstract/10,20\">",
"       10,20",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Surprising, commercially available chest wall protectors have not been shown to effectively prevent commotio cordis, both in the clinical arena and in laboratory animal studies [",
"      <a class=\"abstract\" href=\"UTD.htm?11/52/12101/abstract/3,18,21,22\">",
"       3,18,21,22",
"      </a>",
"      ]. Many of the commotio cordis victims reported to the National Commotio Cordis Registry were wearing protective equipment at the time of their event [",
"      <a class=\"abstract\" href=\"UTD.htm?11/52/12101/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4609703\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Commotio cordis, defined as sudden cardiac death secondary to ventricular fibrillation as a result of relatively innocent chest wall impact, is one of the more common causes of sudden cardiac death in young athletes. (See",
"      <a class=\"local\" href=\"#H4609674\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      While commotio cordis has been reported from a large variety of blunt chest blows, the most common scenario leading to commotio cordis occurs in sports in which a hard dense object becomes a projectile, such as baseball, lacrosse and hockey. (See",
"      <a class=\"local\" href=\"#H4609681\">",
"       'Clinical manifestations, diagnosis, and outcomes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The exact incidence of commotio cordis remains unknown, mostly due to a lack of systematic reporting of cases. However, since the National Commotio Cordis Registry was established, data have revealed that commotio cordis occurs more frequently in younger athletic males participating in sports involving projectiles",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      physical contact. (See",
"      <a class=\"local\" href=\"#H16873458\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Several critical variables appear to influence the likelihood of commotio cordis occurring, including the timing of impact during the cardiac cycle, location of impact, and the velocity of impact (",
"      <a class=\"graphic graphic_figure graphicRef52268 \" href=\"UTD.htm?6/24/6536\">",
"       figure 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H16873792\">",
"       'Mechanism'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of commotio cordis is presumptively made based upon the clinical scenario (ie, blunt chest trauma followed by collapse), available electrocardiographic data demonstrating ventricular fibrillation, and the absence of structural heart damage on imaging studies (ie, echocardiogram, computed tomography of the chest) or autopsy. (See",
"      <a class=\"local\" href=\"#H4609681\">",
"       'Clinical manifestations, diagnosis, and outcomes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      While blunt chest trauma is required as the trigger for ventricular arrhythmias in victims of commotio cordis, any structural damage to the body from this trauma is confined to the chest wall. This is an important point in distinguishing sudden cardiac death due to commotio cordis from more severe trauma, which may lead to a cardiac contusion or myocardial rupture. (See",
"      <a class=\"local\" href=\"#H4609681\">",
"       'Clinical manifestations, diagnosis, and outcomes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Following the identification of sudden cardiac arrest, the management of persons with commotio cordis follows the standard basic and advanced life-support algorithms. Management should include chest compressions with early defibrillation, as indicated. (See",
"      <a class=\"local\" href=\"#H4609681\">",
"       'Clinical manifestations, diagnosis, and outcomes'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/25/36248?source=see_link\">",
"       \"Basic life support (BLS) in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/43/7864?source=see_link\">",
"       \"Basic life support in infants and children\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/33/13850?source=see_link\">",
"       \"Advanced cardiac life support (ACLS) in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/16/20746?source=see_link\">",
"       \"Guidelines for pediatric advanced life support\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For participants in activities where commotio cordis is seen more frequently, a combination of safety measures including coaching and protective equipment may decrease the associated risks. (See",
"      <a class=\"local\" href=\"#H4609695\">",
"       'Prevention'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12101/abstract/1\">",
"      Maron BJ, Gohman TE, Kyle SB, et al. Clinical profile and spectrum of commotio cordis. JAMA 2002; 287:1142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12101/abstract/2\">",
"      Madias C, Maron BJ, Weinstock J, et al. Commotio cordis--sudden cardiac death with chest wall impact. J Cardiovasc Electrophysiol 2007; 18:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12101/abstract/3\">",
"      Maron BJ, Estes NA 3rd. Commotio cordis. N Engl J Med 2010; 362:917.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12101/abstract/4\">",
"      Kohl P, Nesbitt AD, Cooper PJ, Lei M. Sudden cardiac death by Commotio cordis: role of mechano-electric feedback. Cardiovasc Res 2001; 50:280.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12101/abstract/5\">",
"      Link MS, Estes NA. Athletes and arrhythmias. J Cardiovasc Electrophysiol 2010; 21:1184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12101/abstract/6\">",
"      Maron BJ. Sudden death in young athletes. N Engl J Med 2003; 349:1064.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12101/abstract/7\">",
"      Maron BJ, Doerer JJ, Haas TS, et al. Historical observation on commotio cordis. Heart Rhythm 2006; 3:605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12101/abstract/8\">",
"      Link MS. Commotio cordis: ventricular fibrillation triggered by chest impact-induced abnormalities in repolarization. Circ Arrhythm Electrophysiol 2012; 5:425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12101/abstract/9\">",
"      Maron BJ, Ahluwalia A, Haas TS, et al. Global epidemiology and demographics of commotio cordis. Heart Rhythm 2011; 8:1969.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12101/abstract/10\">",
"      Link MS, Wang PJ, Pandian NG, et al. An experimental model of sudden death due to low-energy chest-wall impact (commotio cordis). N Engl J Med 1998; 338:1805.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12101/abstract/11\">",
"      Link MS, Maron BJ, VanderBrink BA, et al. Impact directly over the cardiac silhouette is necessary to produce ventricular fibrillation in an experimental model of commotio cordis. J Am Coll Cardiol 2001; 37:649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12101/abstract/12\">",
"      Link MS, Maron BJ, Wang PJ, et al. Upper and lower limits of vulnerability to sudden arrhythmic death with chest-wall impact (commotio cordis). J Am Coll Cardiol 2003; 41:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12101/abstract/13\">",
"      Bode F, Franz MR, Wilke I, et al. Ventricular fibrillation induced by stretch pulse: implications for sudden death due to commotio cordis. J Cardiovasc Electrophysiol 2006; 17:1011.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12101/abstract/14\">",
"      Link MS, Wang PJ, VanderBrink BA, et al. Selective activation of the K(+)(ATP) channel is a mechanism by which sudden death is produced by low-energy chest-wall impact (Commotio cordis). Circulation 1999; 100:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12101/abstract/15\">",
"      Garan AR, Maron BJ, Wang PJ, et al. Role of streptomycin-sensitive stretch-activated channel in chest wall impact induced sudden death (commotio cordis). J Cardiovasc Electrophysiol 2005; 16:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12101/abstract/16\">",
"      Stout CW, Maron BJ, Vanderbrink BA, et al. Importance of the autonomic nervous system in an experimental model of commotio cordis. Med Sci Monit 2007; 13:BR11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12101/abstract/17\">",
"      Kalin J, Madias C, Alsheikh-Ali AA, Link MS. Reduced diameter spheres increases the risk of chest blow-induced ventricular fibrillation (commotio cordis). Heart Rhythm 2011; 8:1578.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12101/abstract/18\">",
"      Doerer JJ, Haas TS, Estes NA 3rd, et al. Evaluation of chest barriers for protection against sudden death due to commotio cordis. Am J Cardiol 2007; 99:857.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12101/abstract/19\">",
"      Maron BJ, Haas TS, Ahluwalia A, et al. Increasing survival rate from commotio cordis. Heart Rhythm 2013; 10:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12101/abstract/20\">",
"      Link MS, Maron BJ, Wang PJ, et al. Reduced risk of sudden death from chest wall blows (commotio cordis) with safety baseballs. Pediatrics 2002; 109:873.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12101/abstract/21\">",
"      Weinstock J, Maron BJ, Song C, et al. Failure of commercially available chest wall protectors to prevent sudden cardiac death induced by chest wall blows in an experimental model of commotio cordis. Pediatrics 2006; 117:e656.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12101/abstract/22\">",
"      Drewniak EI, Spenciner DB, Crisco JJ. Mechanical properties of chest protectors and the likelihood of ventricular fibrillation due to commotio cordis. J Appl Biomech 2007; 23:282.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 15853 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-61.234.146.186-71A5527948-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_52_12101=[""].join("\n");
var outline_f11_52_12101=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H4609703\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4609674\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16873458\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16873792\">",
"      MECHANISM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4609681\">",
"      CLINICAL MANIFESTATIONS, DIAGNOSIS, AND OUTCOMES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4609695\">",
"      PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4609703\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/15853\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/15853|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?6/24/6536\" title=\"figure 1\">",
"      Mechanisms of commotio cordis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/24/27023\" title=\"figure 2\">",
"      Action potential and ECG",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/49/27421\" title=\"figure 3\">",
"      Chest wall impact VF",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/33/13850?source=related_link\">",
"      Advanced cardiac life support (ACLS) in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/39/25208?source=related_link\">",
"      Automated external defibrillators",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/25/36248?source=related_link\">",
"      Basic life support (BLS) in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/43/7864?source=related_link\">",
"      Basic life support in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/16/20746?source=related_link\">",
"      Guidelines for pediatric advanced life support",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/39/34426?source=related_link\">",
"      Initial evaluation and management of blunt thoracic trauma in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/55/890?source=related_link\">",
"      Overview of sudden cardiac arrest and sudden cardiac death",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/36/13898?source=related_link\">",
"      Risk of sudden cardiac death in athletes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/12/15559?source=related_link\">",
"      Sudden cardiac arrest in the absence of apparent structural heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/3/22586?source=related_link\">",
"      Ventricular arrhythmias and sudden cardiac arrest in hypertrophic cardiomyopathy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_52_12102="Barretts esoph goblet cells";
var content_f11_52_12102=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F80518&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F80518&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Barrett's esophagus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 273px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Biopsy specimen of a patient with Barrett's esophagus shows intestinalized columnar epithelium with goblet cells.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     From: Lewin KJ, Appelman HD. Tumors of the esophagus and stomach. Atlas of tumor pathology (electronic fascicle), Third series, fascicle 18, 1996, Washington, DC. Armed Forces Institute of Pathology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_52_12102=[""].join("\n");
var outline_f11_52_12102=null;
var title_f11_52_12103="AIDS-related Kaposi sarcoma: Clinical manifestations and diagnosis";
var content_f11_52_12103=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   AIDS-related Kaposi sarcoma: Clinical manifestations and diagnosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/52/12103/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/52/12103/contributors\">",
"     Jerome E Groopman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/52/12103/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/52/12103/contributors\">",
"     Bruce J Dezube, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/52/12103/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/52/12103/contributors\">",
"     Michael E Ross, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?11/52/12103/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 26, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Kaposi sarcoma (KS) is a vascular tumor that is etiologically associated with human herpesvirus 8 (HHV-8), which is also known as the KS-associated herpesvirus (KSHV) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12103/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The clinical manifestations and diagnosis of AIDS-related KS will be reviewed here. The treatment of AIDS-related KS is discussed separately, as is the classic form of Kaposi sarcoma. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/37/18009?source=see_link\">",
"     \"AIDS-related Kaposi sarcoma: Staging and treatment\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"./classic-kaposi-sarcoma-clinical-features-staging-diagnosis-and-treatment?source=see_link\">",
"     \"Classic Kaposi sarcoma: Clinical features, staging, diagnosis, and treatment\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"./classic-kaposi-sarcoma-epidemiology-risk-factors-pathology-and-molecular-pathogenesis?source=see_link\">",
"     \"Classic Kaposi sarcoma: Epidemiology, risk factors, pathology, and molecular pathogenesis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY AND RISK FACTORS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H432031148\">",
"    <span class=\"h2\">",
"     Epidemiologic forms",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are four epidemiologic forms of KS, all of which have been related to infection with HHV-8. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      AIDS-related or epidemic KS &mdash; AIDS-related or epidemic KS is the most common tumor arising in HIV-infected persons. KS is considered an AIDS-defining illness in the Centers for Disease Control and Prevention (CDC) guidelines. In the United States, KS was over 20,000 times more common in persons with AIDS than in the general population prior to the widespread use of potent antiretroviral therapy (ART), although its incidence has declined substantially since that time [",
"      <a class=\"abstract\" href=\"UTD.htm?11/52/12103/abstract/2\">",
"       2",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Endemic or African &mdash; KS was endemic in all parts of equatorial Africa, particularly in sub-Saharan Africa, prior to the HIV epidemic. Since the onset of the HIV epidemic, the incidence of KS has increased dramatically in those regions [",
"      <a class=\"abstract\" href=\"UTD.htm?11/52/12103/abstract/3,4\">",
"       3,4",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Organ transplant-associated &mdash; The incidence of KS is increased after solid organ transplantation, presumably at least partially due to chronic immunosuppression. In addition, the transplant itself may transmit HHV-8 infection. The clinical presentation in this setting is similar to that of classic KS. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/23/34170?source=see_link&amp;anchor=H10#H10\">",
"       \"Development of malignancy following solid organ transplantation\", section on 'Kaposi's sarcoma'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Classic &mdash; Classic KS is an indolent cutaneous proliferative disease mainly affecting older men of Mediterranean and Jewish origin [",
"      <a class=\"abstract\" href=\"UTD.htm?11/52/12103/abstract/5,6\">",
"       5,6",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"./classic-kaposi-sarcoma-clinical-features-staging-diagnosis-and-treatment?source=see_link\">",
"       \"Classic Kaposi sarcoma: Clinical features, staging, diagnosis, and treatment\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"./classic-kaposi-sarcoma-epidemiology-risk-factors-pathology-and-molecular-pathogenesis?source=see_link\">",
"       \"Classic Kaposi sarcoma: Epidemiology, risk factors, pathology, and molecular pathogenesis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H432031377\">",
"    <span class=\"h2\">",
"     Epidemiology of AIDS-related KS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although KS has been reported among all risk groups for HIV infection, it is most common in homosexual or bisexual men. AIDS-related KS is much less common in heterosexual injection drug users, transfusion recipients, women or children, and hemophiliacs [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12103/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In patients with AIDS-related KS, the CD4 count appears to be the most important factor associated with the development of KS. In a series of 70 patients who presented with a new diagnosis of KS while on treatment with combined antiretroviral therapy (ART), the rate ratios for developing KS for patients with CD4 counts &lt;200, 200-349, and 350-499",
"    <span class=\"nowrap\">",
"     cells/mm3",
"    </span>",
"    were 18.9, 3.6, and 4.1, compared to those with &ge;500",
"    <span class=\"nowrap\">",
"     cells/mm3",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12103/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In resource rich areas, AIDS-related KS is predominantly a disease of men. In contrast, in resource poor areas such as sub-Saharan Africa, AIDS-related KS is also more frequent in males, although the difference is less pronounced.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H432033191\">",
"    <span class=\"h2\">",
"     Impact of antiretroviral therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Since the introduction of combined antiretroviral therapy (ART), the incidence of KS has declined markedly in HIV-infected patients [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12103/abstract/8-11\">",
"     8-11",
"    </a>",
"    ]. The dramatic impact of ART on the incidence of KS is illustrated by an analysis of more than 375,000 people with AIDS, in which the incidence of various cancers was analyzed [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12103/abstract/11\">",
"     11",
"    </a>",
"    ]. The standardized incidence ratio (SIR) for KS compared to the general population fell from 22,100 to 3640 with the widespread use of ART. Other large epidemiologic studies have reported a similar decrease in the incidence of KS correlating with the introduction of ART [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12103/abstract/9,12\">",
"     9,12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The declining incidence of KS cannot be attributed to a decreased incidence of HHV-8 infection. In one report, the prevalence of HHV-8 infection remained approximately constant among men in San Francisco from",
"    <span class=\"nowrap\">",
"     1978/79",
"    </span>",
"    (26.5 percent) through",
"    <span class=\"nowrap\">",
"     1984/85",
"    </span>",
"    (29.6 percent) and",
"    <span class=\"nowrap\">",
"     1995/96",
"    </span>",
"    (26.4 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12103/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Human herpesvirus-8",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is a strong relationship between the development of KS, HHV-8 infection, and HIV infection [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12103/abstract/14-16\">",
"     14-16",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/27/30138?source=see_link\">",
"     \"Virology, epidemiology, and transmission of human herpesvirus 8 infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In a study conducted in San Francisco, HHV-8 seropositivity was observed in 38 percent of 593 men who have sex with men (MSM) compared to none of 195 heterosexual men [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12103/abstract/14\">",
"     14",
"    </a>",
"    ]. Among HIV-infected patients who were infected with both HIV and HHV-8 at baseline, the 10-year probability of developing KS was approximately 50 percent. The 10-year risk was about 30 percent in HIV-infected men who were not seropositive for HHV-8 at baseline, while there were no cases of KS among the HIV-negative men. This study was conducted before the widespread use of potent combined antiretroviral therapy (ART), and the frequency of progression of HHV-8 infection to KS appears to have decreased since that time.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H432033448\">",
"    <span class=\"h2\">",
"     Steroids and infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Corticosteroid therapy has been associated with the induction of KS and the exacerbation of preexisting KS in HIV-infected persons, as well as in non-AIDS patients receiving corticosteroids for organ transplantation, autoimmune disorders, or lymphoproliferative diseases [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12103/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The association of corticosteroids with KS is important because of the frequent use of these agents in HIV-infected patients with a variety of disorders including immune thrombocytopenia (ITP) and Pneumocystis jirovecii pneumonia. In such patients, KS lesions may regress upon reduction or withdrawal of steroids [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12103/abstract/17,18\">",
"     17,18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Opportunistic infections have also been associated with the induction of KS and with the exacerbation of preexisting KS similar to that described with corticosteroid therapy. High levels of proinflammatory cytokines, which have been demonstrated in the setting of opportunistic infections, may account for these effects on KS.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H432027014\">",
"    <span class=\"h1\">",
"     CUTANEOUS KS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although KS can involve virtually any site in the body, cutaneous disease is most common and is the usual initial presentation for KS.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H865064422\">",
"    <span class=\"h2\">",
"     Clinical manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;The cutaneous lesions of KS appear most often on the lower extremities, face (especially the nose), oral mucosa, and genitalia (",
"    <a class=\"graphic graphic_picture graphicRef60346 graphicRef69357 graphicRef79726 graphicRef74359 graphicRef78116 graphicRef79283 graphicRef70919 graphicRef52327 graphicRef65310 graphicRef60162 \" href=\"UTD.htm?0/4/67\">",
"     picture 1A-J",
"    </a>",
"    ). The lesions are often elliptical and may be arranged in a linear fashion along skin tension lines; they may be symmetrically distributed. The lesions are not painful or pruritic and usually do not produce necrosis of overlying skin or underlying structures.",
"   </p>",
"   <p>",
"    The assortment of colors associated with these lesions is due to their vascularity and includes many hues of pink, red, purple, and brown. Yellow perilesional halos may occasionally be seen (",
"    <a class=\"graphic graphic_picture graphicRef79013 \" href=\"UTD.htm?15/59/16305\">",
"     picture 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Early lesions can easily be mistaken as purpura, hematomas, angiomas, dermatofibromas, or nevi. More commonly, however, KS lesions are papular, ranging in size from several millimeters to several centimeters in diameter. Less commonly, KS lesions may be plaque-like, especially on the soles of the feet and thigh, or exophytic and fungating with breakdown of overlying skin (",
"    <a class=\"graphic graphic_picture graphicRef65310 graphicRef60162 graphicRef69203 \" href=\"UTD.htm?1/35/1594\">",
"     picture 1I-K",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Lymphedema, particularly in the face, genitalia, and lower extremities may be out of proportion to the extent of the disease and may be related to both vascular obstruction by lymphadenopathy and the cytokines involved in the pathogenesis of KS.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H865064605\">",
"    <span class=\"h2\">",
"     Differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;A presumptive diagnosis of cutaneous KS can often be made by a trained observer. However, early lesions can easily be mistaken as purpura, hematomas, angiomas, dermatofibromas, or nevi.",
"   </p>",
"   <p>",
"    Bacillary angiomatosis is the most important alternative in the differential diagnosis. Bacillary angiomatosis is caused by Bartonella species, a slow-growing, fastidious, gram-negative bacillus, and is readily treated with antibiotic therapy. Skin lesions of bacillary angiomatosis usually appear as numerous small red to purple papules that may gradually expand into large pedunculated lesions or nodules that may become friable. The rash may be associated with symptoms such as fever, chills, malaise, headache, and anorexia. Biopsy is especially important for atypical lesions that are associated with systemic symptoms or appear or progress rapidly, in order to rule out bacillary angiomatosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/2/18469?source=see_link\">",
"     \"Diagnosis, treatment, and prevention of Bartonella infections in HIV-infected patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/63/8182?source=see_link\">",
"     \"Epidemiology and clinical manifestations of Bartonella infections in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    KS and bacillary angiomatosis can occur simultaneously in the same patient. Furthermore, bacillary angiomatosis lesions can be associated with neovascularization and solid areas of spindle cells that mimic KS. The diagnosis of bacillary angiomatosis is established by the identified of the causative organisms with Warthin-Starry silver staining.",
"   </p>",
"   <p>",
"    Less commonly, KS can be mimicked by extrapulmonary Pneumocystis jirovecii, even in the absence of coexisting lung infection [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12103/abstract/19\">",
"     19",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/8/22665?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of Pneumocystis pneumonia in non-HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H865064994\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although a presumptive diagnosis of KS can often be made based upon the characteristic appearance of the lesions, this should be confirmed by a biopsy whenever possible. Biopsy is especially important for atypical lesions that are associated with systemic symptoms or appear or progress rapidly, in order to rule out bacillary angiomatosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H865065094\">",
"    <span class=\"h2\">",
"     Pathology",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are three histologic features that are characteristic of KS, both in cutaneous and visceral sites: angiogenesis, inflammation, and proliferation. The lesions generally show two major abnormalities: whorls of spindle-shaped cells with leukocytic infiltration and neovascularization with aberrant proliferation of small vessels.",
"   </p>",
"   <p>",
"    These small vessels lack a basement membrane and display leaky behavior with microhemorrhages and hemosiderin deposition [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12103/abstract/20\">",
"     20",
"    </a>",
"    ]. As the disease progresses, it evolves from patches to plaques, and then to a nodular form. The characteristic histologic pattern of KS does not differ among the affected epidemiologic groups.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H865064429\">",
"    <span class=\"h1\">",
"     VISCERAL DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;KS involvement has been observed in almost all visceral sites, including lymph nodes, liver, pancreas, heart, the testes, bone marrow, bone, and skeletal muscle [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12103/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. The most frequent sites of noncutaneous disease are the oral cavity, gastrointestinal tract, and respiratory system. However, visceral involvement as the initial manifestation of KS is relatively uncommon. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H432027021\">",
"    <span class=\"h2\">",
"     Oral cavity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Involvement of the oral cavity occurs in about one-third of patients with KS and is the initial site in about 15 percent. The dental practitioner is often the first to identify these lesions (",
"    <a class=\"graphic graphic_picture graphicRef61561 graphicRef50835 \" href=\"UTD.htm?31/62/32744\">",
"     picture 3A-B",
"    </a>",
"    ). The diagnosis of KS should be confirmed by biopsy whenever possible.",
"   </p>",
"   <p>",
"    The intraoral site most commonly affected is the palate followed by the gingiva [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12103/abstract/23\">",
"     23",
"    </a>",
"    ]. Intraoral lesions may become easily traumatized during normal chewing, which can result in pain, bleeding, ulceration, or secondary infection. If lesions are advanced, they may interfere with nutrition and speech.",
"   </p>",
"   <p>",
"    The presence or absence of symptoms from oral lesions is often a major factor in treatment decisions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H432027028\">",
"    <span class=\"h2\">",
"     Gastrointestinal tract",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prior to the widespread introduction of ART, the gastrointestinal tract was involved in approximately 40 percent of patients with KS at initial diagnosis and in up to 80 percent at autopsy.",
"   </p>",
"   <p>",
"    Gastrointestinal involvement can occur in the absence of cutaneous disease. Gastrointestinal lesions may be asymptomatic or may cause weight loss, abdominal pain, nausea and vomiting, upper or lower gastrointestinal bleeding, malabsorption, intestinal obstruction,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    diarrhea [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12103/abstract/24,25\">",
"     24,25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Gastrointestinal KS lesions are easily recognized by the endoscopist (",
"    <a class=\"graphic graphic_picture graphicRef87392 \" href=\"UTD.htm?32/62/33761\">",
"     picture 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12103/abstract/26\">",
"     26",
"    </a>",
"    ]. They are typically hemorrhagic nodules that can be either isolated or confluent and may occur in any portion of the gastrointestinal tract (",
"    <a class=\"graphic graphic_picture graphicRef59519 \" href=\"UTD.htm?28/31/29169\">",
"     picture 5",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12103/abstract/21\">",
"     21",
"    </a>",
"    ]. The diagnosis of KS should be confirmed by biopsy whenever possible, although biopsies may not demonstrate KS because the lesions tend to be submucosal. High grade lesions are more likely to be associated with invasion and dissemination.",
"   </p>",
"   <p>",
"    Treatment is usually dictated by the presence or absence of symptoms. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/37/18009?source=see_link\">",
"     \"AIDS-related Kaposi sarcoma: Staging and treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H432027035\">",
"    <span class=\"h2\">",
"     Respiratory system",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulmonary involvement is common in AIDS-related KS. The clinical manifestations, diagnosis, and management of pulmonary complications are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/7/21623?source=see_link\">",
"     \"Pulmonary involvement in AIDS-related Kaposi sarcoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Affected patients can present with shortness of breath, fever, cough, hemoptysis, or chest pain, or pulmonary involvement may be an asymptomatic finding first observed on chest x-ray. Radiographic findings are variable and can include nodular, interstitial",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    alveolar infiltrates, pleural effusion, hilar",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    mediastinal adenopathy, or even an isolated nodule.",
"   </p>",
"   <p>",
"    The KS lesions have a characteristic appearance of cherry-red, slightly raised lesions seen at bronchoscopy, which can result in a presumptive diagnosis of pulmonary KS. Although bronchoscopic and radiographic findings correlate quite well, patients who have KS documented by bronchoscopy may on occasion have normal chest x-rays.",
"   </p>",
"   <p>",
"    Treatment decisions are usually guided by the presence of respiratory symptoms, the extent of radiographic and bronchoscopic disease, and exclusion of a concomitant pulmonary infection as the cause of the clinical findings. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/7/21623?source=see_link&amp;anchor=H19#H19\">",
"     \"Pulmonary involvement in AIDS-related Kaposi sarcoma\", section on 'Treatment'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/37/18009?source=see_link\">",
"     \"AIDS-related Kaposi sarcoma: Staging and treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"./kaposi-sarcoma-the-basics?source=see_link\">",
"       \"Patient information: Kaposi sarcoma (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H432031937\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      AIDS-related Kaposi sarcoma (KS) is a vascular tumor associated with infection by the human herpesvirus-8, which is characterized by angiogenesis, inflammation, and cellular proliferation. KS is the most common tumor arising in HIV-infected persons. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Human herpesvirus-8'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/36/27206?source=see_link\">",
"       \"HIV infection and malignancy: Epidemiology and pathogenesis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/31/30202?source=see_link\">",
"       \"HIV infection and malignancy: Management considerations\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The incidence of KS rose dramatically with the onset of the AIDS epidemic. However, the introduction and widespread use of potent combination antiretroviral therapy (ART) led to a marked decline in the incidence of KS. AIDS-related KS is seen predominantly among homosexual men rather than in other HIV-infected groups (IV drug users, women, transfusion recipients). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology and risk factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      KS typically presents with cutaneous disease (",
"      <a class=\"graphic graphic_picture graphicRef60346 graphicRef69357 graphicRef79726 graphicRef74359 graphicRef78116 graphicRef79283 graphicRef70919 graphicRef52327 graphicRef65310 graphicRef60162 \" href=\"UTD.htm?0/4/67\">",
"       picture 1A-J",
"      </a>",
"      and",
"      <a class=\"graphic graphic_picture graphicRef79013 \" href=\"UTD.htm?15/59/16305\">",
"       picture 2",
"      </a>",
"      and",
"      <a class=\"graphic graphic_picture graphicRef69203 \" href=\"UTD.htm?38/46/39648\">",
"       picture 1K",
"      </a>",
"      ). Although the diagnosis can often be made based upon the characteristic appearance of the cutaneous lesions, this should be confirmed with a biopsy whenever possible. A biopsy is particularly important in cases with atypical features. (See",
"      <a class=\"local\" href=\"#H865064605\">",
"       'Differential diagnosis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H865064994\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      KS can also involve a wide range of visceral organs, including particularly the oral cavity, gastrointestinal tract, and lungs. Visceral involvement is typically a later manifestation of disease, and is unusual as an isolated site for the initial presentation. (See",
"      <a class=\"local\" href=\"#H865064429\">",
"       'Visceral disease'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12103/abstract/1\">",
"      Moore PS, Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. N Engl J Med 1995; 332:1181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12103/abstract/2\">",
"      Beral V, Peterman TA, Berkelman RL, Jaffe HW. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet 1990; 335:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12103/abstract/3\">",
"      Stefan DC, Stones DK, Wainwright L, Newton R. Kaposi sarcoma in South African children. Pediatr Blood Cancer 2011; 56:392.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12103/abstract/4\">",
"      Senba M, Buziba N, Mori N, et al. Increased prevalence of Kaposis sarcoma-associated herpesvirus in the Kaposis sarcoma-endemic area of western Kenya in 1981-2000. Acta Virol 2011; 55:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12103/abstract/5\">",
"      Iscovich J, Boffetta P, Winkelmann R, et al. Classic Kaposi's sarcoma in Jews living in Israel, 1961-1989: a population-based incidence study. AIDS 1998; 12:2067.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12103/abstract/6\">",
"      Fenig E, Brenner B, Rakowsky E, et al. Classic Kaposi sarcoma: experience at Rabin Medical Center in Israel. Am J Clin Oncol 1998; 21:498.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12103/abstract/7\">",
"      Lodi S, Guiguet M, Costagliola D, et al. Kaposi sarcoma incidence and survival among HIV-infected homosexual men after HIV seroconversion. J Natl Cancer Inst 2010; 102:784.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12103/abstract/8\">",
"      Ledergerber B, Telenti A, Egger M. Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: prospective cohort study. Swiss HIV Cohort Study. BMJ 1999; 319:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12103/abstract/9\">",
"      International Collaboration on HIV and Cancer. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst 2000; 92:1823.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12103/abstract/10\">",
"      Mocroft A, Kirk O, Clumeck N, et al. The changing pattern of Kaposi sarcoma in patients with HIV, 1994-2003: the EuroSIDA Study. Cancer 2004; 100:2644.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12103/abstract/11\">",
"      Engels EA, Pfeiffer RM, Goedert JJ, et al. Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS 2006; 20:1645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12103/abstract/12\">",
"      Eltom MA, Jemal A, Mbulaiteye SM, et al. Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998. J Natl Cancer Inst 2002; 94:1204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12103/abstract/13\">",
"      Osmond DH, Buchbinder S, Cheng A, et al. Prevalence of Kaposi sarcoma-associated herpesvirus infection in homosexual men at beginning of and during the HIV epidemic. JAMA 2002; 287:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12103/abstract/14\">",
"      Martin JN, Ganem DE, Osmond DH, et al. Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med 1998; 338:948.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12103/abstract/15\">",
"      Rezza G, Andreoni M, Dorrucci M, et al. Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome-related diseases. J Natl Cancer Inst 1999; 91:1468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12103/abstract/16\">",
"      Sitas F, Carrara H, Beral V, et al. Antibodies against human herpesvirus 8 in black South African patients with cancer. N Engl J Med 1999; 340:1863.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12103/abstract/17\">",
"      Trattner A, Hodak E, David M, Sandbank M. The appearance of Kaposi sarcoma during corticosteroid therapy. Cancer 1993; 72:1779.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12103/abstract/18\">",
"      Gill PS, Loureiro C, Bernstein-Singer M, et al. Clinical effect of glucocorticoids on Kaposi sarcoma related to the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1989; 110:937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12103/abstract/19\">",
"      Litwin MA, Williams CM. Cutaneous Pneumocystis carinii infection mimicking Kaposi sarcoma. Ann Intern Med 1992; 117:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12103/abstract/20\">",
"      Mitsuyasu RT. Clinical variants and staging of Kaposi's sarcoma. Semin Oncol 1987; 14:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12103/abstract/21\">",
"      Ioachim HL, Adsay V, Giancotti FR, et al. Kaposi's sarcoma of internal organs. A multiparameter study of 86 cases. Cancer 1995; 75:1376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12103/abstract/22\">",
"      Caponetti G, Dezube BJ, Restrepo CS, Pantanowitz L. Kaposi sarcoma of the musculoskeletal system: a review of 66 patients. Cancer 2007; 109:1040.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12103/abstract/23\">",
"      Nichols CM, Flaitz CM, Hicks MJ. Treating Kaposi's lesions in the HIV-infected patient. J Am Dent Assoc 1993; 124:78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12103/abstract/24\">",
"      Danzig JB, Brandt LJ, Reinus JF, Klein RS. Gastrointestinal malignancy in patients with AIDS. Am J Gastroenterol 1991; 86:715.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12103/abstract/25\">",
"      Laine L, Amerian J, Rarick M, et al. The response of symptomatic gastrointestinal Kaposi's sarcoma to chemotherapy: a prospective evaluation using an endoscopic method of disease quantification. Am J Gastroenterol 1990; 85:959.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12103/abstract/26\">",
"      Friedman SL, Wright TL, Altman DF. Gastrointestinal Kaposi's sarcoma in patients with acquired immunodeficiency syndrome. Endoscopic and autopsy findings. Gastroenterology 1985; 89:102.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8033 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-61.234.146.186-B09A38F648-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_52_12103=[""].join("\n");
var outline_f11_52_12103=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H432031937\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY AND RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H432031148\">",
"      Epidemiologic forms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H432031377\">",
"      Epidemiology of AIDS-related KS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H432033191\">",
"      Impact of antiretroviral therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Human herpesvirus-8",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H432033448\">",
"      Steroids and infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H432027014\">",
"      CUTANEOUS KS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H865064422\">",
"      Clinical manifestations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H865064605\">",
"      Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H865064994\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H865065094\">",
"      Pathology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H865064429\">",
"      VISCERAL DISEASE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H432027021\">",
"      Oral cavity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H432027028\">",
"      Gastrointestinal tract",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H432027035\">",
"      Respiratory system",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H432031937\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/8033\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/8033|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?0/53/852\" title=\"picture 1A\">",
"      AIDS-related Kaposis sarcoma - nose",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?12/59/13237\" title=\"picture 1B\">",
"      AIDS-related Kaposis sarcoma - face",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?30/32/31238\" title=\"picture 1C\">",
"      AIDS-related Kaposis sarcoma - plaque",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?23/35/24113\" title=\"picture 1D\">",
"      AIDS-related Kaposis sarcoma - multiple plaques",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?29/20/30018\" title=\"picture 1E\">",
"      Erythematous leg lesion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?23/21/23894\" title=\"picture 1F\">",
"      KS erythematous papules",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?23/62/24548\" title=\"picture 1G\">",
"      AIDS-related Kaposis sarcoma - papules on leg",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?41/23/42354\" title=\"picture 1H\">",
"      AIDS-related Kaposis sarcoma - penis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?33/20/34114\" title=\"picture 1I\">",
"      AIDS-related Kaposis sarcoma - sole of foot",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?10/61/11220\" title=\"picture 1J\">",
"      AIDS-related Kaposis sarcoma - ulcerating",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?38/46/39648\" title=\"picture 1K\">",
"      KS plaque like lesion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?15/59/16305\" title=\"picture 2\">",
"      KS yellow perilesional halo",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?18/16/18693\" title=\"picture 3A\">",
"      AIDS-related Kaposis sarcoma - gingiva",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?38/44/39617\" title=\"picture 3B\">",
"      AIDS-related Kaposis sarcoma - palate",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?32/62/33761\" title=\"picture 4\">",
"      Kaposi sarcoma of gastric mucosa",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?28/31/29169\" title=\"picture 5\">",
"      KS involvement of colon",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/37/18009?source=related_link\">",
"      AIDS-related Kaposi sarcoma: Staging and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"./classic-kaposi-sarcoma-clinical-features-staging-diagnosis-and-treatment?source=related_link\">",
"      Classic Kaposi sarcoma: Clinical features, staging, diagnosis, and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"./classic-kaposi-sarcoma-epidemiology-risk-factors-pathology-and-molecular-pathogenesis?source=related_link\">",
"      Classic Kaposi sarcoma: Epidemiology, risk factors, pathology, and molecular pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/23/34170?source=related_link\">",
"      Development of malignancy following solid organ transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/2/18469?source=related_link\">",
"      Diagnosis, treatment, and prevention of Bartonella infections in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/63/8182?source=related_link\">",
"      Epidemiology and clinical manifestations of Bartonella infections in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/8/22665?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of Pneumocystis pneumonia in non-HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/36/27206?source=related_link\">",
"      HIV infection and malignancy: Epidemiology and pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/31/30202?source=related_link\">",
"      HIV infection and malignancy: Management considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"./kaposi-sarcoma-the-basics?source=related_link\">",
"      Patient information: Kaposi sarcoma (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/7/21623?source=related_link\">",
"      Pulmonary involvement in AIDS-related Kaposi sarcoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/27/30138?source=related_link\">",
"      Virology, epidemiology, and transmission of human herpesvirus 8 infection",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_52_12104="Measles lesions on face";
var content_f11_52_12104=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F61958%7EDERM%2F73806&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F61958%7EDERM%2F73806&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Measles",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Numerous erythematous macules are present on the face and trunk.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Measles",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAF6AfgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5z0+5Il4KCLP3CCc066WRTmQBhn7u7P4VJAJo9p8pVB+Xp2NVpQVkZA6hTwT3H41uBJbtJGyFWZXHQ56iukjhK7Ejli3Mu7aAcjP1rlmRwMfeZeMZwcetbFtdbo0WaJWYLgSAYOfrRIqL1LD2/wC/YLO8gUZLEY/Kug0TzJE2oi5B43dGHvWSZkUm48tY8gLtBzz61o6XMFcb32bhwegzWEjoikdHpoJ3oYw7tkDngH2qRI3hLjzF3lfmXHPpkVR0WYyJIsfDhzt7mrMVwBK6llaRRln7is2zaJPE+IpI9xWNunPWrEJVlZl+Q7vL2Hrj1rLeWZ41dotkbDeChzmn/bIzGjiMqq4BbPU9zU3HfU2VYRyqgIBwdoqRckggjFZkVxu+Z3JXsfSrW4sm4EgdjUFJlxWCtyORzgnINPEhPfOOTVRZGJG//gPvTndm+cdB29aRtHUsMxaPdngdj1phdgQQoyfSos7mOAeOvvUgG5OOO31qTZaEse7aABz6n0q7AoKg/KvOM9aqwxMhG7O4jHWrqZXK4xgDkjqapNDlboXFQL8hZS/ucCo2Yh2UHK5zknkioy/r1HUnvS+YqbGQEY4Io3M+Vk25QCeh7epqjd3IVQe/pVtwfvbwCKoXduZCMgke1BpGK6iQ3mZGDEA5GRVr7TleQBzjFULe1SNSADnOdx5xV5VBPz4UZ644NUXyoJHDP8wOMVHjy8gcEc49RUhjQRlgxxnFKzBxgsXK8YXjigdittjWKRmID59PWhI0G1nXAIxjP3vepdpLktgg9BUijauFX5vcdKdxiwKqqDj5geasgFdrMBnqaIUBA5JJ4yBUywgglmLbR+tIhjYIgFUjBYcmp0TB2oeScnIojXy1BfBzyTSSP8235gOzZ68VSFa4sThXZCVIPOfWnsCMZZVFVd7DAKBWJAxU6NhGKAFRwS1JilBJaEhjVk+UYA9D+tMKbWIGCAvJNG8qAoDHB6jvSkkn7oJ6YNSZvQfwQoJByO3YVXmjC8kLg5AX1qxI/wDsBc8cVUlBLsQc4H8XagnUqTFgc849azptzZ2jjHrV9wdnVQPf1pixNjLgHHIOKZaRmOhJGQCfYU0WjMSNuMc5xWwypHkhSPfFK0W5AxLMx6VSYGOsHOV3EnuRin/Z1UYxyeorTcEBWySBwR2FROSGwQNvqBTTDlMxoDztAHbr0qCWHGcjkda1HQsDt4H86glh6Fsg+lFyXEynQHHAJxUJj2ZwDn1rSkgAbOMGqLNjIJJHbNBlKPYrSgkglfxqkyeW+M5Ga0m3be7D6VUeMquODnnHelYjVMI7gBwJDx7dqvxlOq4PrisKVWjZhjKd/arWnXq4EbkZJwrU2jSnNKWp0dq4I56A1v6dErGMkc54rnbdGBRsDByc5rasLoLkMT7cUJWZ6Cd46HcC8WK3C4VFwBtz39cVSu9VZYpEj+VyfvY6isy51BI4VU8tjgnqazLy7DdOT04Naykzl9npdmN441b7PpU8qn95jA57145b232mQSSAtk8/Wu/8YQzXkYjTJAO7A5z7VgWFhJHgeWQvr701K0b9Tz6y55+Rs+GfDiswd9kajnJbGK6G6eO3GyFsqOhrn0t7jYdzuFI4ANRzTXUSKhBYYwCKi5Wq2Ld/cZAwRzyc+lYNxfyXNwsNooaNOrkcsajvWmZfKJ+R+Cx/hFdJo9rpEMUaR3K5xznqWreKdvdOeWr1HeHVlF0qycb1INFWEuLSK9UxvlEPrRWVpdS00tjyKS+MyqoRRGn90802NtpZo4m2Z6vjFXrG1jDMBGGY9GYdanurcMFknTMQJXIHB4re5z8rMSUMAh7sMZ61cs4g7Luk2c5QZ6n0q2sUSzrIYyyjAIHYepNQlEum3xYj2N8yA5/Gk3caVjTkWF5jEHLRKBuLDBz6U54/Omh8skqrZIaorJXQFo5OF5O7nJq4CpVURyZQM4A6k1lJs6IeZpWTmDlZnV2fZlTgAe9WbmZ4PlTypmSTO/1BHH1FUIkcRKvmPvzllbuahuztnYgbc4z2yazfY26XNoX7R22Qqs4B4Xopp0If7GpVyQPmcv696zItjxSBW+VSDgnIc1OJyRvWJtwIy7N19selTJJAWopJESQkFQ3btj19qv2NwVjjEkm/jK4FUXuVuEMcKkhhgYXoD3pbeJQhVy3XAIPGPas2UjX3hSN3IA456VbiljZSpK7mXjac1kQsIgS7ksflwe49qvhgscZSNlwfToKk0i7FtVLYG7AJ6etXbWNFfOcjsKqQvlsjbtHPWrYZccbskc470GibLhKKCyqR3PfFMPPALNnnB4zSR/PMCOpH3WORUjAqm4ctjgDigtEGMNnOSOcdqkbduBYjjpiiFM8nneOfUGmDIkBYMyY4B4xTsbIsIowXJJGentQW3dj9aULkEnhT04qeJVTClSC3FMUikQR8uee47mpW5jVdxY4+76VM8Slm+UghsA+vvSfdILDB9e5pj3GOoEQRl5x2p8YBIwQQBniiRDszyAx49AKdCDswiggD72atajEjVGYZTHNTrHuUnHI96TJC/wAO1f4u9SIDKRjhPbtU2Bj7U7iABtwOPapwpQ8j5TRGrRZ2sCO4I600SxAFiTkc5oZk1d3HNGpbpyB+dQ/ZW4ZidueBU7yHbubnI4xxSFmY/Nlc9OOMUiouxAwZX3EBnHQgdaeqZIcqPUCnBvnwvT1qQKdhAHAGBmqE2+pE6oE56f1pQ/oOvVjT2iYR4PAPoakW3CAlicAZOalkS2KZR853BlHIphVZATjaevXkVcwGB2n5R3xUTofMG44I6YpCWpnMob75JA6jHNC4DfKMHtk8VZkhZjl2BP60xrQbmBTjjJAyaaNkkwBCZL/MPrUT3KKMLHj/AHulSiPBI8tl549qjniAJ5Y8Z55psShdkDKrockEjkemaZt6fxewpxSUruZeP9njNHltGGYZwfXtRct07DHWPLH7rDoDUTKHzgcDnrUqHHzMMk9880oYgHcAM+vWi5LgZ12di1neU8rklhtz0rZkEcu9SB9aiEQUABQMDsaRHIZnlKFIAOR71XliOMAfU1sMinjbhf5mq0yjkA5A7U07GcqZjzQbl4xj+dZssBjk8xFwR2HPPvXRvGAM7QaqvAD0ANUpGMoEdhquI0iuS21cDdjtW7byrMWEUwYA8Z/rXNSW4BPH6VEY9pBUup9QcVd0wjUnA7FrqZ9izPnAwB6VUubzazYznPasFL26QYWUsMY+YUxrtwQJU+U/xLxStzbFSxLa2NOZvPDMzAe3f8KGhjSL5mQYGetYn2lySiqdvqT8351ErsrE5bB4OeauMV1OZze5sC5iSMqG4PftVS6nQqNhwCOB6VRwzKQeFpoXJBAyQOMUcpPM2RThGJzt98VXG0nI6+1WJIwWxg5x0piW7sRwQ1F7Ba4+zhLMPn60Vs2FioX94fm60UczYKmjzqe/Ijy08cgbjAXlfpWb55UErI7em7vV6Sb7KELtIFcY5QfMabc3TuBuJJH+x2rc5G7jop1lhcs0gDcEbsDNV7Hb9phUER4ySxPTHb3p1qfPXymcnechQMA0yJcjy43CtuOSR8ox707CubVnKZEDKAo64A7/AOFWrSTyZQ6P+8Zjkj+VY1uyGZUlYlmU8h9uKt2qIixAOqMhOGU5JHpWco9TaMjpFZSreZhZP4Sq5AqC8TdHnejnjnHI9aj89FjQu3yH8waj+0wzBkRvnJwAOmPWsLanS2rECMilU3HBc7gOgHrW5EYpFCxRISOh9fwrCjt98QPmAuMgGrFrKsCc7/NPAbvn1ptXRCdjTtGESSsSSwfbkdNvcVoxr+5VSu5ickHtWJYv5zSuWClRlkP8Va5n2rHukySMZ6Y4rGRrBksZCvGFIYrlsjGB7VZknMUHmNh1B5xWbM4LM0agMT0HQD6+tTRyBovmlXKjHtUM2SRtwyL5SsCCc9hg/SrNuSzHcMN3/wBmsyynaSAMQCOmRVqE5HzZTnueopGisaEUiqxck46Z9a0YiXwfMAB7e1Y8YDMqw5EWcnNaNs6goGUHI4pou1kX0gR3dlOAvY0xot7ABeg696sJtkUbz0P0pNwYHbgHPfj8KGQpsiC8kMDu7jtU5BUHftIP93rSBiwGAc9cGlZ/MIyhJPp2ouVzXIXYhcNnOO3aoHI4fOc44NTyqB86sfQ7qrSHjGTgnsOgqjSBNGjFdpbIB6+lWI5G2kcbBwMAZqmuCyjcOhx7/WrCYjQEHIA6+tWmaMdcwlQHTBJHr1pY2KxjdkHvipAFGAOQe2ehpHwqnDFmz8opi3HRuTgk/KDu608rlvu4XqDSR8qBjnGOR19amC7t3dV5qWS1YanzKC/zDB4p5UkHscfdzmkk3OGVRhDyDToScgKpOD0PakJjhHn5uPY1PtxgSHGeTgdaY24xg5VVBwKTzGZgGcHH3aLkO5MxBKlSduP7vFMI4yTxnB74oD4XY5JJ9OAKQyBF2qAQTgkjP40ibMXYv94gfe6cUyUAv2J9Pb1qTcWTOTtHBH96mECT7gK5FBSQwxgMG69sVDIY06jLnmrflNsOMk+vfNVZYXBACtuxgk9aaNIrzKb3G7+fSkA+QNzx71bFuoQKACcdSM4qOWMrt+ZAfYdabNkkVijZGQMHknPSopQigruYHtipgvyYY4HfjOag2/IxIOR39qRVhqMu3gAjPJxyKrzxrJnBz6epp0j+Xkg7lPYCp7cAxBg2Xz/DRcTXKVI4ZFQccD070x4wwXKFfWtVTkcAcdh601oQ24KcEHo1BBjTI38AIA4wf50xoSw52jHbua05UQZHJprwKRjGOhyKAauYzqdpwo47etRsgHA5rWkgAUljjNQ/ZwUyACPakzKUUZTpjGBnFV5YAVPIyK05I9vByAaieIYOetJMydK5jG0fn5iM1DNBJwockDpW2YTwxGB6VF5QOcjHoarmM3SMdIWz8yfMKkih54wR3Bq+8HKsN2e4pjQYXjJbrinzMiVIqi36sRnjOAajNuSoZSNx6AdvargjK/O0e3tRJDjpkegFPmZnyFJgCw3BcDjg/NVuytQ+HAPJ7inrbK2C2Dnuev41o2kAU4ClQKa1GojLmLy4DnsO/Wiq+sXB3DLhlxjIoq02itTy5BcO20wQhUH8bVCq3BlAO1lydqhs4HpWrMJZV2MFA7kHmljUyBYxGAyDGQOT9a25zz3TMaSOV5j5MbLgc8cL701QwhVPl4JQhh8ufWtiSAxiQoxDsMYPemPasNjLtCgdxT53YPZlCVGICBNoBGcDt9atFAXAtlYRxnlHGCP/AK9WGiU25Hmncego8plUM3J459ahzuVGmTCVWYRswUDBPoBUdxAM5GQpOFbHepbdAcnYQX/iqR0POVkwowBWdzVptajEaSGAhX3EcE44Iq1bSiW4iEeNkYyQBwTUEjlFIK4kYcAUWkMqIjqcA8e2e9DtYnVaIv2rKbrzmlCrgjKjOT9K1kjDRmREBYncWdc5/CqlvE0LRpIpjfIKuO/0q6N3mP5dwCNxJycEVjI2gRTxptCxgOZP4CMYNWoEzGYpiruuBwBgCsueUSND5gkHz9cVpQwy3A8uBSiA4ZyOSKhmqkX4dyYEK5jBPQ8VOFUSDcWLsMHuKgRZmPlgBY8che5FXbZEjDeWGJJAYkc/Sg0iyVnCAKxOMZ4FXLbPlJyMsBwBzVZIRvJfdn+EVatYwijYec0jfmiX42ZAzhtynkFj0qUMGUbsHPLE9vpVZWX7pIc+h7fWp/lBGGA2jnPr6CgyZKrjA3En0pGVQT5eQPQHFOUrjB5UdVH86Rihk+f/AICRQCICjSHaSCAOmeoprx7EwNwq2uFGRjb9Khn3AqVPOedw6+wpo0hPUgYAdCAv8qtWiq0YycAnC8VGBuOGUKRzz0qxBtAIf5vp/Sruayk7CIpZzkbe5Ipd2SAV5xge9TMwEbKTx3xUSqPMAXDf7XalzEqXccZADsdWC9cg9M9qs/LIw52g9iPSq0cbRtvbBUnnmpmkwdy4UHg5ovcJMk2t94ADHr61LGhUEhwWYc47e1RrOMAx/LjqW705JMjKDAHemTdkjwhx5Yzt4PNNWJVyD90fdz2qaNiu8HOMc5pqqXJLEBV7etISbZIY1IKsuW68VEU+TzCV9CB296sx5JZyduR1pzrvb5cHrlqY00nqU4VIRdpPBzmp4024HAAHFSqoViABtI5pIzGWKDAB7+lA3rsKTkEjOO9RqMv0A/uk96sxptUkjOemaiWLiQ849ewoDYjACgksTj0FVJojNnKrj06Vdfcg2qAcd6gUMhYynII6U0aRdtSiLTLcFhkc471DPCUDBVILcfNWzEinc2SWYYJqjebI4mGTk9OMmmWp3djmZlZ58FgFOVC46mtC2jKInGMCmQwnz8hO3U561f8AJAGVOTgGpLk9CF4j9/d16Yo7ELjPXJ61YTgHK49DSlAoLbQM9fpQtTNFF18z5cDB7ioWUq6rk8evFaBiRhhWXrk/SoWhUbsZwenpQy0UA2flYbgDUiQh2OxSp6gY6094QuGGAD1IpYwUyCPx9alsma7Fa5tSWCnJK1VltiGGVGO/Nam8FFyPzFRsoYsozk8daRn6mcIQVOMHHaoJrXJIY4PFaZiKyADGDkVFIQhB2jriglFEQEJlh361XaNeoIz27ZrTJyN23j1zVW4UM3Geec09QkiqwAUj7vbFQtHnZwcdc9M1M8YOSSAPT1pE+6ATwOh9KcWc0o2YyKPa244IJ4Bq28qxweYAN+Oh7VVZgrFcgjsfeqWpXQSMIvJrVaE6FG/l3u2doXPQUVmXEqu5waK3hG61Iclcy5ELEK5Y5OQeKbKk0eGiY5HBJGM1pWUAWJHbaMcY71M8P2jhE3ds9AKw5iOTTUzIIExvlJZhxkmpngEis6AhU6HvViC1aB8sSxXpjtSztsZx0VgDg96Oa5LRmQQ7mdQPmPPPepwj+W0bBtxPpwKuR6cWt/NACyZyCT2p67/vBSzocZHQ0XGkrFe3Rwu0sEeMc7v6VLLu8tgi7t6nkZ4+tSWbCYXEZVhLJwAKbcO6E27bfMDbiVz+VIGrlCeI21sLhnIBHIIww+lGmSJMqqm4Q5yWHJ/KrV5bS3ZSJ5lYEZ2f3far8WlwWkIiUtkAEgU7qxmt7kkjoiIwLOqDKknOKc5hlC+XLvYtukCDBUUqQqHiW3Yl5DgKTwfr6U9rNi8jyFBIvG4cBfb3rJs1RVvJvtE0VuGk2jnjHFXra4mt/wB03D44zx+NV7SM2zsw8tmYZ3Dr+FSlXuriOJtijGSM/Mfqai5S03L1vMTNsX5z/eHT3rQtohsLgENz8xPBP0qtYwLGCqAlCeSOM4q0pAJ24BJxgnpQaIsxyyRkFtrHqMVdhlUAlwu885xVOKUggOg9ARVmPymVyAAegGc/jQWTLJvHIIHbAxTlmC7cqGYHoarhAB8zKcDsOlLtOwKHDBuue1BcUi+JIyoDvt65ND7d4JOSOlV44xtO7G4HAI7VIsbISeW75pg0idAyquV4PcGopWy4yCNpPHrSFnO4hW5PTPSkIJ285fpwM4oHHR3GzB9ikdM5JznIp6SKqlT8xPbHOPWm+UwUjIznoKcvIOQ3TGKLmqkmWIzuJ3blYnsM5qy77V2cKPTHWq0DOEUFSWboQaWRjIOo3D9KGZvV6D0lUtnPA6HGM08yMU4wWJ9Kgi37RuOQvApwBKswwueD6imi0SwhnkUnaQDjbir0GNzE464IxxVDLYVThQeCR1q9Ay44G7bwDjqaoUiVY28zkE5744NWBEVYgD5sY4qu0xiBLbifpwKjS6ZzuWNi3tUrchJsuEGSRQ7nb04/lTpXEWCeDjk0yFXJVjySPpTpGUoyN97H1xVFFYOHyDk85IqS3IB+Q4IxwaaUZFDRk8cn6U+FJXJMYAGcbj6U9zXSxbjYOSQeB0GKFQuEyCMdqnAVVJB/+tUSupJXcFVuN2eaRn1IJ7bLMVb8PWpYQWjKCHlepPNTiJjIpIIQdO26nsoY4OarZBzaWKk0R2fKcY4J96wNVEgK5fnf8o7V0kzEKwJCjPB9ay7pUMwG3PPYZyf6UWLhIht4cxoJMbzkkCkmTy1zywzhfarsBwuWwQT1A6Go5HAYr6jhsdaHqVq2VAFdMA9OcnvVcoxOGUAE44arm35Cqgsx4OR+tJFG6n5sDp2qGrFfCV2AERAAyKieRXi2gBc8ZqeRdzkhzuJ4A4FQTLgkDC88g96ARWUH5umzuPSomRi5YE/TrVto2x+6UBj70ySGQAZO1e4FFirIpNjHzIc+9N6JkFT7d6tNAGYFuh9+RVJxIrsFwVz6c0rDSHKxPc4zgH+dJKAw4AzTkRVO8bm5xkChoht+V2xjByOtO1zOSSKzRuOE4PYnkGq0+QPmOCPSrZyjIScKDgjNVpsAMNp688dadiWVQy4DEc479qrTyeXFkNyasSOqYBzjGRWRqMqiEqOWHQU0ctRkN1eBWwSMj0PFZV1clnbJJX0zVa5kJZi5x9arpueMt1yea6Ix01ORz1sJK5JAU980VFPlFAHLnoBRVXG/Q6EWDB0C9O+Tmraxs5aOOJFb+6DyMUxLl9hViuG5yByDUsMrht0YDORwScGuTmKT6CSwkBPJYHaOSRgj1qmwyzu0Yb5RjJ6VpeeGVSEbdnlSOtMMYcyPyrNgbO1F7EFRbV1w6hQdvKtyKqPGwIUxyMvOdh7mtZ4gQR5nG3p2FVXtyp+VjkjqDS5hpGbO0oIxGUK9GrQsImjHmOokaQbjinEB0VdwYg4wakt1MIDRknb94H0oUrlOJLIgdvMNuoZOQg6/jTCN6l3CocY5P8qtk9TkrkdRVXahkJKgHuy8j60myOUbFbBIAyMUbHJJ+bFQTozDy97Hc3OBmrSqWBERSQ9wRzTWSeTjCY7BTgGpuUkQLJEvzCU4xhRjHPtV23j8suCBuZegPQeuaW3gRGBEStjjgZxV3ZIygFFWPpg4oNESxbGjQEt0yAtDhARhQzAfdz/OiESFD8wwcKT/AIVa8pUG9hnPfuKCiJJHAIUMXxjH+FWbY7nypbeAPk6ce1EbBhkg47FanSBcKQSzHvnn/wDVTGmWYdqoTIg3D7ozzj1z3p5jDMBHyOvIxmkjAUglFZcYxnkGphIQwVMADPDUh3CNSQVL4PY46UjFiVPLD+JqFYbcM2Qx6IM0SlwBggID949RQO9yMEqM7jgHvxmpmlZzgphe2OMe9MRgzbjjCnk9jRhnzJgZPAyeFFBRN5q+ZkkqCOaFf5zsckNx04BqIcKEGDnkkCnqyN0XAxzt70CuTREdSSQpPPbNQXNxHGQDIisTwpPNIrnfggsOwWszVNJh1G4hkeR0khOfl/lQrdRXfQ2kZG2jJP06U6JQ7c5Cg/ezioUQLCPmxjgdgKHm3MsUeSD3NO5rFlmNgF2lhu6Vat2YqePlRuPX3qmpBTaAA4OORVm1YIUV/ujOFHequN7F65VJPuk4PcmoY1IBKnDZ2jHpUgbMap8uwklfpTCWPzKwx/WlbUhN7ItGQhdoBLHj2qXOwhV++RhlpoG75uNu3BAojUDbvOCvHriqYMmZFMe2QncfagbVdYhnAII9DShthwG3FqZLuidSBx69cUDRaeIsrMPl46VBHGqvlI2z2J6UrTERMrcgHqD1FSM237qjAAHFNAtCYu2zaTzjJ96hlclQFflevvUjRkNhyCAfl9jTiPLY70UjHPrTsNMqZQRtu4U5+UjNUnQqAWGBjHHWtF2DKOSFxgZHNVH2CQdc/wC0OBTNIOwiKCF25UY/CklUSAIcAAZ4qfZ5rcNsXgnHenmEcjhsClcfOtyksTRkupPHQnpTjgoCwO7HHvVg4Tov4dagJ3bhgY7VDJ5ru5WeE78jAOMYNUJ4iclXxg8gVq8kE5DY6ZqtLCd20oVyMnA6j2oNIu2pTtElLfvBgA9RzV8pGyhWPUYC+9SQIN21VK4Gam+zor+fjJ9fT6UGc566GM8ZV3CqAE6561XMAY4PG4E/lWvIgaQk5DtxuPeoriNY1yfu4wNvehMvnMwxYCgHIY4Ge1JIm4MiqF4wCfX1q60EfytkEgdKr3LHcCy/IvpTTsQ5NmVLGQ+WALFecdzVWUuOc7SOlXXbaWCYcY+Zj6VTlGSu3JHPbr7VW4mzPnYEEdR0rLniLlwDuxgir12p8xm6D2qKGLcSTnB4wKm7TOapucze2u7cXjPr7VUhgfLIiny+vPY9xXUy2hkVhIOB780+PTVa3XAzjkL610Rq9GYOjfU5iS32lfKUtnv6UV1I0zoV6DqKKmTi2dMbpWsVyFCALljnjPBpssRwCvLDpzVKO53FMyHA4B71oxEEgJ856knqPauZnMtiaOPMCqxIx+lDoHkXGCBwSetSR7WQBmA74A4qWJeSG+ufaixaiis0Sgrhce46fjUMoByMqB1rU8ogE44PtVaSIMDkDA9qTQWsUivyDAT6rT1hxGoOTnr705kIcLgbB3HapAB1LEqMHOKEO1wIURrlQNvAqIxIH3Hlc9M4xVgIGJLe/wBaY6rwSMd9v9KCSBAnmtlsN0yO9WQMEscAL0wMVAygzZGM7R14pyRzJGVZsDr65pMSRZhIEeUOQTz61LGUK7ivzdwaovuQKVCZ6ZBqSJXZyfNG7rgDIpFJlrccrgBR1x2qwuwNndx6npVeKAg53MWJ71YiXZHjnI/DNUilcmimLNhdqr90gDg1bt12lhIQqgfICevv71WXauCFBI5yMU7asiqFXkdCf6GmMthpNwc/OPXHtT5JAg8zzQC3GNveoopCwyR06nuMU9FQgMFDSnklhzSKuSrMcqS6qcY+WlmZWB2jIPSq7yqHWQxr7kHv9KQyAvuQk+o/woAkQcZYEcdO1Sxn5T1xjO3/AOtUQlC42+mMnvULTKWwecdPWkNFncGLDkHOMU9WUthtuAOSKqhkMnzMQPYU9HSQMAcEnkKMZpjsTM2PuMB6U7OEPOCRzgVGRnhTlcck9qYFydhGc8k5pDSFRizFATxzn29altgZmbooB4PqKYkbb1CDaQD+PtVxI90flkDnlcCmXdCRtKmSSQe2B2q1EHaD5kwV6tnkVAoVl2qPmX14qWFQiHbk5HSgXMSyHAUKG5bluwFTQuvMEi4wck+1RsM7S4x32g9KeiALkthwfxNUgTSJ/ObZsT72eBjpTlkLrjGBnnnrUcahuf8AVnpn+lTwQbDhR757VVwvEsiJTgqWBHcfyqRwGUAEZ/ix1H1psUbCP5WLc5wKQFCNpAL9cHtQTcbHESd29cdh3PtVuJEGV4z13dKgaPY33fmPQmonklacKH4z/kU0NXZdEgRWG4O3XOKZtLMTjf8A3jnH5URkFwzk4xkgU+RtyAEBWHPHai49nqMfcq8bSvTpyaqhx8yvynUDHQ1pJgqhIHr6YqrcxrI/Azzkk8flTuOD1ZCkueEXHt3qzFyr7l2kjoTzTUtssiY4IOe2adImyIbOABt4HIqRuxEVAwORzzUSxruO0jAJ696spGGztB55z3obaBkDJA6npSsK9iF4+ADtAH5VDGDK6gnOCVJqw3y8DkkjIFIlu6AKg+QknB6mmO42KIF9xRWIOOO9TnyynyEbAemeQaUxlEGAMHnPpSHAAB3BmHpSMmyk6Az7ivJPPtSTRKQdwxk5+XtirrLgEEZPQHFQT8Jk7iVFAuZmZIoIcMNx6jFZtzwSHxwO1arkOoYEAjgE8YqjOoZ2Gctjk44NWlY1iY0saNGQR0Oc+oqKUryVK4BzgVdmhwiydWHGPWsidjl0fC98AUA1fYqTxkH174qOD5zkHB/lU8nzxgg4I4HuKbAjbsEA8dSOlR1M3HqyK4BAYAdOc1LbSYxyenU8Yqd8hAAR164qHG1hkg5JqkCRchxI4wFAzn8BRUFuUVlYnlTwBRVolnEx3aOS2OfetOCXgD5XJ9BisCzUnkgj0rZsoWypK9O/pWMtGZxV0aVuxYqNu1QeTWrFFlTuOAelUrePAGc5HpWpbqQuGG4DtTRaRI67gNy4wMD3xVSSIsuVGB3BrVhHlAZVTkHAZcjmo3jCgE9AOhoYmY7xZBIJz6elQdxkcCtN4wAx6t71RfG8ep5NSSNKHkZBY8fWoJMnPqKs7skgj3pWRQuSMqOMZ5oaCxWEWCH+83pS7ehGcnrk1LsKnCdPejbnb3P5VLEkROVVeASO3tRFPnjoPUcA1JPCdpIOM9cDNRKrE7MBl9aCooteYjOVQ7fYn+RqzG+wZJDP6E9P8apKuQAYyWH+eKkVpR8pbGOzjkUyrls+WQWRQcjG3uKdHIFO0NsOOM81XMRG1m2liOozmnxglWAVc9ck9KYi00yhMHcJP71ThnxuZw23BIPUe9Z4dmGzAZh1pTI6EF8AgcD1FIpI0GZGJZT83YdBUKhg3JXeep9DVeO4BR2KkxjoCOnvTWC5+WQnPO31pAXPMaNm3DcF7AZB+lRyXEflZTIkbIK7cbfxpiSFVAZTgf54pjSAgxqxznp6UDT1JYJjv4+9t6E9qkSQeWXQ4A4PuarpIFbduIwMdKnkA8sMQpPUn1qix8ZQlTJnn7wqcEbicjBHPt6VQRivzuWIb06VKsvmMB0znOO9A+Uuq6hQM/OO471OMgAj5gevrVAlwsbD7pOMAc1ZtmIwzN8p7nqKEh8uhd2fK2c7hz+FTwAeUDnkdfaq0b7ovMCfN3OecelTIy78uuQR27UjNqxZklwpLqCR94Ht71CJf34KBsg5BHOfrSSk4XBzk8ii3Qw3DSIApIOGIyBx6VS3NIWtqaCzM4D5y7ckY61JBI7MdynA5xntUUCgkMPlbGQPw60ZdGcfdYD5hn17/SmQ7Nl5HChm+bd2GO1Em0KuU7c884qK3kLxfMSDnAPf6VYThQGA355IHJFBIsbqUG5cEdAeeKrOWRmEm1snrjGB2qwFZmZgp2npmldC6PlAcZ2561SKiySFSrR52/Mc7h2q95Q3LuIA67vU/SqERIAZvlK8Adc1fgYsm/gccgevrT3FN3GeXtPVVHJOecn2qFkV5QoPGO/GKertyVA3v94Z4/CnRsmPLWNlPB9aLCi9AB8uVIyGCDuetOlVjuJYkDgY6UO4XcSmdvABNNkKsyBjgsPlKnPH+NPlHZ7ka9doO0g4INEqM8eAN3OBjuKdJGGddg3KT8hJ+b6Gp/LVEjaRSGIyQB0pNWHJ2KscRY5dS390dMVKkTO+PuqBxk/nVmMAZBJWMdCR0qNxtlyCdpHBI9KRLlzMaybpcImOgCt/OmujYXeoA24PrnNRrcM5VSSWB5FK8ymTa6kp35p2FZkEjLFIWDEg9BjpSbM/MMEHk1PIN+CMOCORiog+DtQLxxz/ABU7C2My8EYR8Lt28EAVjOrKEGfUAjjmtW+jCndnZuJPc1SlYnfwQMckdKGjRNlVwjIUJC46NnOaycMZSSFHHGDWhdN5ZCMWB6DPTNVwFd8gjn9Kl3Q9UUZYxHjCZLZ5pqp8vPDH71aMykDcoOAOMVSnBKEk5PXPrUsNyjIxBIxmoGf5ufw9qRWcjdJgYPApSNw5pXE9A83aTg9aKqzHYpIxnNFVexlcoW2m4OCm4Dv6Vs2tkfLHHyjpV+MwocKFK5GRj+da1k1nlV2YJOSfSnGnd6sSnYz4LBynKgMMZIq9FbFXG7JUZH3a1gqMEdSuOhz+lSsF8t2z904IPQVThYHMzvs4VQXJOeg7Cq1xBywB6dutbWzMWGbIY8AVQvIvLTbGrHPKsD3/AK0cugk7swplAXoazp0AbOBn1rVYEDcdxXOD9aoXCgnp0/Ksmi7FVeuc4BFOB4wSSMZJNIUCsenPUelBducjjpSYMkQ7hlsAjtUb8SADkUsKt5ah8EdTj9KlOQctgHsKGriRIoG0c4PemEAyHIZQOAacpyTu5+gpxQFTtB9eaLARBiGB2qcc8Hmjzw0m2RTvznJHFTLGiKNyKc8Z71CUBIyWxnAx2osAgdoy2N2T0ppnb5QwVgf0qRV+Yb8nb0J9aR5ihIK7iec4/SgCNZljcDBOTyQasSbXOOR3Oagl2ursUUFscY5Ap0cWFULIfrnilqNOxLHt+8rMG6EL6e9IzYABhPIJODzSpKnTA3jhsnr7UyVzgkEgg/doHuEc2du/n+6R0X61O0gblgcd9o61W82NiRjbjuOhqeMuzbQAVx1HQUFWtqIrbXAiDlf9oZzU5jYMQSCvXGen4U1UaMxgkhvvcVIytIQ7OFLcADrTFchlG4ZUbV7DBz9aWAbpgxyCBkduakEbHGGLY4AHrVi2gIRhIR97JJ5I9qRopaDpEcYBKuT781LABEzCUkIo7jg0irgkR/PkYB9BUuPNG1gWBGM9qaBT6FiEkhQWA3DIHtVhQ29c8r1+lVYQ6rtdgKurICCoO09welBDY2JP3hkkckMflGelTkhmYKQSO+OtM+XftYgKeRx09qWA4O5cAHqPWgZbgdwoBwOcA4p5BaUBwH9WA6/jVfLCZWQFdp7npT4xlflxn0BqiS3ECJMAEYH6U4SBXVtxZD1PQj2pkZUYbg564qBkZJmKYA4x7UDWpellCjzGOWHbGcCpUJm2EHPOQwqGI+ZGOcg5yT0qaJI1jZkj2sFyCuTVxFsTsjbg29jxyw7GpwCVyXGWOeuMD8KqK2+Ib+Ce4NSQsqEx/eH94DkUxNXLEh8oI5wQTnHcUwxu7koTgjoaQ4cvvBVMjaMVIJf3aMuASCASPXtQJaEeG8wb23ORkEdeO1Q2ySrIzscnrnOD+VWGAON4KgDJ2nBzUigPJgTAED7tMrmZDFKY5GZwCpOFDdvpV4FZY9+PlJ4BHX6VWkXdIxOAUHK0hBiiJYZAUHHTA9aCXqTPKSxlXBZeqgcGmszTLIPvDH0Jqk9z12g7f7wHanxylTvLglvzoDlcdSN1C87TyMYA5pAfMnC7fmXnntntU1zMrqDHtz0zmopSUG4jcxOc4oHzEm4x5DDaqnB+tU5f4wBzjjjqaN5+YOxwfvHHQVFcSoxXcCoHB2nkD2qkNIqXTB3QjAZRgjPpUAiEgeQ9B2NL1kkZlKhidoPOPep0Q7D1K/dwRUMJNrYyryIsu/G8oAuKpKADsJ2lc4GB1rVuWjiGcMQxIx61ljIuCSVZSMDjpUyKTbVhZcH5CxPGSMYrPnztKEgE9R7VaBEqq8iAFuMj2qi2A5B5GeDUlxVihOgDYI471GwHyqmee3er3ktPPFAmBJI4QE9ASetLcw2EGsNDJLO1pGdjyADduHBIHpmpM5sx72JoJmguEZJkOCrDBB96Kn1i0ktNSuYJHMjxvjce47GipZlY5WPxVCcqxYY7nrXQaZrkUwVkcEfXNcdc2VvIR5aA5PStLQPDFzfyhbIMj9R6Ae9babIx9+O56FYXu/yzvbA/KtWK+Z3LD7voRxmvPEnm0rUmsL5kMqYAZDlW+hrqrG6DxKpHXkE0czWhrFpo6GO7AU7zuA4AH9aqz3AYE7hleOOMVWWTDcDn0HQ1VnkK8gYA5we1PmGkQyPjkliM4GarDABCnp696inuWZ88FT19qRH3dCBkZ6VN7lNgy5c8AUnllhwcZ7VZRfMKkDNKY8AButS0JMhiG08D/wCvVlwJDk9R3piqF74IpwcKx4yDzTArsrEEbmG7tUkDYUADP8K59alGC2c8nt6U6KI5YMMjoOxqRjHT5cqcVWkRo2z1Ge9XJYmGCD83oKbjzm+ccdCB2qkkIYr7FUMCU6Kx7Ux2+RlIHPQ+1CsURg2Qpbbj0ppViNwYhQfmX0pMVyAMuDGTx2NIxMTgMwwRwadjLfMAMcioWbCksdyP+lSWiZmLcSbcn04NEjFcKwB4xjFMhG9cKQR0J9KVFbpzlux60DHRwqXDJgjvU8bbRtGVPv3qIQyhtqtsTup71Kg+b998vOABTC9iwvzEeZkv0BB7VIisCobpn86iZVYfe+fkhR2qRJUYAMN7AYoIHIivI3zNnrgetWAsibtsp3Y21Eqhslk27TjANPw2CqyEnHfpQVcfCSJF9unOKlRthYDJ3NnnsKiQE5AG1sAjvVm2hSVdruEPYnpQtQuS8MxHHr16UPKAodmJHrjGafJbW8CsTcKWYAAe9Vsq21nfEZPbpTaaHF3J45S0bFTmQndgVYRwACcjIwQDVGSNfPKWpLsenanI0kSEEZHQGjbc1tc2gwcllIzjOPanw/u48g8E9BVCB2IAYgso5+lW1baAcAZHSi5k1Ym3s64Bxg52kVKpXOSuVbj3qFZDu54UfdPrTwyyN90jHOc0XCxagAQEMAAOAP8AGrUWIYgSc89VrMgfEwyCWPzbeuBV2G4jRyo69u+atCaLDglAcAg8ADrVZY5Rc7x0PVScVZeRUfrgnhR6U2ZXIYuwLDoTzTuCdizKxO1XC7hgkH/EUyUksm0gYzubNRM4SLy1AfocjvTMhYmJy3tjt70xbks0hkjMxUsyjHzdx7UxJBGCUZiDyOeabPK5XaCqd1wKrZw/vnGff2pplxNQphBIpOPc/nVeYqGPLDIx1yDVSS6zt80MQgw2TgUz7TvbaY2VcYB6CgORlkrGsWSBvPcZyariTzMeUc4GMkVFO4TbuBOOjdBTEnYEqij3wKCnHQvITICoyMegpCzOrHBYDoajiOScrlh3HapYxtAD8kDHGcUGL0IHkbGCOMHOe9ROEdmVcHoxbPCirXlKwfzEHy9j1qM2ocBUXJX5sEYzTTGplTIaTYmWxxvIx8uOtMkYxxOqN8545PTNTxxsizzsTyeo7AdqzpHeS4LMFBAIBx1zRYe7KhmVm8pjwMjnqRWfIwMTnf8AMMbFH161NqHmBpYwczNyWPUVUi/ec8KoXBI7n1pNdGbJIkEhTcrEE4z7VVyCQxHAOSPehmXzASpCsMADufWmltspHJAHp096ydwkyJzI06tGT5m4bAvUntiuhlgunmM1zpekfbwcs8lwFO71K5xmsW1xHdQTbwArht23OMHOas6jHo895NIuqsplcuM27NjPJ/Cpsc8ldmNqpmN3cG6lR7jeTIyHcC3sRRUFwkMdzMlvKJYgflkC7dw9cdqKQJEPh/w1Ld5kZQFAyWP8I9a3dX1iz0DTDBYkqzcO3cn0+lJr+vJa27QWo8uEAjA715vcyS6lcZdiVHIWtV7uiM3zT3M7V724vLk3MfylWyMfWuy8Mat9qtUBHzCs7+w/LtQzOgkYZC7u1Z2niTTdTKYwrdOePwolrvuZqLi9Nj0bzgYzu/8AHeKiu5yYvl2kYxz1FV7ebzVUg5OOaWZRsJ7k8iovodEXYy7q5KZXoN3JqJJ3MihSeTzVPWSYs85B7elVtIuRLIVBOQamzaJcjsrRsxgt09quTMMIABwetUtPyU5bp2rTETdW647elWUkUJJHbcB+JFQS7gOPSrc8Rjk3gfLgj/DNVGyxUkc4xzSZpYs2x2x4IBLc5FWIzgjdyapp8vIP0FWohuQk9RTQmic52bhyCe/UVA6sjrtIJJznvToXAYqwIJBolO5Rt4TpmgmxBPGxl6ZY+/eoPLkSOPPO0YIPar0SJuzlgB/F61BOqIxVyxRuFb0oJtrYrTopxtyV9elVpFyxbIPr6Cp5yVBO4k9OBxVfd5bYzlT271LLQgXb3IIbIX1+tWo33qB35pkDK4O0cn17U1ipQFcr3x2JpAy1FI3qCR3I4pBI0kpCBcdST0FJbuDGRg7jgdcD8aWIHeuMZB3BdvWqasSxUVS7MWOV68dqVnXIfaW547UjCQAsyqATzg8E04szjIQDHB/+tSYXJVlfDGRgIs9OvNT722bGwBj8DVRFCOzPkgj7vap9odeDlCOKCtixHIVjJ7YAIHQVN5DSYAYhepIFV4ISGBJBCrjGOgqzC+R82fl7Y60IbHmE8HG7bT40Byo2564NSoo2h1Gw8nHY0yP/AFgzlvm5PtQxEjFTmXGwjgbaQQ7m6kt13UIxD7n52nhR6VOu2IB3zsPTnrmjUu45GAIHGQMHipcFZF24YsM8nmq5bDcZIHU4/SpBJGu8YDADk56UWGlctRuIwyk89M9eakt85JIBUDaRVNH2qTlefusB1pVfagZieKpILF+EFZGGPp7fSrEJYsHkxn8qoi4VlITJcnpnAB9KuQNtwQmSy4DdfrV2FJFoFV3OANzdAO/uabu4UAkjpycYqBWXeQvAx+VLwUKr1HPTmkRa7JSrgEI2454PSgSsGznD52hTTNwVPmIJAzS7xn7gz+vSi4IbM7F1zgBenfNV2bLvtUEEcZPSpzwcMcAcfWoFVZQVBxtPNNDTsQgsXjTq2cc9D71MXI+Yr2wcngCo7kqHyAAAMArzUFxcoVwBleAeapGilcez+cNqdB/eyM1JGrugVW2KDxxVRZ2wUT5twwFIqdbg79rBvTgdOKYSb6DjOls67nIOAScEjPpV61uGmjDAlST+PHtVOYRSRgsgYHjI4p8bi2j+cFieFUHnNBhLVF+Jy+Xx83TbTHOch2CD1znGahRiZFZ2II42r15qaR1AwSDjucUGZXmYIPLTdgjaS1Y1xOomPll3IyuD2HatS+kUqER0zyzcYUD696w5JVSMBmZWY469apm0VYiuEMjiVjzn5iOfwpoSVY1cRgx525x61Ycjy8fwgjcO9R3QxCBjLFt27+77Vm73uW2UZlHmxqG+cdPb2qOSFvOKudsobke3pV+cF4wSN5UYXA4xnnNVGYMZGKhcktgHp7CpaBO4WmsXFhuS3EWG674wT9OaSbxDqKjay2oHr9nXiqkuWm3ouFIOMjP6VVjUPjO8IT6UrWBwTI7udrq6knmZfMkO5gi7Qfwoq7dW1uHH2JpmX1mCjI9RiioYKOhw+qT/AGm4dAcrn1rR0fTmkdVQ4YcgdyKyobfzmLcjnj611Wl77Y79wwvIYfeHFawSdrkyT6FjU9Pt4bdvILFwgw4HRjzzXEaqGiuIy+N6nt0H0rstb1GOU4t/M2AclgByevSuL1Eh5kAYsM9aKji5aGfI0tTrtFYyRKduPrWlIMJ83b26msbQWAjXJIx3NbNw2Yuvyj86yQcpyXiAlmK7enU1k6KoF654xkV097Akx29SeM1zl5FJpt6jOvyHvVx1TSMpKzueh6NDG7ZfAH6VsLbsCyo3sDnArh9J1qJkGJACvqa3Y9XLw/6wHnPWhJdTdNPYv3EZZGH3O20d6zJVAIXOT6Yq4NQjnf5yAQMccdqbMsbqpQjOO3WiSKT1IYzuJHUj2q2FBC7V4PO0/wA6rQKFb5/WtGP5uO4Oc+1TcG7FKRWLMQ2Af0qWHLIVAOD6DvViSPKgYbnoR2pI1CcZ4HTNMXPoMVWBOw4KnPJ4qjctvYBhweoIq+425XHHT1yfWqM42YJ5OOvrQSt7srsG8vDglScZFRmL97tYjgZznipJ1AjG04BO4+1RMB/FghugxUsuxEz4JCt83QZ7U9XB++TtPYUyWEMpHljGeoPNNjDgluCO3PNIT0LkGABvwRnnFO2qFVlyWzkHOKhjIEoC9AO46n1NS5UAls+2egqnqS9R/wB4bnUIvOeeD7UmT1boMAD1FNwrKTngYwtSTjcoAUKBjikA9fcZAHT1q3ErNHEcA8EhFqgsmE7ZA6VNbyDg/N/QZoKtcuQsyzYXJyOamVmyVyVGePaq+Nq7s8nqO5/+tTt5Pf5vQ0AW0cEGMkgdT71JlfKdlOxjjAx1qvE+91ABG3JY96bMxOwg42nj3FA0rlpA4wAMEjnHVqdkFsKQygZ54qh9oIySTn1p0brkMhLZ4NNI0US6kzwsSyErwd2ak8sO24Fj36VBGx80x53L15HFXVkbduGFIX6UxN22GKpOc5A6g4705V8mPOSR1x609FVZC2VIfnGeakZfNBVW5AJIx0FLqJSuzPDM5Dpgex6Vdt5mIDyfI4Pbp7VDboWRkkXkHoOMVOQY1OD8mOcckVSZcpXL6uQVzgHqWxUcjMfnyW2jketRQvlQMfMB1xTwjYcr37e1BlfUZHcOVMbcr16etWLRRFEQzZXPUnmoypDBwVOOBxwPrTZ14V+T64NAm7lgSAPksCD0BqJ8pJlXA3fjimghmKkA4A61HLklgOCDQJCXPyjLZVj0xUCOpH+r27PvHrvPqacZCuVYZ/3qfuAjOSFXGRz1q1saX6lEs5l3REox4GO1TxPMrAMwTI6nk5qZxGQmVLDqMdM0ySRehUsO5UU0gu2WomYovlgHpz1xTnbDMAh3EYzjkGqe6YBYi+CeQO/50kkxRVDSO5AJGOcGqViXG5pxsyxoWKgEcBTTWcFGDFPkyAMZBzWbFIrKzs/7xj+7VOi+ua0IwsYTaMnqCelO1zOSsyqy+a4EcR2p1OP0qvOhmnDHaojOAAOSKvyXCGT5m2sTt+Tnn1zUJDCInkAnALkA/U07DUiuIysuduJT0B5yO+ahleOQIi7WYjIPQj2qWaR8uq8sAAu3jJzUM0e1CrnaTzk9Rg1DVgSIhvWWPytwGDk+tV7qP5VOz5lOCPUetWxncGUKyYwcds1XuiUKlQwAHII9/wCVSzSKsVI0iF3Clz8sRdQRn+EnnmulNtdWjTyWscCXt5OEiRQpAhXv7A+tc6iGe7gjPypI4GWGQM1rzQafDEskNs5WG7MLEyndIAOR7c9qVhzM3WkhXVLn7PsEAc429PfH45oqTVLUWmoTRqSyxMVXA7Hnmioa1KWx51p0bLJvxnbzjPWtUylIwVw8bdQOKr6aI8fNyTzWhPbBo8j5d2Ofakr20NFYxr87U+Q5U+lZdtbs82Nm7B5962J0IBHVQcD3p1nakuBCSXBzUrcmaNCxj8uLDAbeuAamZGnVyBgAZOT2rSjsyYVeOE7cfOSOnvWbqN1Bar5ZBklboAK05EjOVrXCygBkUy4AxnDVU8ZafJPp6yhiYxwMjpUcdxcTAcCMddvXH41cdNRurL7NJcq0Jydu2qjKKWhzzg5HmMsF/BzDlkU5yB1p8eu3ELKro4B659a7l9EuolO0q6Htisi+0y4BJa2U/QCqU09zndOUfhMzT9fZ5+JOe+e9d1p14ssQYnkjIriU0RZpov8AR/KZTnPTNdbYQ+WiqoPoSamo4q3KaU5T+0bayhiowMdatwyHJOMD1qlBhSSxGwDpVhSIwHOMHnJ6gVnY6FqaUTb/AJWJ45yDRIqkgggL/Oq8A6FSwXufWrnDhdq4UdxzTsJoouSsgZATjj61TmUDBI+UD8q0pEBk4PvVaYgqVVcc4PpQFzOmAbgEdOMjqKqBsSAPjA6VelXYDx8vY1VkJUhdoYnmgpMepHOfT16UydUIQoMKOhFRMwTqx3E8A9qc2cYXHToO1SJu5Mq94/mHf2qVSFYbgWz0+tQRbTE7ZITr9any2xFVsjHXHNIhsbIVOS4yQDSBhgB24OMYNRsSykKv3Tzn+dLG37sn5T3oGmSFd6g4HHBp0LYUqTwcYxUKzA5BO3JI4HWn5XzAkbHO3OPSmzRF2M8qcYxnAPep0kJ+ZcgZAIPeqkZ3RE7VDfeODU0YXlCxwMc+hNPcZadsOxVdjEYwOgqOOQvKAWHZcjoKRjtWRATk9zULTiLbtUjuaQRLDIVOXRmTOCehFEcWJfl5UHgdMihZiVKgkkjIGaYzldhjXCleAT370X1NEy9AzKqgA4559vTFXFAljBdgG6jb39qx4ppHJ2qSTxkVoxMNgA5bufSqvciWhaZldwQdpUbRmmiWRUYDMavweeCKRi2Om0Hj1z70AGPkYKdPU5osShHRTtZCwPTO7NWEztA6r/OoCcDAATauSSKgE4k2huB2weaAV2XLYcMcEAHkk1bLsiswJ6YqiSGjd0I29yeoNPjlcxqHIJ9aLCd+paWVgj7FwCO9RMS0nLE5HLD/AAqNiAQ2488de9SyfLGM5GRwW/WnYCSKRWLEcMODk0FgRgAbsdRUKhCRj7+OoFOGwAk8GnYkYyFmwx3E9SfSmiOPgkqvPX19sU8cKxPI7Gqvm/MVWRfl6qec1SKiOJkjZtx2x4JX2NRNNMRsUkRdOaRn2LvAYvkcYyMH3pzT5ceWIxng57GqRo7kqOItolVY+mCTnJqSJVMrbwPXC9KrRvuDFCqnO3k5P1pRL5D4Uh/lwW96pGbLhMY2CKLc3dlXAz/Wh4TISxB45X0HtUH2pmjCo2WbPmYHzH6elJvkABLu6qCOnOPU0zNlpFHmDaCW2Z2joT9PWq0we4lAmdcDC5J4B9PrTI7tRGQsv7zIAweRnualt1V2wVjZV+U57f7RofYa0IrjKELEXOwcfX0qScyOglIG4R7WBI6E/wA6XChC/wDCMYCnrz3z7VZKAfLmPgcY5xQWmUGgMfA+dSpYYPf3qncZnRt7hSqg55wT6fWtRjt3tuII5IwPzFQRRZZ4yR5WQWyf1IpNFRZUe2aV0K4SQ8K5PT0z6V0kMOoo7xD+yHn3BwWb5t2OpHrWUubeeByN5VgCufT1q81tp1xdPcm7lUM3mbFiO7Oc4B6VLVhSd9zLvLO6hlee62SF5CHaKTI3eh9DRV3ULqFra6AUpNcT73QjhAM4/wCBGip0NI3tqeWafJHwSduDkNWsmEC7mO1uRnvXK203AOcfrWzBONo3ZzjhjzWV7Di7k8yiT+EAE8YrR8P2yvcKJCEjzkn1rKaZFBJIx6k8VJDq7wfJp4DyEYMzDgewFKLV7sJzSR0nizVI9Phaztdr3DgDYG+6PU1yEcTKTLMxaVurH+VTQWzM5kkYvM3JY8k1PKvyHtg8+9VUnzHKtSSxg86RQvA759K6ez09EgEgUgdRnvWJpSEOrscDvmuwilW5URLtPoxOMVUIpo22VkUE8lw8e0Er1asy8sl4IwM1fntzazON2QT1HSo5JIyuWIJPYily9GDjpcwfsa7un3fanrEijG07s5xVq9mjRTt5NZjyvw2NpbuT2p8tkYO1y0Jlzxjg8expYptz/MMEHv3NVY4mJY9z1q5DbHYHZcrnqKnc3gjRg3/LllHqtaKNstVQYYA52njmsy3AyrE4b19qvs6bMrhiOpxyDVxWgSWpG/y5XIJ+9n0qjcN8+Ny7vTPWrE0xbK5Q5U5I6iqksgPyq24jjOMYpNWIasV5WJBOOB2NVVDcEj6A+lS3LnY4B+YcYFRqVEYB/GpIuRzpnDsePTHX3qNAQPlYkHvjrU08mQFHJYcc9KiICsq7uOmRUsVwiB3FSOnb2qcybWOPlA7HvUGSGYAdOrZ6U0NuckuG9AR1ouBZBLtt2nJPJ9BSrgbt6gjoCKZuBwPur1OO9BJBbBAjznJ70hoVwRsHBI9KfGx4+Xkcbh1IqJZBvG0ktjBPTBojbCnezbhQWi0ACAAw54Bz0p5YFuAOMDk9TVEuMdTu9DVmBwGAOD7+9NMu5fif5GMgwMcCpPLdgrNjyyOM+lVElwwLeuPYVO7uyhcgqBj6/Sm1clvsOCgL8uPlA4z1pWCNvEhxkg56VGG5IKYI6+9SAhvnP3h1X0+lSHMyWM5LFMlj6elWEkj2bSxDE/MM8MPaqkcqMSDxzx6091LLlV6HOfamh77l2WTzFzE5Cg4Pt7VFDJsZg+CpHTOearxllbeOB/d6inBVMmdoUHkkCq5ilZExuGORnBPIB5yPcU0q8qSNtK47AfypUZQMkke+OaRpCCSScnoam4c1tiDzvKIYPlSO3b61YaaQoGUhgO561GwB++AOhHoKeiDZnnB4wDTWo27jI7yV3OF3L1WnxXTSrh2IO7Geu2miMAqI3woGCaIAEJVlUIO4ByapMTasXUdycq5yeCvQU7cC0YA5GRyarLMASHbBHIYGnJJmPDZOeTnt9KdzPqPWWZSyBtyr+lHmGVAcIrEfKMcj8agkBC7slgO44zS+bEh38U0aLYMO5ZWdsZ4OevtUTYUBFj8yQH5SexoaQSFSJBznCHjFMkkDxkb/AJzwRjp9KpCbJZPNUZmZUY4B9B6Zpd8jTks6kg8FBhR9KhjkUJ+8cBicfdzgdqflzJvkwzkdV4x+FO5Jai/1rOJMSqNvHBI96Ry4XD4BIw3c4+lMtUaXekiFT1Y5++asLBh1Rgckc89aLktpEMEPmNhcoqDAI61oxAIoU78E9hjP1qPzYW4j+8vdRxmmyOxdTuMkY+9gZoTJu2yWVRtkjGdiNn5vX8KbAjOQNxAznnnFV5JOVCFlz/D6CpYo5BGApwCeQTTcik7E0ymRnO4P5afKFX19aZHbvFaKVdTMVO4nk5pNwt0YYYyHjkZH0zTQynAlYjI+YA0aF2JPkWeKSVgsSsu/PoT61uG5vx9qSMZuIZ1KoqAhojngAdulc0gS6aCKR1jjLgN3wM9TWhNe6fa3kkS21yHTKbvPKkgf0pNlTRFq8WzUbtjIZMvjJPSiq8rRSO5jUojcqhbO36mis9yLs8vXRN0jYDDcf4auw6BhWbMwVcDAPer9lcfeBOCcEj1rXgn45OMsGP8AWpVmZRTRkR6CADmMkYxn+tSfYxAuFXaOn0rcM6Izqwb5egA7fWq+pGMx71IJCgkjvRyrdFmRJiMDaevXAqEsH+8OPWluHIOW4P8ASoIDvcnAAHPHepE0a+nllYD14rpbFVj3EN8xT64Nc5bOrkL2HJFa0c5cDIxgdAccVtGyOhv3S5cTB1Ky5IPr2rCvZm3ttOT0FS3T72xk4xxUSoZNm4bWHHFJu7DoY1w9yNxjVScbVOOlR2FlJu3XUjSsTzx09q6OPTiDknnru3cCtC0062I3PtYISDk9T9aqMG0ZOKvcy7W1LbSqkZ65GcCrotdibuAASTVg3EMUJiUAlT0B/wA5qneaggiby8ByME+oo5eUuKd9CFpVQlVBVffvVK4v/Lk3ocEDHBxVO5u+AzMBXNaxqirN5atnnj1qLt7CnJROpiuQ24AhmzksOKm83GduTnpmuRsL7AyxwT3rZtbxWbAJJx1pN9zNzuaRyDyRkgkjFVCf4Oo60PMZADnkHt2qHzCHJJ4zU3Mmxz/IzEtz0UE9KUjIwpz9abKQwVpFyOx9Kdv6kkEsOeKliuJnBALAE/rSn7wIUDBqJ2Vh93cx6EjpUe5kLKMsx7+lIpMsrL8zY6k84pxf5QSe/wB2ocnAUkgH+dPGCuCAdtO47kqfOcLxSLGZGJRWO05POKjJGCvPPQYqyoIUqx5I4wf0oKuRNgsoyevP+FOjOHIxyDillG5foB+ApAQseB2P40DUi7AQ2d5JB4H1qTdsRlC5BPp0qtEyRjjIA/nUhlJU7c4J5Jpg2Wmf5hggkdc1IG3OQABgZ69qoK5ONgycZz61Otwu1VkHzAY4FCK5SyIxIQVyFA6+tTo/ljDMAoHPGQRVYTIhIdP3WPpzUbZx8hPlEA4Hem0OxbDgcghR2APWhrliykABAeQe9Zjuc/KAB0x6UsM7hApwcHjPenoWrGyZYwCVwT2JzTGlG4FxnjpjIrLEzB9oJC9vWm/aAn3gceueaLj5TUm2bR94Ajkk5FOBIjVVKgMMjB61RjnG1fMY7Cw5IpC0SsVj2g5yGNBLRfbAUAZJzz3qPJc/fLAZG0k8VGsvbO1un40rydQow2OR2NJGexMrYXCgBe5NEjsIlU/Og/iFV2fGC6hR7Hio7mYBMAjr0qhdS1IW+zlo3OAOCTVMzPkfNl/QjpVZ7gYPJOe1I0pmKggKV9OKdy72RJHM4dm2Agf3jxn2qZDn52Kn0HpVRdyyfKTtHOM8ZqQSblIUA9c8UCvctptRtzk/7oPWpBcwtuz5ijPygjOTVASkAMpw46bqQzMrAsMDuc5zVXBm0srRlGD5J7+lSoyvnzHyCeDVCKUGMoQSB3A4qYyK0KhgVbtxxUokuxHMvkwgCQnqOhHuKd53lyGN03c87eOfTNZcjNjfCWBHoeRSS3ASPJctIRzTuUo3NFrox7SsigE5CgZI+pqL7Qxzl/mBzz3PbFUFmUjIUbW6/WkaQKNgPzdgRS5jTlRom4Yj52ZjnJB5+tKjLsxyCTxj0rOjn4zgL/Dx3PvUjTbBzjIPT1pJsCzFiS5hWQb03rle5GeldJeJr32txCkTRbj5eEQ4XsOea5azeylEp1F7hMt8ohUHA/GtK2Gjqg23Ooe2VGabZFR2I7tZ/tUwuMC5z84GAAcegoqtdNEJpBAzNDu+RmHzEe9FIz5zk7cFR8hBOe/atK3kcxfOQRnNZkB8srn7o/SrauMEhePSoQJ2LCTmMsxbduXAU84NI74BDqcn9aYMFQ/GPSnkk7XOABwDVopyuULhWIYuRg8Ad+aihQooXqfbtV2QoULk5HTp3pik7gFxhR0/wpEXLNuQvzkEjt9a1Ld9y5yOP1rE88LwCc/zp7XYXocY5p3LjLQ2n2xsWY5Rs5FNaWOFDkKCR1rn578ngknAwOetZ82pExEKVABycmqU10NrpLU6h9RKlhAcq3B47VVn1diN0hGRxgDHFcTeeI4YQc3AB9AcmsW68VLn92rsemelVebMJYiETvrvVlZsoB/hWfdapGM5k2kDqelefy+IZ35WJVJ7k5qhLc3d8+0sTk9B0o9m/tMynjI/ZOh1bxIXLRWoLMT1HSsu3+0iTzpgWZu/pVrTtMWAB5FBf0rUEa4wfrjHeqSUdjmfNN3ZDbSNkZBHHetqzuCMcc/zrNVFA5HucVbhYYA6Z6VlLU1jsbaO3lkjGTyT2oLAHgHGetUUdgp+YZ7j0qUuxHPIAwccVm0NMsSyk27Dn1J7CmNIWYD7oHGSetV7aUxmRHUOGHBPb3pXiY7fkywbJz1p2KVupOkrvF1IDdSfTNWXw5B3YPQAVTtgP7wDHjaKnWRfLLnjnoODUsH5EyOGO0gADkE09dm0BWzzyaqFg6kE+4LdxT1+UkqgwQMikNMtq2SSD9CakUkBVHJyTmqavuByWAH94VIhyANvvyelAy0CjcHjA+aoixUNnABwfpTUO35VPy9NxHNPWcgFc/L0OQKY0yRWbKlhlT6VO7A5EgOD029qqjhs5yMdBUiTHayKAR1570x3HZJ5VsKOBTDuG7GcU4ELhQM+3rS+cAMqME8HjjFKxaY7dhWyxzx+NTRzFBlcj2boaqO4WQBfu1EZCHJLEr2z0ppl3NCQ+fk5VWHp39qRIN57ggZ21TSddwDDkjnFSiZmU72IPYn0p6MVyyDkKGBBXqajcBt2eeeOe1RiVgCHZSp7HrTkIAzvBGDkUh8w5AduRyvTk5FNDbJBlgMeopXYZULkrjHy1XZwSy7TuHRiaCXPuW3nDBfXFItw23aT81ZnmtGrAtk5+tPilcjLMCPpVbESmmtC61yuBjP400SlmI6rjkVWlI4JBX02+tIu9UOBliMcUN6k3LG/YMBQSOnvQxRxyGUgd6qNICQzAoAOtLFOQSQQy444oug3Lm4IBj5ietRNIQ3yOWyRnPaoo5eMlhk9h2/ChmLD5Ac+vY0rlrQsg5IztIPUVLE64bcQBnpnn8qzgQDucHPqelSRzoAWXIfvTuFzSB6qrsG/hDdKGmmZh5jv0wDWaZhtyrAt3zT0lZyONqj360XC9jRWfj7x+Xr70xpdzKxwR/eHaolYHLHb7Co3nVVxxj0FFxqZYSZhwByegphc/e3A81AJfmHLbcd6idsMNpx6j0pXKdQvqzAnDAjNKZwqHruH3c1SDnG0nbnmoy24kMc45oRn7Q3LGCW+RpI5rWPaQp82QIfwrQGlTbj/AKZYbs/89xXNWirPeWsL8CWRVLZ5wTXTSXGlW1vcv/ZEZjtrsW7jed205+b68VSsZSqXMy8ka3nkiZkLKeWjOVP0NFU9fb7Pq95EFSNUfCqnCgY4xn2oqkjPnMxXUjAJ/p9amSZc5XB7Z7ivPbfxHDtG6Qo3fNXovEUGcCdSCOmcUnSZSqx7nZrMu7POO9OWZSdo3belca3iGIDaZgcdwc0jeJbdBhZE9cgU+SQe1j3O03qQQGAAqs04UMGPGexrjZPE0IDbZAfwqhP4pDIdqSFvyBpqk2J1oo7OfUBFlVBz9c1l3+t+SCXkC/WuJudbupzhX8sZ6CqEsrytl2Zj6k1apLqZSr9jor3xLIwKwD/gTd6xp9QurjPmSMQf4RwKhtrd5WxGpOa3NP0B5MGf5R165q7JGd51GYSKzEADk+lWodPuJsYiIHdj2ruLDQ7WFULYJPTitmHT4kB2qMk0uc0VDucFbaA5G6Zhx1ArattNjtAAq5zz+FdBLCsfoB15qtNG0Zw44xkc9qycjaNKKM54lxnrnJFQqpQkjmrzghPlVQQPlx3quVbPsOaCnEiGd2SasLnGQ3TjPpUBOM9MGlUlQRzx29aGrgkaEcv7o8gkdeOSKICxlYlW8s9vSoFkTC549SO1WBIylcnd9KlomxJGyqATxn9Km8qYwvOhyiEIW9zVU4yc4Kjj0qf7XKLT7IrAxFvM6chunWkiW2IHO8eXggc596mWQMu4kncdvFVRwAB1B5peIwpDfMDzjp7VLRSZZ++gXAwOPrSBwhJHJxjANRo5IDM2WzkY6UA/OArZXOTkd6VgLMLnB8w57j0qYscqQT7iqgcKcbQVPQ+lTIxHBUcDnmlYpsmBPDAY7AUzzCH5bPqSOlQqeDjJPc075A4P8J7Y5NAJ2Lu/cm4kYPQj1o8zLZyMnoR/WqpOxPkzg81GJZFkXKn0z60yr3L4ckHJDDsR2pF3O25Ccd6rK6pkSZUDqB3pVl8vdgDa3Tmgq5clAC7hkcYJHNQCb5cBcEdQab5ykfKCT6ZqNixywO0d+5oDmsOGDGCpxzznqDSmZgihl3Enkniqrz7OisUJ596k+0OAACAueo5wPpSHzFoNnnIJ9aQEpjJPJ9eDUStnkMH6HOPWnl9vXK+x5p2Jcydbhl3Z4UHGaa7sH++Dx0qmcFs7iQe5oaTHB+Yjv3qrdzNyuWBkHLfLnrilXaHCAkk85NQrMNpKsCvcGmSOWAIx9aW4kyz5wycsCp/SkEgU9Wx2xVRpADwFBPcdKhe5YNggD8eKLXKuX3fOAjDnsahLocq7EcdQKpNLnO7JY+nalSfbhwenGDRyivYshc4PP19asBifuk7frWeJ5GclSMDtQ1yzZCjGeeKOUfMy4ZB8wY5HbNPhYkspDEg8YPNZxldsBxux17U5pwSRyCOeT+lHKTzGgJVIOV/PrThcYbhV6YwRWcXHybeG9xQkpLAqRjuB1FHKHNY0fPCJlnXHbHagXHzgMykdvesuSZuVz8h6Z61XMj7sbsflTUQUzZe6AJ8sgMDx6U37XhTuII71jbyR95cA9xzT967RtU5H8WetVyg5mi10pOFbntQ10oGc44/Os1nChsncQOhqF5gCfmwuO9HITzo2IpWluY4oTulkYKijg5PTntW0NansvEksM+qwvuVYp7loN8e9egK98HjdXJ24ux5d3ao7COZEWQLlRIeVH1OK6m4sDPdG7uvCWpm7Zt7xpKBCWz6dQPatVAzckY2tzXcWrXcV+wa7VzvbdkE+v4jFFZetT3Uur3b6ipjvGcmSMjGw+n4DFFaqJk5nmANLnn2ptHamZD884GBS57g1F34qQIx4AoAMnufwo74HWp4bV5DkAVq2mmxKN0u40mxqNzJit5JT8iFvpWzp+kDh5s/StSCKOMbUAHuO9WIzjK8ZqG7G8KS6k9taxxr8qgYrTt4VcYIHTt1rKRiDxkfWtC2n2kVk22dMYroattDgAZBYcA5q6CpweFOO3rVKGUs6hvmOcjtUzMSPlzu547CouF9RZNrIySYJPOAKo3KHeCCdhOB7VbkZQvIIyOeOfwqCZQZGB5yM8cUikzMnzGcFSx5H096ZvOODjp1HNXHTMw3nC4yTUYQYDKu4Z6+tUpF6FR03ZYcimhSDtIH17irewIctwuahbGWIYhT+tO5FmIo2sFHIPrToyQfm4zwB6UBQ2EU5IGc1II8hFzl+vFTcloeVPltIFJA65ppO4Kd3PpUgKmPD/LzgEHOajWPLDJGO3rQTYeJAshMgPPAA7mmknLLjv83pzTki3scnBzSNgOcZwfvAd6Bjg5UqAcsvAB6YpUcb/nwQfTpTQQ5YYG1fXrTJV2kDgAjjNAFldpVuWCg0LKdwHAGetRKxwOMHHJHSlZlK9Qc9KXKK5YEigbm4zwcUgcgkggjHHFVS7Z2kgj+dEZkB3E7QeM0WC5Ze82Daw4PenC4RxtJ+UDjBqnMQcBsEdcVEu3edgPtk0y+ZF0PgqN5znPrUiNlzkgnr9KpFuQwYj2IqUTOAuWBB9BzSsJyLOcuflIb8sU52ICjH4hs1D5hKYbnv71GX2jJG09qOUi5MSWGFDEdeKYG6BWweuDUEs5X7xz6MPWmtPv8Av5KnqO+afKHMyy0gH3soc8YHWl86QE/vNzdQCO3pVB5ig2qd69cGo3uWcDnBHp2qlELmgJWZgxBAHLD0/CkaYqQ6ngnBqgJxk+ZuLjoR2pBdOSM7RjgU+Ud7GiLgKSucsfWka4V1+bqD2rLMgPzDPXqaQTbWJWnyi5i4853bQAVbpk1FvGQCeM1B5pI/h49aY0uBTUQ5y1vIcggHvn1pTODGQcAnoapecFPz52nvSM68jOV7c0cpLki2ZvkxgZA/OiSXK5QkADlc81T3/KQ3OemaQSFeVPHenyic0XTMwk4c9PWlNwzd1JPqKolwQCGFK0qljnjHTFHKLmRbWUlCcgnPOTSmUN/FtPaqO9SDzSljjgZHt2p8qE5l4ORgEheOvUUgJJOdp+lU14Vsn5e2aVXUN1/xpqBLmWi2OUHB7E0GXA6ADFVi4wcA89+1BkCKN3JHTmmoCcyYsScgD1zTC4YBiDUJlBU/MAahaRyMYJq1DuZ+0NCzUz3tvAhkKSSou1Wxk5xx7+9dDdf8I3Bqb2bX+t4EnlNMJFKg5wffGe9cfBJLE6PCzeYGBQr13Z4x+Nd+bSR5/Pu9J0L+3WIfypbso7SerRfd3H0zVctiea5h+INKt7ZbyaxluXeyuFt7mK6wTkjKsGHUGiqeoapdSWs9ldQrHcSXDTXchBEkrgnAPoFzgAUVSRFzzpYd20Nhcjg/0pRCh7DI6ik37Bsfntn3pyMM/wC160rFkixLgZ4/4DU4jDxkoAWzxxUPmhmBUHI4z2qdcKylG69eaTQE9vhXIZQpIq6sgB4fcpHeqO9Wz8pyO9TL8gyO/TiosWpWLsUmT8oOPrUyyfMc8VQDYYn+LvipFK7xhufep5TWMzTWVsDHJFWomVWGDx1/GsqOXBXqD0+tXEkX157+lZtGylc2I5BGA27cx6f4VP8AaCfm+YZ5AFZIlGDswFOPwqwkru3H0zWbVirF8TZwVLNzk5GcUOy/KeTnNV4TgsHyO2fWpFHzY6rUl3Hkq2U7EYqNBhcb8cYxTyVLEZ2D1Ipy7U5BWQnjPtSYyJVUEoeG65PeoSBuKkDOeBVlsOwAQ9c89qhlX94Bn5SecCmIrhG807yAc1MrYYKfvHgEUqqNxXr1605lRlHlqSy9KYMkgs5LhsQtEirz+8cL/OnTwm0lEcrwu2MkowYH8ap/KOHViQKGGNowAvtVaWJSd7k0mGyyAhepprbVCDgZ6e9KHYAh8f8A1qaYwWJ68cZ7UrBYYRtyygjI70nmsuRty2O/9KlZCiAsMkn1ppXe+Op/LFFhDfM3Y64z0IpQwGSRkZ6YxS7Gfdk4YdcVGcrggN+NNEknyk5B79PSnkgAZyCOcHpVZnCZy5BJ+9Tw4TqocY55yaaQgaZsENgLnINJxu6bgeeKjeQOOBnA44oVgFJVckUWAfvwflY47AihZjvJ3Dd6AVGzjb0PvSBw+OTgdO1FgJWnYfORh/WozNtYkgEn17VG7ENkgkDtmmlskkAHPb0p2C5MZFyOaj34Y8E56Go2IBx/Kk8zLcHgU+UlsGbnA696QY2+ophOSTn5qa24DABFVawrsm25yWAx+tNIA6/hUeXZjuJ4pMPkknI7GhBccz9f4hTSehFKg+cetDbcZI5piuMZ3Ixx+VD7uRlT7HigfMSAOfSm+XggOT9aaEJj5cEYNKQO+PxpcDsd3pml6jOMEUCG/MMHcfx5pjFlJYtgHoDUhyw579DSZ3LjB29MkU7EMhySCWBLY4x3oc4hUjOM5INSEDOC2FA6UxcFeXB7YNNIm45Ziqjarbe4pplLnco2j0zyaYSwJ4xk8DNKwJYnIBXnH+FXZCuSCcEDdyfQ0bznAGCaiBOAxXIPemnB2guTkZ47e1Owmyx5jDOcgf3T396buGM9WNNByArZJApckqDgLnvTUSHIdxlscD0oAOcg5ycc+lCpjOTk1NkLtxgn+VWkRzD9PmFpfwTYVvJlWTaOhwc4rfvNO0e+1KbUP7fhjgkk85kkiY3CZOSMdz6GszTNG1LVIXews5Z0RtsjrjAJ7VKPDuuQSqYdEvJDuHIACjB+tDC7YazeDUtZvLxYCiyPuw4wQOAM+9FZHj65nl8Y6wjPgCfbgcY+UdaKFawrHH5BYqwy3XNI6BME8H0qKMnOQanDBm+bHTvUGxIgyoYZOf0pQzq4+X5aYDhflPGKkjYmNecYPfvQMlilO4kuAanD7sBSy985qvt3HdtAx6U4cMNp496lgXIWyCSxJNSspGN2FPrVGKUqGZOT/F7CriPvUMzZJHAxxU2sMnR1Vw2/6Z6VbhkJ+8RhuelUNocYLYcDpUkbPGq+Ycpjio5TSMrGmJFxkAmpw+duGIP9ay4Jdw4/KrayYBDZ59KiUTojK5pmUnBfJ5xmrAZSFBB+oNZkUh2oR9wHqatwsSh+bnNZtF37F3JZQW3Mc9SKcpVQCCOeTUCysuctnjvTQzMhzjaRwRWdiostRynDKJAu71pzZcKGx8nf0quiIwBRTz1JqeRREzEkknggc5pbFCeSMncyjHQ55NARiqgKCe2D0pcIxU4b/gQ6VI0e5cLIwUe1UQ2VpWbHyHBHBHcVCVIACjc56k9q0DbphWwCSexp2oraNCn2WCSCTP7zc24E+1UgUkZ4cBV42kjr61JhtpBYYGCMd6DEyruxx1bHpREi7GCEkLyKZTQ6NQxOcqc5xjNRojhwWQcHpmpwowpRsn61K37zBAUg8cnpU3Ikivj53I4I7A1G24su7HtjrVtxtGGx06gVG0ZIKgjGOCBRckqbTjJAOOOe1RmJWxs4z15qw6lnVHCn9DTAF5BUYB6+lNFFUbi+BhT06VHKj4zuAXoMVbYMxYrwOgNQmJg/zE8dDVpkMr7TuO4/KO/rSqMZXJ579RUpGecncfbg05kDd8UXAr8AnIAoMm4gGNcYxn3p/lD8fehQQQNpI6mnuIiKNkjpSZ+XIXGOM+tSMx3ZUHaKYwJOex54qiCEDLc8n8qcNwySSp9MdafjJwD79KXduQjd07YpjsRfN0IpSeSGH4U4lcAHANI3zEbjgeooEIrADj+VISuRlvrxRgYzjNBXI5JA9KYhPk7Hr6Cj5c4JPHfFHG0Ypu7nnIx3oAVtoyBg/QVH5hUgKmB70pK4JBwfel+XbnGCaCWQg72OGPX04p4KgfeYc9xTgV6PhQOhFQyMwHUNmqRm9BXyWyentTZI0IG1sn3pu7ceGAprnpkgn1q0Ji4IOM8+vpTt6jsDjrn+KomIK/cwfXNNXO3kkg9qpIlskyuC3INPXbx347VFjA+UnBp6NhNq8DPX1q7GbY7oMHPfmplXChfxOaVFWNQ9wwRByWY9KoX2tRxnZZLuPeRv6CqskQ7vY02CRKWlZUXGSWrKudZhjJFrEXOMBmPH5VizTy3DZmkZj9aaAAKV+w1DuWpNQu5B81zKo/uo5UfpTVurrP8Ax9XH/f1v8a2fB9rouoXb2erx3JuZB/ozRziNGYD7jEjjPY1L53hVZGVtI1gMCQR9uXg/981N22X0Mdcud7szM3JJOSaK1rPT1v8AUX/s6CWO0Zv3aSNuZV9Ce596KdrmDmkzkUbGcCnqcjkY9xzUPfFKGxUHUTbsNnsKkZuhBG70quDxkVIvI560AWhJuQkjkcYqZZAQA7HAqgpIBAwe9SJKdpBPNAFosW7lR24qRdoKFSd3cdqp+YQpySVp/mh8cHHcUmMuCXafvbmHQntVlZwZFGCB3zWauDjPG6nwS7IyWBOD0NJodzVU8ll5Y8ipkl2r95mPcVn28hG0hzg5GPSrPnMcKMDPc1DRakaSOuAV6HqKswuNqkZz71mq+MDI3A1PC4Cgljknp6VlJGsWaQmJGCvtT0cbSDgEdKpKcgYbIqRWIbIINRY2izRhJEHVskZ46VZU8ZQ84z15qnExCcqMVZXbkFeT0FZvcu5MihlOJQWHJPerAY4VgvzfrVON2WTJG4E5qdTvPOVYDpQkDsTDdvIOVOc/WmMiSMfvhutSxAFQGLD9KfGGAKMD6gk0iDPMWOCzAHnipI9m8qQQ2Pve3pU7Rev3T09qb5eDgKW9yKdy7kDIFPTjswFTIhXbhgM9Ae9SMECp83G7pQyhWBVcsWxzQSxjo2CHQt+FMOxVKltjZ6Yqdg4Ykythfbj8aVkEiAAqwbn3piRTlVGX7mcHHFRbVyVYKwb8MVJcpIstqsJI3OSeegx0qz5BIJKrv3YyKAuVFiXGFYEEYPHSmbHA2gAgHt3rQ8sJt3qo+n9aYwBXEUZ2+/agkpGNjwFwnVV75qGVeflXj07iry7k+dAQ/c1FKylgTEc5zuz3poErlN4SwzgsPTFRmNiTkZPQDNW3GSfnK44IFQSDLfP8vfNUmJlaRdigYII4IPTNMBIQZ2k+oq0ygx/MzBT0AGfzqvt6HgY7YxmtBDCGBPPJOeKTaQxOGx696UISQWXFADIWyOPWgYxgRzjIphA3cH6AipCxbhs59qQHHufemSxm3jjg/wA6QgkY6EetOY8jpupWLE/MpA9qCSIhsHPBHpTeWHIPHepWGRxx6ZppaTj7v4UxMiK5PIJ96YcpwBmpcOScnI9KiKsBgfd7iqQmRHd1ZQV9zzQWTkYAHanMmG6jgcZNROD0BAPrVIyY0gDOV49qY5G0YXj680jcdN1Qs205GScdKtIhseHJUdcDinIWyApNQ7sMeOe1Too3L61cUZtkkUTOwwcYpbu/hs1K26iSfux6CqV9ekZii4PRiKzVBJ561V1sTy33FuZ57l980hc+9RAZ47dqtRoGwAMmtjSvD9zqLAQwNg9yOBUIpyUTACY69aeInbGFznpivUdP+E2oXiA+YqPjOCK1j8Lrmzt1VhulXrt71rGnffQyeIgjzrw94L1bX0nayjgCwjMgmk2Hb6gEcitbT/h7qRQzSXWkeWhww+2Lx9a9x0C0l0nRHltLVGvYIjneAF5GMNnjFcTbeDbi80a78mezF1OfMKwSq25s5wB7V10sPBt8zMXXc46I0fBmlaVbym2eSAzx8Eq2QTgdD3HvRWhoWiaVDoov9VlYC04lG3GCO1FW6NNOyOKV2z5ccqTlV2j0zUZp2eB60dfpXls90MYwR+NOyRgZxTaQ8UgH7iDweKcp53Ejj0pnbPSgdOePpQBMG5POachweKiUgNz0p2ef5UAT7wfug596cr5YY/EGq4YZ55HepNw45JH8qBl2KR4ycbcGpUcSDPP0FUgw7HJpyuccDB9aTQGkk+xGUg7vXHar0RGRgH8axYnY7ehOehq7BLwATgZzk+tZyiXGRrow/hGR61LGVI75HaqsTADjJ9amVjgFR0rJo6Ey3HIpI3b8dquQyYAYHnPSs5W3A8/KaniOYiuckHNZ2NU7mrDnzOoYYzVxSCBvQ5HTHUVlRODyOo6eoq6jqDlCXfGTk1INFmMAOSNzU8OqqSGwP9uokAPzZKgdjUnBIC4YH+9SE9BFCsEKsQamBAPLlc9CKZlwGZeFBwQKI3OGO1WUcYPFMEAQNGFyH77sUNAxGVRsr0KmnRD5WDrtb25xTojMAwyWGCAVOc0WKI1WbcQshHGTkdTTd8iY6o/XcoyanQqzBNsqseOGA5/GhkKIdkmP7wYVVhNigGTIkAPfdjBpsUCI+Z1cLnqp/U0RyZiKgF0U5PzYpTu2hjETGefmHApMkepTlGYFSONw/rTGjicALlSeeuc0/wCWQGQ4QHnhqdKSuwzRhiwwrE4I/KhBYqyKF3CQH7uQM8fjVWSEBdrZVuuK0QrAEMmPfOarzRnbsMasf72etA0UyhRAJABnpTWCqhBXLHpg9qtCFlQDywT655+lRMjYcKQoHYjmmSylypJaMuD3z0qMorj5Ez6k1Y3BAFZyyHqMdPrSbUbb5e4ZPNWKxSEZIJIXGcYzSG37gHA9TwauCPJZkIOOPmpkkRK8NtOeQaewiouS3OAAKaVA7c+tXvJPBygYDsOaNkrDqCO+Bii4GcyKD0wPrSFQqkfKc+hzVx4A0mCDn19KiaEBsAk49Kq4rFRuBwKZwMEHBq1sIBIQkD1NMMeOq8nrRcOUrMu3+LOahYBzznI7VakT5sEACoJFwfvYPtVIzaKriPkBXY571Cx546DrViQsDtByPbrVZ1z8wB6VojGQzcGOMn8TTWUltoK+vNKVIYnGAaQADHUkdCO1aJGbYnUnIpt7cGGMKv3z39KmGNhZsADr61Tt4ZtU1FIYk3MThQKt6EebKsaM7DPJPp3rpNB8L6hqrr5EDhScbiK9F8FfDUcSX33xzjsK9i0rRLawhRIAq7RyB/OqVJ7s5qmJWyPMPC3wwhiVZL4hsDJB6g16bpWhWVtCnkxID24FakiggCNc7qlhjWJG3JkfoKq1tjilVchvlxwsQqjAHLYqN43aNvKC7Rgkt1qRHMqsgUFc5/CrflmVFCsuMdMfzobsQyrNptnf2Etncp+7lwzHs3sa5dPhrpVvKJLS4FuAQxCZ4+npXcwjy4pGjCtKDgluQBUojWaJWjAEwOSF6EeoqVVlF3izWL0RxOoQGA3ZSxMiytvI6hvciiuzuI83UgI3c5x2FFX7WRPtGm1Y/PtsEkqcCgZPahffGKfG6rncgc4wM9q50e4MbpSDkinEcc0dFIFKwDcUvrRjFC8fQ0WAM4xSg4PtQBz9aTHvSAevSnE8gdqi9qepHfrTAmB24Ap65IyD0qDvxUq4DdSDSAseYSASfyFWUYBN28FT/DVNcAg+napUYbiB39KTQ0zVhmyoJ4J7Cr0TZA5wB2rFhUK/3j9etaUD5OG4+lZSRrCXQvoxHXPNTqy5GM++KqI3OM5ANWInAbOOD2rJ6G8WXVZUYYBBIxgd6sxqrIWDNvA5HpVWJh6c1OsgTDYI4rNlcxdjJ2nMmeOlSoy5G0kkHnHeoI5Mrg4HH1qwnUjy8ZpBzMk3hRlCq+uDn9KkCqXAmRfmH3d2KapJVVOzAHUjrTGxu+Zh14I7e1UkCepYSNdqnOznBY+np70/bHHJlUy2Ov8Ahio4pX3glkz64p6z8/IwVlODsH3qEiibzN8IhbGc9WwOPrUZXL7l+duhDJ2+oo3yyQ+UW+Rmycpz+FMDEOSJZQuQDt44+lMkcQAc58ojkpt+9SG5l3OCGKN1C8/kKUrIm5EV2G7gsuP5U1tykbnTaccbevtmgaYkrwFWOHCHkZSgyQBU++7ZyQR1+lRMULbGz977oYkAVIqs4ARUHYMoOTSFzCuYy7so28+hp6eYBlHUDoMnpTWiRY1aV/nbjae31pjKHIyyqPc0eYm7iSIq7t0ik9ehzmoXCTfffLjsORT+ckKSQTyV602SAuSVMq9xx1oEVfs8gO1VAOe3GRSrHIDksoI4JxUrREJln5B59qhaPjLMNhPXGaaAHRCDkEEHOcUxWyEQKzE5OSKeInBdg3HQf/WpBa/OMSku3RiKaAaYwvIYbjyQ1OaLczbmAIHQHg0LHNC52fMM/exTSZY8+XGxbdwAOMUDsNkh2oCrY3fLSeXgc7RxzSGZ1Zw6gKTke1QFk3Egk9snoaB8o5omCsfMXHpVVgxJZ1JNTrEGyRJjHtTX81SQMsOmSKdxWKjAHO3r71BJG2RkDB9KuSQy5+coM+oqu8RzhycdwtWjOWpRlCAnkrgdaheUqGCkkdtw4q+YBkFgMDpmqpUZOEBNaRZjJFOTcxJzkHt0Apu3j5etTTDAxtwe4NMQYBA5PtW6ZzyIZVL/AC54710Xw6EMPiCMuPnP3T2Fc+/zE4FXtNkazuYZhxhs8elUmk9SZRvGx9RacVeEBcYXuO9bFof3Ks5+YnAJrhfCOtR3tlbgjJZa7izk89Fyu1MkAY/WuiR5ElZlgR4yxJBqFmUoQJM/Nz61JKxDAA7x6A9qSCOENuZQoJ5HcVLdiBbdQSfLUhV45/nVlS2D5eRjqO9S+S7xlYVO0YIz3qykTlRv+U552jGazlIjmI1ZRG0iuBkYOP5UxJSpzHHubruBwFq9HawpkrGqsx4PXHvTI3YblL7xjOD0Pr9Kyciu2pVdpJTl3I3fe2jn86KldCsrIDke9FFzNt31Pz6wQSKMcc049RQ1UfSjRy3PSkbJp56UncUgEbGcilUAkk9BTT0pW+6KYC9eRimnrStx0p0PMnPv/KkwEHT0oGCaTtSVID+Qx54pwYj73Sox1FPP9aAJg5ORx0qUAhBxt96rR9/pUwJ2CgC3HIoAxkEdatW7nceePWqKfcFWrfo3+8KiSGjXil4Cnr71ZiPy9iazoOVGfU1oQ9R9Kxkjoiy0h3Y5PSrMJ5IPUfrVW2+/Uq/eT/erNmpoRStgJlST045q6JGHyhOD0LHNZ03+rX61NFyYM88d6lgaCMrKUmJDA9hTgqjcYHB7EqOfyquOLXI6561IwAQEDB3CmC3JXcyoC6RqRxuxyalEEW794GhI5HByavKinTbxioJAGDjpWdbsXgG8lsKevPagLkm4sSnmMW/gHQH8aPMLLtYY28Hyxkg1GgBj5GelS7QLwYA+4e1A+go3tbM7TJ5ecbS2G/KmvBGV3Es4IyDuJH5VHZKGmwwDD0PNSAlLuUISoweBxTASMN5YEcKBR6tgn8aawQksZEi2nhRnP6U9GZoxkk/Mep9qltANx4pCGIsgYeXcK4I9c4ps0bLuVwWcDJyuM0t5xM+PSlmYmSXJJ+7QxrcgDuFzEqbO5PUVC7AZIYA9AAeopuocTOBwMCqx/wBYv+7Qh2JCfnLMuBnmhVQyfKjOAc5IxUhJKRZPenj/AFp/GgLDPKZzlUbrkjt+FStEqPvlYgngKO/1NWUA8p+KW3AMZJAzQIqgIrgqpbtyeKlCFl5U5BwCWxRIPkFLHzjPpQIiMeQF+U44ORnNQyWZ5PQem2rHRjUVwT5fU9aBN2GCNkhZC+ARzgc1Qm3K3y5BPTPerUrHaeT0qO4/1f8AwCmIz3L7iGI6Z61UlVxhnOAavSAbRx/CKqH/AFq1aEys5UYHUnoKjJbk7QoHfNM1Hjysf89KLknzB+NaIylsVXYGXAO4H17U0HCdix9+RQ336XAz/wABFbI5nuNC7mXHA61Lxyc57Ypsf8P0NIfu0dQPR/hxqBAjQsxCnae2K9ss52EUHl4ZcY69PrXz14A/1sn+8te8aT/qn+ldSd4nmYiPvM2YVMspVNoxy0h/pWvbwJGoKoGPcnqayrbqn1rdtf6VjUZwyLBRCN2WUgDgdKkTBXKkc9c1A/3xViLkLn1NZkiM4U/MMc8Y5AqCQxjcCYwD1CDkj09qdc9KpzdW+tKxam0rAzNLlmXGTxiinScbMUVaIP/Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Numerous erythematous macules are present on the face.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_52_12104=[""].join("\n");
var outline_f11_52_12104=null;
var title_f11_52_12105="Treatment of dystonia";
var content_f11_52_12105=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Treatment of dystonia",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/52/12105/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/52/12105/contributors\">",
"     Cynthia Comella, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/52/12105/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/52/12105/contributors\">",
"     Howard I Hurtig, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/52/12105/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/52/12105/contributors\">",
"     John F Dashe, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?11/52/12105/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 26, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The treatment of dystonia is symptomatic. No curative therapies are available. Management options include oral medications, botulinum toxin injection, and deep brain stimulation.",
"   </p>",
"   <p>",
"    This topic will review the treatment of dystonia. Other clinical aspects of dystonia are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/60/970?source=see_link\">",
"     \"Classification and evaluation of dystonia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DRUG TREATMENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many oral agents have been used to treat dystonia, but they have not been extensively studied in rigorous controlled trials. The available evidence suggests that several drugs are beneficial in a proportion of patients with dystonia (",
"    <a class=\"graphic graphic_table graphicRef75422 \" href=\"UTD.htm?5/25/5533\">",
"     table 1",
"    </a>",
"    ). However, the therapeutic window for most of the oral agents is narrow, and side effects frequently limit clinical benefit [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Levodopa",
"    </span>",
"    &nbsp;&mdash;&nbsp;Levodopa is dramatically beneficial in dopa-responsive dystonia (DRD). Often, small doses of levodopa one to three times daily can virtually eliminate the dystonic symptoms of DRD for an indefinite period of time without causing motor complications [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]. A sustained and complete response occurs with variable doses ranging from 100 to 750 mg daily [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/2,5\">",
"     2,5",
"    </a>",
"    ]. One case series of 20 patients reported that the mean daily levodopa doses for clinical benefit in patients with and without associated dyskinesia were 343 mg and 189 mg [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In other forms of dystonia, the response rate with levodopa is approximately 15 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Levodopa is available in combination with the peripheral decarboxylase inhibitors",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/9/3221?source=see_link\">",
"     carbidopa",
"    </a>",
"    or benserazide. Treatment should be initiated with low doses, similar to its use in Parkinson disease, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/36/36423?source=see_link\">",
"     carbidopa-levodopa",
"    </a>",
"    <span class=\"nowrap\">",
"     25/100",
"    </span>",
"    mg, one-half tablet two to three times daily with meals. Once started without side effects, the total daily dose can be increased carefully and as tolerated over several weeks to a full tablet of",
"    <span class=\"nowrap\">",
"     25/100",
"    </span>",
"    mg three times daily. The usual practice is to titrate to the lowest levodopa dose that produces a useful clinical response.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Anticholinergic drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/7-9\">",
"     7-9",
"    </a>",
"    ], but not all [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/10\">",
"     10",
"    </a>",
"    ] studies suggest that anticholinergic drugs are beneficial in focal and generalized dystonia.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one of the few controlled trials, with 31 children and young adults who had early onset dystonia, high-dose",
"      <a class=\"drug drug_general\" href=\"UTD.htm?6/1/6165?source=see_link\">",
"       trihexyphenidyl",
"      </a>",
"      (up to 30 mg daily) was effective in the management of torsion dystonia [",
"      <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/9\">",
"       9",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Another trial of nine adult patients with cranial dystonia found no benefit for",
"      <a class=\"drug drug_general\" href=\"UTD.htm?6/1/6165?source=see_link\">",
"       trihexyphenidyl",
"      </a>",
"      or a peripheral anticholinergic agent compared with placebo [",
"      <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      One open label study reported that anticholinergic treatment for dystonia was effective in a greater proportion of children than adults, probably because children were able to tolerate higher doses [",
"      <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/8\">",
"       8",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Evaluating these data, a systematic review from the European Federation of Neurological Societies (EFNS) concluded that there is no proof that anticholinergic drugs are effective in adults, and that the effectiveness and tolerability of anticholinergic drugs in children is poorly documented [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/5,11\">",
"     5,11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Trihexyphenidyl dosing and side effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anticholinergic treatment is initiated at low doses. For adults, the typical starting dose of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/1/6165?source=see_link\">",
"     trihexyphenidyl",
"    </a>",
"    is 1 mg twice daily. The dose is gradually increased in 2 mg increments at intervals of three to seven days until sufficient improvement or unacceptable side effects occur. Full benefit from gradual dose escalation may be delayed for several weeks or months [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/9\">",
"     9",
"    </a>",
"    ]. The maximum suggested dose (given in three or four divided doses) is a total of 15 mg daily for adults and 6 to 10 mg daily for elderly patients.",
"   </p>",
"   <p>",
"    A more aggressive regimen, which should be used only for children or young adults, begins with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/1/6165?source=see_link\">",
"     trihexyphenidyl",
"    </a>",
"    2 mg twice daily, followed by gradual dose increases every week as needed to achieve benefit, unless dose limiting side effects occur. In children, the maximum dose of trihexyphenidyl may be as high as 100 mg daily given in three to four divided doses. As noted above, benefit may be delayed for several weeks.",
"   </p>",
"   <p>",
"    Other anticholinergic agents, including",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/55/3958?source=see_link\">",
"     benztropine",
"    </a>",
"    , and those with both anticholinergic and antihistaminergic effects (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/43/19124?source=see_link\">",
"     procyclidine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/2/33824?source=see_link\">",
"     diphenhydramine",
"    </a>",
"    ) have also been used anecdotally. For each of these agents, a similar slow titration to benefit or side effects is recommended.",
"   </p>",
"   <p>",
"    Discontinuation of anticholinergic agents should be gradual, as withdrawal effects may occur.",
"   </p>",
"   <p>",
"    Anticholinergic side effects include dry mouth, blurred vision, constipation, urinary hesitancy or retention, tachycardia, pupil dilatation, and increased intraocular pressure. Dry mouth may increase the occurrence of dental caries.",
"   </p>",
"   <p>",
"    Additional side effects of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/1/6165?source=see_link\">",
"     trihexyphenidyl",
"    </a>",
"    include dizziness, confusion, memory impairment, nausea, vomiting, and anxiety. The central side effects, including memory loss and sedation, are dose limiting.",
"   </p>",
"   <p>",
"    Narrow-angle glaucoma, confusion, and dementia are contraindications to the use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/1/6165?source=see_link\">",
"     trihexyphenidyl",
"    </a>",
"    . Trihexyphenidyl should be used with caution in people over 60, and in patients with benign prostatic hypertrophy or obstructive gastrointestinal disorders.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Tetrabenazine",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/31/32246?source=see_link\">",
"     Tetrabenazine",
"    </a>",
"    combines monoaminergic depletion and dopamine antagonist effects. Evidence from small trials and case series suggests that tetrabenazine is beneficial in a variety of hyperkinetic movement disorders, including dystonia [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/12-14\">",
"     12-14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a small double-blind crossover trial,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/31/32246?source=see_link\">",
"       tetrabenazine",
"      </a>",
"      treatment resulted in improvement in 9 of 12 patients with different types of dystonia [",
"      <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/12\">",
"       12",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A retrospective case series that included 108 patients with idiopathic dystonia reported sustained benefit for a mean duration of 6.6 years in about 62 percent of patients [",
"      <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/31/32246?source=see_link\">",
"     Tetrabenazine",
"    </a>",
"    is initiated with 12.5 mg daily for one week and increased by 12.5 mg increments every few days, according to clinical response and as tolerated, to a level of 75 to 150 mg daily.",
"   </p>",
"   <p>",
"    Side effects of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/31/32246?source=see_link\">",
"     tetrabenazine",
"    </a>",
"    are frequent and include sedation, parkinsonism, depression, akathisia, nervousness, and insomnia. Tardive dyskinesia has not been associated with tetrabenazine, probably because its site of action is the presynaptic nerve terminal. It has no dopamine receptor blocking properties.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Other agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/45/26328?source=see_link\">",
"     Clonazepam",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/31/36342?source=see_link\">",
"     baclofen",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/48/13064?source=see_link\">",
"     zolpidem",
"    </a>",
"    , and dopamine receptor blockers have been used to treat dystonia, but evidence of effectiveness is scant.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/45/26328?source=see_link\">",
"       Clonazepam",
"      </a>",
"      was reported in uncontrolled studies to improve symptoms of dystonia in approximately 20 percent of patients at doses ranging from 1.5 mg to 12 mg per day [",
"      <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/6\">",
"       6",
"      </a>",
"      ]. Clonazepam may be particularly beneficial for patients who note worsening of dystonia with stress and anxiety, although this has not been studied. The typical starting dose of clonazepam is 0.5 mg once a day, given in the evening before bed time. The dose may be slowly increased in 0.5 mg increments every week. Adverse effects from clonazepam include sedation, depression, confusion, and dependence.",
"     </li>",
"     <li>",
"      One review found retrospective evidence that high-dose oral",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/31/36342?source=see_link\">",
"       baclofen",
"      </a>",
"      (40 to 180 mg daily) was associated with improvement in approximately 30 percent of children and adolescents (n = 31) with idiopathic generalized dystonia [",
"      <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/15\">",
"       15",
"      </a>",
"      ]. Baclofen was less effective for 60 adults with focal cranial dystonia, with sustained benefit in 18 percent. Side effects of oral baclofen, including nausea and sedation, may be intolerable.",
"     </li>",
"     <li>",
"      Intrathecal",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/31/36342?source=see_link\">",
"       baclofen",
"      </a>",
"      administration allows for regionally elevated spinal fluid levels, thereby reducing the occurrence of central side effects. However, it has yet to be established as an effective treatment for dystonia not associated with spasticity [",
"      <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/16\">",
"       16",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/48/13064?source=see_link\">",
"       Zolpidem",
"      </a>",
"      has been reported to improve dystonia in patients with blepharospasm, Meige syndrome, myoclonus dystonia, and X-linked dystonia parkinsonism in small series and single cases [",
"      <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/17-20\">",
"       17-20",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Dopamine receptor blockers such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/21/35161?source=see_link\">",
"       clozapine",
"      </a>",
"      are beneficial in some patients with dystonia [",
"      <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/21,22\">",
"       21,22",
"      </a>",
"      ]. However, this class of medications is not recommended for the treatment of dystonia because of the associated risk of tardive dyskinesia, a disorder that may be disabling and irreversible. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/26/36264?source=see_link\">",
"       \"Tardive dyskinesia: Etiology and epidemiology\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/40/27269?source=see_link\">",
"       \"Tardive dyskinesia: Clinical features and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     BOTULINUM TOXIN INJECTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Botulinum toxin (BoNT) is a potent neurotoxin produced by Clostridium botulinum that causes regional muscle weakness through its action as a zinc endopeptidase cleaving specific proteins involved in vesicular fusion. Disruption of these fusion proteins interferes with the release of acetylcholine at the neuromuscular junction, resulting in localized muscle weakness.",
"   </p>",
"   <p>",
"    Botulinum toxin treatment is beneficial for 50 to 85 percent of patients with cervical dystonia (spasmodic torticollis) and blepharospasm [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/23\">",
"     23",
"    </a>",
"    ]. It is also viewed as the treatment of choice for spasmodic dysphonia (ie, laryngeal dystonia), limb dystonia, and oromandibular dystonia. The available evidence suggests that BoNT is effective for cervical dystonia and is probably effective for blepharospasm, focal arm dystonia, and adductor spasmodic dysphonia [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/24\">",
"     24",
"    </a>",
"    ]. Two serotypes, botulinum toxin type A (BoNT-A) and botulinum toxin type B (BoNT-B), are available commercially.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Cervical dystonia",
"    </span>",
"    &nbsp;&mdash;&nbsp;BoNT-A treatment is often used as first-line therapy for unilateral focal dystonia with spasm and pain involving the sternocleidomastoid, trapezius, or cervical muscles. BoNT-B treatment for cervical dystonia is an option for those who develop resistance to BoNT-A, and it appears to be as effective as BoNT-A, as found in a noninferiority trial comparing the two types among patients with cervical dystonia who were na&iuml;ve to botulinum toxin injection [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Both BoNT-A and BoNT-B are significantly more effective than placebo for the treatment of cervical dystonia, as noted in the following reports.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A meta-analysis of BoNT-A treatment for cervical dystonia published in 2005 identified 13 studies that enrolled 680 patients [",
"      <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/26\">",
"       26",
"      </a>",
"      ]. All the studies were short term (6 to 16 weeks), and the dose and technique of BoNT-A administration varied significantly between studies. The reviewers were unable to access much data from the two largest trials, which were unpublished.",
"      <br/>",
"      <br/>",
"      The meta-analysis showed that BoNT-A treatment resulted in significant improvements on objective rating scales (odds ratio [OR] 4.31, 95% CI 2.68-6.94) and subjective rating scales (OR 6.58, 95% CI 4.55-9.54) [",
"      <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/26\">",
"       26",
"      </a>",
"      ]. The meta-analysis also found that BoNT-A exhibited a clear dose-response relationship for subjective and objective benefit and for frequency and severity of adverse events.",
"      <br/>",
"      <br/>",
"      The reviewers concluded that a single injection cycle of BoNT-A is effective and safe for treating cervical dystonia, and that repeated BoNT-A injection cycles appear to be effective for most patients, based on evidence from trials that enrolled patients who were previously treated with BoNT-A [",
"      <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/26\">",
"       26",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A meta-analysis of BoNT-B treatment for cervical dystonia, also published in 2005, identified three trials enrolling 308 participants [",
"      <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/27\">",
"       27",
"      </a>",
"      ]. All patients had previously been treated with BoNT-A. There was a statistically and clinically significant benefit for BoNT-B therapy as assessed by the number of patients who had at least a 20 percent improvement in the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) total score at week four (OR 4.7, 95% CI 2.1-10.7). Subjective rating scales also improved. Subgroup analyses showed a clear dose-response relationship with BoNT-B treatment for subjective and objective benefit, and for frequency and severity of adverse events. In addition, BoNT-B treatment showed a greater benefit in the primary outcome for BoNT-A resistant patients than BoNT-A responders.",
"     </li>",
"     <li>",
"      An evidence-based review of data from seven randomized controlled trials (four evaluating BoNT-A and three evaluating BoNT-B) published in 2008 by the American Academy of Neurology (AAN) concluded that BoNT is safe and effective for the treatment of cervical dystonia [",
"      <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/24\">",
"       24",
"      </a>",
"      ]. Similar conclusions were reached by the 2011 European Federation of Neurological Societies (EFNS) guidelines [",
"      <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/11\">",
"       11",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although long-term data are limited, an observational study of 45 patients with different types of dystonia, including 19 with cervical dystonia, reported that the response to BoNT injections remained consistent for &ge;12 years [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Limited data suggest that BoNT-A is more effective for cervical dystonia than anticholinergic treatment with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/1/6165?source=see_link\">",
"     trihexyphenidyl",
"    </a>",
"    . In a short-duration double-blind randomized trial of 66 patients, BoNT-A was significantly more beneficial than trihexyphenidyl for improvement on the TWSTRS disability score, and the difference was similar in size to that obtained in the meta-analysis comparing BoNT-A with placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. In addition, BoNT-A was better tolerated than trihexyphenidyl.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Other focal dystonias",
"    </span>",
"    &nbsp;&mdash;&nbsp;The 2008 AAN review concluded that BoNT is probably effective for the treatment of blepharospasm, focal upper limb dystonia (including writer's cramp), and adductor spasmodic dysphonia (ie, adductor laryngeal dystonia) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/24\">",
"     24",
"    </a>",
"    ]. There was insufficient evidence to support or refute the use of BoNT for abductor spasmodic dysphonia (ie, abductor laryngeal dystonia). The evidence is illustrated by the following studies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In six patients with blepharospasm, BoNT-A was injected into one eyelid and saline into the other [",
"      <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/31\">",
"       31",
"      </a>",
"      ]. Assessor-blinded evaluation showed a bilateral reduction in blepharospasm that was greater on the side injected with BoNT-A.",
"     </li>",
"     <li>",
"      A trial randomly assigned 40 patients with writer's cramp to treatment with either BoNT-A or placebo injections [",
"      <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/32\">",
"       32",
"      </a>",
"      ]. At 12 weeks, the proportion of patients who reported a beneficial effect and chose to continue treatment (the primary outcome measure) was significantly greater in the BoNT-A group than the placebo group (70 versus 32 percent). In addition, improvement on most, but not all of the clinical rating scales favored BoNT-A treatment. Transient hand weakness, generally mild, was a side effect of BoNT-A in 75 percent.",
"     </li>",
"     <li>",
"      In a double-blind trial involving 13 patients with adductor-type laryngeal dystonia, seven patients were treated with BoNT-A and six received saline [",
"      <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/33\">",
"       33",
"      </a>",
"      ]. There was significant benefit for several outcomes in the BoNT-A group, including quantitative measures of voice function and subjective patient ratings.",
"     </li>",
"     <li>",
"      In another trial of 15 patients with abductor spasmodic dysphonia that compared different injection techniques of BoNT-A into the posterior cricoarytenoid muscle, improvement with BoNT-A injections was reported by 11 patients [",
"      <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/34\">",
"       34",
"      </a>",
"      ]. However, blinded assessment by speech pathologists found no statistically significant objective benefit with either BoNT-A injection technique. In addition, there were no differences between techniques.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Dosing and side effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the United States, three different types of BoNT-A are marketed, which are designated",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/16/12549?source=see_link\">",
"     abobotulinumtoxinA",
"    </a>",
"    (Dysport&reg;),",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/48/43781?source=see_link\">",
"     incobotulinumtoxinA",
"    </a>",
"    (Xeomin&reg;) and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/27/10681?source=see_link\">",
"     onabotulinumtoxinA",
"    </a>",
"    (Botox&reg;). In addition, there is one marketed BoNT-B, which is designated",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/30/7653?source=see_link\">",
"     rimabotulinumtoxinB",
"    </a>",
"    (Myobloc&reg;). Each of these products is a unique drug with regard to formulation, potency, and dosing [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/35\">",
"     35",
"    </a>",
"    ]. Unfortunately, there is no unique dose ratio to permit switching among different BoNT products [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Furthermore, there is no consensus regarding standard practices for BoNT injections, including dilution ratios for the different BoNT products, the dose per injection, the total dose per muscle, the number of injections at each site, or the methods of targeting injections (eg, whether guided by vision, electromyography, or ultrasound) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/35\">",
"     35",
"    </a>",
"    ]. All of these parameters vary among practitioners and centers.",
"   </p>",
"   <p>",
"    Side effects with BoNT treatment are frequent but typically mild and transient. In the systematic reviews of BoNT for cervical dystonia, adverse events that were significantly more frequent than placebo injection with BoNT-A included neck weakness, dysphagia, dry",
"    <span class=\"nowrap\">",
"     mouth/sore",
"    </span>",
"    throat, and voice",
"    <span class=\"nowrap\">",
"     changes/hoarseness",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/26\">",
"     26",
"    </a>",
"    ]. Adverse events associated with BoNT-B treatment included dysphagia and dry mouth [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/27\">",
"     27",
"    </a>",
"    ]. These side effects are clearly related to the mechanism of action of BoNT. They are attributable to excessive weakness in injected muscles or to diffusion of toxin into nearby structures. In a small retrospective study, the addition of ultrasound imaging to electromyographic guidance of botulinum toxin injections for cervical dystonia was associated with elimination of dysphagia after treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/37\">",
"     37",
"    </a>",
"    ]. This finding needs confirmation in larger controlled studies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Resistance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinical resistance to BoNT develops in 1 to 20 percent of patients receiving repeated large injections [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/38\">",
"     38",
"    </a>",
"    ]. The availability of the alternate serotype BoNT-B provides options when resistance occurs to BoNT-A [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/39\">",
"     39",
"    </a>",
"    ]. Long term observational studies suggest that over two years of treatment, the occurrence of clinical resistance is low with BoNT-A brands [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/38,40\">",
"     38,40",
"    </a>",
"    ]. No published long term studies are available for BoNT-B.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     SURGICAL THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgical treatment is reserved for patients with severe dystonia who fail treatment with pharmacologic agents and botulinum toxin injections. The mainstay of surgical treatment is deep brain microelectrode stimulation of the internal segment of the globus pallidus.",
"   </p>",
"   <p>",
"    Bilateral thalamotomy was used in the 1960s and 1970s for generalized dystonia. However, permanent and serious complications from the procedure (hemiparesis, spasticity, ataxia, dysphagia, and dysarthria) were prohibitive. Since the advent of deep brain stimulation, stereotactic thalamotomy, pallidotomy, and cervical rhizotomy are rarely used to treat refractory dystonia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Deep brain stimulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Deep brain stimulation (DBS) of the internal globus pallidus (GPi) has emerged as the surgical treatment of choice for children and adults with disabling primary generalized or cervical dystonia who do not respond to pharmacologic therapy or chemodenervation with botulinum toxin [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/41-49\">",
"     41-49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One of the larger controlled trials of DBS randomly assigned 40 patients (18 to 75 years old) with segmental or generalized primary dystonia to either GPi stimulation or sham stimulation [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/44\">",
"     44",
"    </a>",
"    ]. Two investigators, who were blind to both group assignment and to chronologic order of the examinations, assessed the severity of dystonia by reviewing videotaped sessions of patients made at baseline and after treatment. The primary end point was the change from baseline in the movement subscore on the Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS). The following observations were reported:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      At three months, improvement in the severity of symptoms on the BFMDRS movement subscore was significantly greater in the GPi stimulation group than in the sham stimulation group (-15.8 versus -1.4 points). DBS was significantly more effective than sham stimulation for reduction in disability and improvement in the physical aspects of quality of life.",
"     </li>",
"     <li>",
"      In the GPi stimulation group, a positive response to treatment (ie, a &gt;25 percent reduction in the BFMDRS movement subscore) at three months was observed in 15 patients (75 percent).",
"     </li>",
"     <li>",
"      During a six-month open-label extension period, patients originally assigned to sham stimulation had a similar benefit when switched to active treatment. In addition, improvement was sustained among patients originally assigned to GPi stimulation.",
"     </li>",
"     <li>",
"      Dysarthria (n = 5) and infection at the stimulator site (n = 4) were the most frequent adverse events. There was one lead dislodgement.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Long-term data regarding the utility of DBS for dystonia are limited [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/49-51\">",
"     49-51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One prospective study of 22 patients with generalized primary dystonia found a clinically significant improvement in motor symptoms and a mild improvement in quality of life three years after bilateral DBS of the GPi [",
"      <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/49\">",
"       49",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      An observational study of 26 patients with the DYT1 gene mutation who had DBS and were followed for mean of six years (range three to 10 years) found that the benefit from DBS persisted in most [",
"      <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/51\">",
"       51",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A series of 10 patients with cervical dystonia receiving DBS who were followed for a mean of three years (range one to five years) reported that nine patients had continued benefit at a moderate or better level [",
"      <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/52\">",
"       52",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Accurate placement of stimulating electrodes in the area of the intercommissural plane provides for optimal outcome in generalized dystonia [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/53\">",
"     53",
"    </a>",
"    ]. Specific locations in the GPi should be targeted for dystonia in specific body regions, reflecting the somatotopic organization of that structure [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although not mentioned in the larger prospective trials, several smaller reports have observed the development of bradykinetic movement disorders including micrographia, parkinsonism, and hypokinetic gait in patients with dystonia who were treated with DBS of the Gpi [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/55-58\">",
"     55-58",
"    </a>",
"    ]. In one of the larger studies that retrospectively analyzed 71 such patients who had no gait disorder due to dystonia before treatment, a new gait disorder developed after bilateral DBS in six patients (8 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/58\">",
"     58",
"    </a>",
"    ]. The gait disorder was reported at three to six months after DBS surgery and was characterized by shuffling steps and difficulty with gait initiation and turning. Freezing of gait developed at higher voltages but resolved within minutes of stopping stimulation. In all cases, electrode misplacement was ruled out as a cause for the gait disorder. Because all six patients otherwise showed benefit, the DBS settings were adjusted to achieve an optimal balance between controlling dystonia and eliciting freezing of gait.",
"   </p>",
"   <p>",
"    Although less well studied than the GPi, the subthalamic nucleus is a potential alternative target for DBS in patients with primary dystonia [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/59-61\">",
"     59-61",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    DBS may also be effective for focal dystonia, although the evidence is less robust than it is for generalized dystonia [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/47,62\">",
"     47,62",
"    </a>",
"    ]. As an example, a single-blind study evaluated 10 patients with severe, refractory cervical dystonia who had bilateral DBS of the GPi [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/47\">",
"     47",
"    </a>",
"    ]. On the primary outcome measure one year after surgery, there was significant improvement in the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) severity subscore compared with the presurgical baseline (8.4 versus 14.7).",
"   </p>",
"   <p>",
"    DBS has not been consistently effective for the treatment of secondary dystonia, although small case series and case reports indicate improvement in some patients with various types of secondary dystonia [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/62-66\">",
"     62-66",
"    </a>",
"    ]. One series of six patients with pantothenate kinase-associated neurodegeneration reported that GPi stimulation was associated with major improvement in all six [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/65\">",
"     65",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     GENE THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The technique of RNA interference (RNAi) is a promising avenue of therapy for DYT1 dystonia [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/67\">",
"     67",
"    </a>",
"    ]. Using this method, it is possible to inhibit gene expression by inhibiting or degrading the targeted messenger RNA.",
"   </p>",
"   <p>",
"    RNAi &ndash;mediated gene silencing is particularly relevant to treatment of DYT1 dystonia, which arises from a single gene mutation and is primarily a disorder of neuronal function rather than neuronal degeneration. In one study, investigators successfully developed viral mediated RNAi and effectively silenced the expression of mutated torsinA [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/67\">",
"     67",
"    </a>",
"    ]. This technique has not yet been applied to humans.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     CHOOSING THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The choice of initial therapy depends on the type of dystonia requiring treatment.",
"   </p>",
"   <p>",
"    For patients with focal or generalized dystonia of unknown etiology, we recommend a trial of levodopa (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/36/36423?source=see_link\">",
"     carbidopa-levodopa",
"    </a>",
"    <span class=\"nowrap\">",
"     25/100",
"    </span>",
"    mg three times daily, slowly increased to total levodopa doses of 600 to 1,000 mg daily) to confirm or exclude the diagnosis of dopa-responsive dystonia. This is discussed in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/60/970?source=see_link&amp;anchor=H19#H19\">",
"     \"Classification and evaluation of dystonia\", section on 'Dopa-responsive dystonia'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with a clinically significant positive response (ie, those with dopa-responsive dystonia) should continue levodopa. The dose is then adjusted to obtain the optimum response. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Levodopa'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Patients with primary dystonia who do not respond to levodopa can be treated with other oral medications, botulinum toxin injection, or DBS in refractory cases, as discussed below.",
"   </p>",
"   <p>",
"    For secondary dystonia, options depend upon the availability of treatment for the underlying disorder. Oral medications and botulinum toxin injection treatments are sometimes useful.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Generalized primary dystonia",
"    </span>",
"    &nbsp;&mdash;&nbsp;For children, adolescents, and young adults with debilitating primary generalized dystonia that does not respond to a trial of levodopa, initial treatment with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/1/6165?source=see_link\">",
"     trihexyphenidyl",
"    </a>",
"    is a reasonable choice. High trihexyphenidyl doses may be necessary to achieve a clinically significant response. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Anticholinergic drugs'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Older adults are generally less able to tolerate high-dose",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/1/6165?source=see_link\">",
"     trihexyphenidyl",
"    </a>",
"    , although they may benefit from lower doses, provided that dose adjustments are done slowly with frequent monitoring for side effects. However, in appropriate adults, trihexyphenidyl may be used cautiously. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Anticholinergic drugs'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/31/32246?source=see_link\">",
"     Tetrabenazine",
"    </a>",
"    may also be useful for adults who have debilitating generalized primary dystonia, although careful monitoring for side effects, including depression, is advised. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Tetrabenazine'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    In patients with generalized dystonia, botulinum toxin injection of selected areas that are the most troublesome may be beneficial [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12105/abstract/68\">",
"     68",
"    </a>",
"    ]. However, it is NOT reasonable to use widespread botulinum toxin injection treatment for all symptoms of generalized dystonia because of dose limitations. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Botulinum toxin injections'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    We suggest bilateral deep brain stimulation (DBS) of the internal globus pallidus (GPi) for children and adults with debilitating generalized primary dystonia who do not respond to or tolerate pharmacologic therapy or botulinum toxin, and who are appropriate candidates for the procedure. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Deep brain stimulation'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Cervical dystonia and other types of focal primary dystonia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Short-term randomized trials have established that botulinum toxin injection therapy is significantly more effective than placebo for the treatment of cervical dystonia (spasmodic torticollis). In addition, there is limited clinical trial evidence that botulinum toxin injection therapy is more effective for cervical dystonia than anticholinergic treatment with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/1/6165?source=see_link\">",
"     trihexyphenidyl",
"    </a>",
"    . Therefore, we recommend BoNT for early or late onset primary cervical dystonia. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Botulinum toxin injections'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    We also recommend BoNT for other types of focal dystonia including blepharospasm, focal upper limb dystonia (eg, writer's cramp), and adductor laryngeal dystonia (ie, adductor spasmodic dysphonia). (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Botulinum toxin injections'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    We suggest bilateral DBS of the GPi for children and adults with debilitating primary cervical dystonia or other types of primary focal dystonia who do not respond to or tolerate botulinum toxin treatment or oral pharmacologic therapy, including levodopa.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Tardive dystonia",
"    </span>",
"    &nbsp;&mdash;&nbsp;The treatment of tardive dystonia is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/8/34952?source=see_link\">",
"     \"Tardive dyskinesia: Prevention and treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?34/2/34849?source=see_link\">",
"       \"Patient information: Dystonia (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For pediatric and adult patients with focal or generalized dystonia of unknown etiology, we recommend a trial of levodopa to confirm or exclude the diagnosis of dopa-responsive dystonia. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Choosing therapy'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/60/970?source=see_link&amp;anchor=H19#H19\">",
"       \"Classification and evaluation of dystonia\", section on 'Dopa-responsive dystonia'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients with multifocal or generalized primary dystonia who do not respond to levodopa can be treated with other oral medications, botulinum toxin injections, or deep brain stimulation in refractory cases:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      For children, adolescents, and adults with debilitating generalized primary dystonia that does not respond to a trial of levodopa, we suggest treatment with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?6/1/6165?source=see_link\">",
"       trihexyphenidyl",
"      </a>",
"      &nbsp;(",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Anticholinergic drugs'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H5\">",
"       'Trihexyphenidyl dosing and side effects'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For adults who have debilitating generalized primary dystonia that does not respond to a trial of levodopa or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?6/1/6165?source=see_link\">",
"       trihexyphenidyl",
"      </a>",
"      , we suggest treatment with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/31/32246?source=see_link\">",
"       tetrabenazine",
"      </a>",
"      &nbsp;(",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Tetrabenazine'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For children and adults who have debilitating multifocal or generalized primary dystonia that does not respond to pharmacologic treatment, we suggest botulinum toxin injection of selected muscles that are most troublesome (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). However, widespread injections are NOT a reasonable option for multifocal or generalized dystonia. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Botulinum toxin injections'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For children and adults with debilitating multifocal or generalized primary dystonia who do not respond to pharmacologic therapy or botulinum toxin injections, we suggest bilateral deep brain stimulation of the internal globus pallidus (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Deep brain stimulation'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For children and adults with early or late onset primary cervical dystonia, we recommend botulinum toxin injection therapy (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Cervical dystonia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For children and adults with blepharospasm, focal upper limb dystonia (including writer's cramp), and adductor spasmodic dysphonia (adductor laryngeal dystonia), we recommend botulinum toxin injection therapy (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Other focal dystonias'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For children and adults with debilitating cervical dystonia or other types of focal primary dystonia who do not respond to botulinum toxin injections, we suggest bilateral deep brain stimulation of the internal globus pallidus (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Deep brain stimulation'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/1\">",
"      Jankovic J. Treatment of dystonia. Lancet Neurol 2006; 5:864.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/2\">",
"      Rajput AH, Gibb WR, Zhong XH, et al. Dopa-responsive dystonia: pathological and biochemical observations in a case. Ann Neurol 1994; 35:396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/3\">",
"      Nutt JG, Nygaard TG. Response to levodopa treatment in dopa-responsive dystonia. Arch Neurol 2001; 58:905.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/4\">",
"      Hwang WJ, Calne DB, Tsui JK, de la Fuente-Fern&aacute;ndez R. The long-term response to levodopa in dopa-responsive dystonia. Parkinsonism Relat Disord 2001; 8:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/5\">",
"      Albanese A, Barnes MP, Bhatia KP, et al. A systematic review on the diagnosis and treatment of primary (idiopathic) dystonia and dystonia plus syndromes: report of an EFNS/MDS-ES Task Force. Eur J Neurol 2006; 13:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/6\">",
"      Greene P, Shale H, Fahn S. Experience with high dosages of anticholinergic and other drugs in the treatment of torsion dystonia. Adv Neurol 1988; 50:547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/7\">",
"      Burke RE, Fahn S. Double-blind evaluation of trihexyphenidyl in dystonia. Adv Neurol 1983; 37:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/8\">",
"      Fahn S. High dosage anticholinergic therapy in dystonia. Neurology 1983; 33:1255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/9\">",
"      Burke RE, Fahn S, Marsden CD. Torsion dystonia: a double-blind, prospective trial of high-dosage trihexyphenidyl. Neurology 1986; 36:160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/10\">",
"      Nutt JG, Hammerstad JP, deGarmo P, Carter J. Cranial dystonia: double-blind crossover study of anticholinergics. Neurology 1984; 34:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/11\">",
"      Albanese A, Asmus F, Bhatia KP, et al. EFNS guidelines on diagnosis and treatment of primary dystonias. Eur J Neurol 2011; 18:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/12\">",
"      Jankovic J. Treatment of hyperkinetic movement disorders with tetrabenazine: a double-blind crossover study. Ann Neurol 1982; 11:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/13\">",
"      Kenney C, Hunter C, Jankovic J. Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders. Mov Disord 2007; 22:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/14\">",
"      Jankovic J, Beach J. Long-term effects of tetrabenazine in hyperkinetic movement disorders. Neurology 1997; 48:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/15\">",
"      Greene P. Baclofen in the treatment of dystonia. Clin Neuropharmacol 1992; 15:276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/16\">",
"      Ford B, Greene PE, Louis ED, et al. Intrathecal baclofen in the treatment of dystonia. Adv Neurol 1998; 78:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/17\">",
"      An JY, Kim JS, Kim YI, Lee KS. Successful treatment of the Meige syndrome with oral zolpidem monotherapy. Mov Disord 2008; 23:1619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/18\">",
"      Park IS, Kim JS, An JY, et al. Excellent response to oral zolpidem in a sporadic case of the myoclonus dystonia syndrome. Mov Disord 2009; 24:2172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/19\">",
"      Garretto NS, Bueri JA, Rey RD, et al. Improvement of blepharospasm with Zolpidem. Mov Disord 2004; 19:967.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/20\">",
"      Evidente VG. Zolpidem improves dystonia in \"Lubag\" or X-linked dystonia-parkinsonism syndrome. Neurology 2002; 58:662.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/21\">",
"      Lang AE. Dopamine agonists and antagonists in the treatment of idiopathic dystonia. Adv Neurol 1988; 50:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/22\">",
"      Karp BI, Goldstein SR, Chen R, et al. An open trial of clozapine for dystonia. Mov Disord 1999; 14:652.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/23\">",
"      Comella CL, Pullman SL. Botulinum toxins in neurological disease. Muscle Nerve 2004; 29:628.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/24\">",
"      Simpson DM, Blitzer A, Brashear A, et al. Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2008; 70:1699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/25\">",
"      Pappert EJ, Germanson T, Myobloc/Neurobloc European Cervical Dystonia Study Group. Botulinum toxin type B vs. type A in toxin-na&iuml;ve patients with cervical dystonia: Randomized, double-blind, noninferiority trial. Mov Disord 2008; 23:510.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/26\">",
"      Costa J, Esp&iacute;rito-Santo C, Borges A, et al. Botulinum toxin type A therapy for cervical dystonia. Cochrane Database Syst Rev 2005; :CD003633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/27\">",
"      Costa J, Esp&iacute;rito-Santo C, Borges A, et al. Botulinum toxin type B for cervical dystonia. Cochrane Database Syst Rev 2005; :CD004315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/28\">",
"      Mejia NI, Vuong KD, Jankovic J. Long-term botulinum toxin efficacy, safety, and immunogenicity. Mov Disord 2005; 20:592.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/29\">",
"      Brans JW, Lindeboom R, Snoek JW, et al. Botulinum toxin versus trihexyphenidyl in cervical dystonia: a prospective, randomized, double-blind controlled trial. Neurology 1996; 46:1066.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/30\">",
"      Costa J, Esp&iacute;rito-Santo C, Borges A, et al. Botulinum toxin type A versus anticholinergics for cervical dystonia. Cochrane Database Syst Rev 2005; :CD004312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/31\">",
"      Girlanda P, Quartarone A, Sinicropi S, et al. Unilateral injection of botulinum toxin in blepharospasm: single fiber electromyography and blink reflex study. Mov Disord 1996; 11:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/32\">",
"      Kruisdijk JJ, Koelman JH, Ongerboer de Visser BW, et al. Botulinum toxin for writer's cramp: a randomised, placebo-controlled trial and 1-year follow-up. J Neurol Neurosurg Psychiatry 2007; 78:264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/33\">",
"      Troung DD, Rontal M, Rolnick M, et al. Double-blind controlled study of botulinum toxin in adductor spasmodic dysphonia. Laryngoscope 1991; 101:630.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/34\">",
"      Bielamowicz S, Squire S, Bidus K, Ludlow CL. Assessment of posterior cricoarytenoid botulinum toxin injections in patients with abductor spasmodic dysphonia. Ann Otol Rhinol Laryngol 2001; 110:406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/35\">",
"      Albanese A. Terminology for preparations of botulinum neurotoxins: what a difference a name makes. JAMA 2011; 305:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/36\">",
"      Chapman MA, Barron R, Tanis DC, et al. Comparison of botulinum neurotoxin preparations for the treatment of cervical dystonia. Clin Ther 2007; 29:1325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/37\">",
"      Hong JS, Sathe GG, Niyonkuru C, Munin MC. Elimination of dysphagia using ultrasound guidance for botulinum toxin injections in cervical dystonia. Muscle Nerve 2012; 46:535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/38\">",
"      Brin MF, Comella CL, Jankovic J, et al. Long-term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay. Mov Disord 2008; 23:1353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/39\">",
"      Brin MF, Lew MF, Adler CH, et al. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia. Neurology 1999; 53:1431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/40\">",
"      Lange O, Bigalke H, Dengler R, et al. Neutralizing antibodies and secondary therapy failure after treatment with botulinum toxin type A: much ado about nothing? Clin Neuropharmacol 2009; 32:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/41\">",
"      Coubes P, Roubertie A, Vayssiere N, et al. Treatment of DYT1-generalised dystonia by stimulation of the internal globus pallidus. Lancet 2000; 355:2220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/42\">",
"      Vidailhet M, Vercueil L, Houeto JL, et al. Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia. N Engl J Med 2005; 352:459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/43\">",
"      Zorzi G, Marras C, Nardocci N, et al. Stimulation of the globus pallidus internus for childhood-onset dystonia. Mov Disord 2005; 20:1194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/44\">",
"      Kupsch A, Benecke R, M&uuml;ller J, et al. Pallidal deep-brain stimulation in primary generalized or segmental dystonia. N Engl J Med 2006; 355:1978.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/45\">",
"      Parr JR, Green AL, Joint C, et al. Deep brain stimulation in childhood: an effective treatment for early onset idiopathic generalised dystonia. Arch Dis Child 2007; 92:708.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/46\">",
"      Alterman RL, Miravite J, Weisz D, et al. Sixty hertz pallidal deep brain stimulation for primary torsion dystonia. Neurology 2007; 69:681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/47\">",
"      Kiss ZH, Doig-Beyaert K, Eliasziw M, et al. The Canadian multicentre study of deep brain stimulation for cervical dystonia. Brain 2007; 130:2879.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/48\">",
"      Alterman RL, Snyder BJ. Deep brain stimulation for torsion dystonia. Acta Neurochir Suppl 2007; 97:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/49\">",
"      Vidailhet M, Vercueil L, Houeto JL, et al. Bilateral, pallidal, deep-brain stimulation in primary generalised dystonia: a prospective 3 year follow-up study. Lancet Neurol 2007; 6:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/50\">",
"      Isaias IU, Alterman RL, Tagliati M. Deep brain stimulation for primary generalized dystonia: long-term outcomes. Arch Neurol 2009; 66:465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/51\">",
"      Cif L, Vasques X, Gonzalez V, et al. Long-term follow-up of DYT1 dystonia patients treated by deep brain stimulation: an open-label study. Mov Disord 2010; 25:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/52\">",
"      Cacciola F, Farah JO, Eldridge PR, et al. Bilateral deep brain stimulation for cervical dystonia: long-term outcome in a series of 10 patients. Neurosurgery 2010; 67:957.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/53\">",
"      Starr PA, Turner RS, Rau G, et al. Microelectrode-guided implantation of deep brain stimulators into the globus pallidus internus for dystonia: techniques, electrode locations, and outcomes. J Neurosurg 2006; 104:488.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/54\">",
"      Vayssiere N, van der Gaag N, Cif L, et al. Deep brain stimulation for dystonia confirming a somatotopic organization in the globus pallidus internus. J Neurosurg 2004; 101:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/55\">",
"      Berman BD, Starr PA, Marks WJ Jr, Ostrem JL. Induction of bradykinesia with pallidal deep brain stimulation in patients with cranial-cervical dystonia. Stereotact Funct Neurosurg 2009; 87:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/56\">",
"      Zauber SE, Watson N, Comella CL, et al. Stimulation-induced parkinsonism after posteroventral deep brain stimulation of the globus pallidus internus for craniocervical dystonia. J Neurosurg 2009; 110:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/57\">",
"      Blahak C, Capelle HH, Baezner H, et al. Micrographia induced by pallidal DBS for segmental dystonia: a subtle sign of hypokinesia? J Neural Transm 2011; 118:549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/58\">",
"      Schrader C, Capelle HH, Kinfe TM, et al. GPi-DBS may induce a hypokinetic gait disorder with freezing of gait in patients with dystonia. Neurology 2011; 77:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/59\">",
"      Sun B, Chen S, Zhan S, et al. Subthalamic nucleus stimulation for primary dystonia and tardive dystonia. Acta Neurochir Suppl 2007; 97:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/60\">",
"      Kleiner-Fisman G, Liang GS, Moberg PJ, et al. Subthalamic nucleus deep brain stimulation for severe idiopathic dystonia: impact on severity, neuropsychological status, and quality of life. J Neurosurg 2007; 107:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/61\">",
"      Ostrem JL, Racine CA, Glass GA, et al. Subthalamic nucleus deep brain stimulation in primary cervical dystonia. Neurology 2011; 76:870.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/62\">",
"      Pretto TE, Dalvi A, Kang UJ, Penn RD. A prospective blinded evaluation of deep brain stimulation for the treatment of secondary dystonia and primary torticollis syndromes. J Neurosurg 2008; 109:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/63\">",
"      Eltahawy HA, Saint-Cyr J, Giladi N, et al. Primary dystonia is more responsive than secondary dystonia to pallidal interventions: outcome after pallidotomy or pallidal deep brain stimulation. Neurosurgery 2004; 54:613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/64\">",
"      Deutschl&auml;nder A, Asmus F, Gasser T, et al. Sporadic rapid-onset dystonia-parkinsonism syndrome: failure of bilateral pallidal stimulation. Mov Disord 2005; 20:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/65\">",
"      Castelnau P, Cif L, Valente EM, et al. Pallidal stimulation improves pantothenate kinase-associated neurodegeneration. Ann Neurol 2005; 57:738.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/66\">",
"      Zhang JG, Zhang K, Wang ZC, et al. Deep brain stimulation in the treatment of secondary dystonia. Chin Med J (Engl) 2006; 119:2069.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/67\">",
"      Gonzalez-Alegre P, Bode N, Davidson BL, Paulson HL. Silencing primary dystonia: lentiviral-mediated RNA interference therapy for DYT1 dystonia. J Neurosci 2005; 25:10502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12105/abstract/68\">",
"      Tarsy D, Simon DK. Dystonia. N Engl J Med 2006; 355:818.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4887 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-58.240.98.179-BD8FC545DF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_52_12105=[""].join("\n");
var outline_f11_52_12105=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H20\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DRUG TREATMENTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Levodopa",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Anticholinergic drugs",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Trihexyphenidyl dosing and side effects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Tetrabenazine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Other agents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      BOTULINUM TOXIN INJECTIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Cervical dystonia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Other focal dystonias",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Dosing and side effects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Resistance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      SURGICAL THERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Deep brain stimulation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      GENE THERAPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      CHOOSING THERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Generalized primary dystonia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Cervical dystonia and other types of focal primary dystonia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Tardive dystonia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEURO/4887\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/4887|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?5/25/5533\" title=\"table 1\">",
"      Oral medications for dystonia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/60/970?source=related_link\">",
"      Classification and evaluation of dystonia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?34/2/34849?source=related_link\">",
"      Patient information: Dystonia (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/40/27269?source=related_link\">",
"      Tardive dyskinesia: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/26/36264?source=related_link\">",
"      Tardive dyskinesia: Etiology and epidemiology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/8/34952?source=related_link\">",
"      Tardive dyskinesia: Prevention and treatment",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_52_12106="Prevention of falls in children";
var content_f11_52_12106=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Prevention of falls in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/52/12106/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/52/12106/contributors\">",
"     Anne C Gill, DrPH, RN, MS",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/52/12106/contributors\">",
"     Nancy R Kelly, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/52/12106/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/52/12106/contributors\">",
"     Jan E Drutz, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/52/12106/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/52/12106/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?11/52/12106/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 3, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Unintentional falls are the leading cause of nonfatal injury in children younger than 14 years of age in the United States (",
"    <a class=\"graphic graphic_table graphicRef65440 \" href=\"UTD.htm?7/46/7918\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/1\">",
"     1",
"    </a>",
"    ]. Fall-related mortality in children has declined since 1987; nonetheless, according to the National Center for Injury and Prevention Control in 2009, 93 fall-related deaths occurred in children younger than 15 years: 65 in children younger than five years, 126 in children between 5 and 10 years, and 16 in children between 11 and 14 years [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/2\">",
"     2",
"    </a>",
"    ]. Boys are more than twice as likely as girls to die from fall-related injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Emergency department and outpatient surveillance systems indicate that falls are one of the most common injuries requiring medical care and the most common nonfatal injury requiring hospitalization [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/4-6\">",
"     4-6",
"    </a>",
"    ]. Each year, 2.9 million children are treated in emergency rooms for fall-related injuries, with children younger than five years of age representing the largest proportion of visits (",
"    <a class=\"graphic graphic_table graphicRef65440 \" href=\"UTD.htm?7/46/7918\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/1,7-11\">",
"     1,7-11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Children younger than 10 years of age are at the greatest risk of incurring fall-related injury; they are injured in falls at approximately twice the rate as that of the total population (except individuals older than 65 years, who have fall-related injury rates similar to those of children) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/1\">",
"     1",
"    </a>",
"    ]. Falls are also the most frequent cause of any injury during infancy (an estimated 35.1 per 1000 infant-years) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/12\">",
"     12",
"    </a>",
"    ]. The combination of curiosity, immature motor skills, and lack of judgment renders preschool children particularly susceptible to falling (eg, as they climb on furniture to obtain toys that are out of reach).",
"   </p>",
"   <p>",
"    Falls by children occur mainly in the warmer months [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/13-15\">",
"     13-15",
"    </a>",
"    ]. The location and mechanism of injuries caused by falls vary depending upon the age of the child. More than 80 percent of fall-related injuries in children younger than four years of age occur in the home; among children aged 5 to 14 years, approximately one-half of the injuries occur at home and one-quarter at school. Infants are at risk for falling from furniture or stairs [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/14,16,17\">",
"     14,16,17",
"    </a>",
"    ], toddlers are at risk for falling from windows, and older children are at risk for falling from playground equipment.",
"   </p>",
"   <p>",
"    Children from low-income families are more likely to be injured from falls due to lack of safety equipment (eg, window guards) or deteriorating housing [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/3,18,19\">",
"     3,18,19",
"    </a>",
"    ]. Additional predisposing factors for fall injuries identified in case series include history of previous unintentional injury, neurologic disorder (eg, seizures, developmental delay, hyperactivity), documented parental neglect, and acute stressors (eg, recent move, illness, or job change) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/20-23\">",
"     20-23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     FALLS FROM HEIGHT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The severity of fall-related injuries is related to the height of the fall [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/20,24\">",
"     20,24",
"    </a>",
"    ]. The mortality rate increases from 1.0 percent for falls from &lt;15 feet to 2.4 percent for falls &gt;15 feet. [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/24,25\">",
"     24,25",
"    </a>",
"    ]. The mortality rate for short falls (&lt;1.5 meters in vertical height) for infants and young children is &lt;0.48 deaths per year [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/26\">",
"     26",
"    </a>",
"    ]. Head injury, orthopedic injury, and thoracic injury occur more commonly from high-level falls, whereas abdominal injury occurs more commonly from low-level falls in children [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/24\">",
"     24",
"    </a>",
"    ]. In children, falls from heights usually occur from windows, balconies, and roofs. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/7/32889?source=see_link\">",
"     \"Evaluation of cervical spine injuries in children and adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/38/12906?source=see_link\">",
"     \"Minor head trauma in infants and children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/63/27640?source=see_link\">",
"     \"Initial evaluation and stabilization of children with thoracic trauma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/62/33768?source=see_link\">",
"     \"Overview of blunt abdominal trauma in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Windows",
"    </span>",
"    &nbsp;&mdash;&nbsp;Compared with falls associated with other products, children are more likely to be severely injured or die from window-related falls [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/27\">",
"     27",
"    </a>",
"    ]. Each year in the United States, approximately 12 children younger than 10 years of age die from injuries related to falls from windows [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/27\">",
"     27",
"    </a>",
"    ]. Head injury is the usual cause of death [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/28\">",
"     28",
"    </a>",
"    ]. In addition, an estimated 4000 children younger than 10 years of age are treated in hospital emergency departments for injuries sustained by falling from windows [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/27\">",
"     27",
"    </a>",
"    ]; 45 percent of the injuries are serious (eg, fractures, internal injury, concussion, intracranial hematoma, intracranial hemorrhage) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/20\">",
"     20",
"    </a>",
"    ]. Head injuries and fractures are the most common of the serious injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/20,29\">",
"     20,29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Fatal injuries related to falls from windows are usually from the second story or higher; the mean height for fatal window-related fall injuries is five to six stories [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/20\">",
"     20",
"    </a>",
"    ]. Serious or life-threatening injuries rarely are sustained in falls from less than 10 feet [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/30\">",
"     30",
"    </a>",
"    ]. Thus, many trauma centers use \"fall greater than 15 feet\" as criteria for transport to a trauma center [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/31,32\">",
"     31,32",
"    </a>",
"    ]. However, this criterion may be a poor predictor of major injury [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/24,33,34\">",
"     24,33,34",
"    </a>",
"    ], particularly when no unrelated witnesses can corroborate the initial history [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Intentional injury should be considered in children with serious injuries from falls that were reported to be less than two stories and in all unwitnessed falls [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/30,31,34,35\">",
"     30,31,34,35",
"    </a>",
"    ]. In one series of 61 patients who required hospital admission for falls from at least one story, approximately one-quarter of the falls were intentional: some children jumped to avoid beatings or fires, some were pushed, and some attempted suicide [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/36\">",
"     36",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/54/26473?source=see_link\">",
"     \"Physical abuse in children: Epidemiology and clinical manifestations\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Most deaths and hospitalizations related to falls from windows occur during the spring and summer months [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/20,22,29,37\">",
"     20,22,29,37",
"    </a>",
"    ]. One author suggested a possible association between record-breaking temperatures and an increased incidence of pediatric falls from windows [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/38\">",
"     38",
"    </a>",
"    ]. Children at increased risk for falling from windows are boys, younger than five years, and playing unsupervised at the time of the fall [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/18,29,39,40\">",
"     18,29,39,40",
"    </a>",
"    ]. Children living in apartment buildings are five times more likely to fall from a window than are children living in a house [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/20\">",
"     20",
"    </a>",
"    ]. Falls from windows occur more often in urban areas with multilevel, low-income, poorly maintained housing [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/3,21,37,41\">",
"     3,21,37,41",
"    </a>",
"    ]. The windows usually are in bedrooms or living rooms on the second or third story of apartment buildings or single-family homes; they typically are left open (with just a screen in place) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/28\">",
"     28",
"    </a>",
"    ]. Furniture often is placed under or near the open window.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Prevention",
"    </span>",
"    &nbsp;&mdash;&nbsp;Window guards or stops can be used to prevent children from falling through the window opening. The maximum opening should be less than 4 inches because most children younger than six years can slip through a 6-inch opening, and none older than one year can pass through a 4-inch opening [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Two years after the introduction of an educational program and the provision of free, easily installed window guards to families with young children living in high-risk areas of New York City, mortality related to falls from windows was reduced by 50 percent (from 108 to 54 deaths per year) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/37\">",
"     37",
"    </a>",
"    ]. No child fell from a window equipped with a window guard. The success of the program in reducing fall-related injury and death persuaded the New York City Department of Health to require landlords to provide window guards in apartments that house children younger than 10 years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/42\">",
"     42",
"    </a>",
"    ]. Admissions to local hospitals for injuries related to falls from windows decreased by as much as 96 percent after the mandatory program was established [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The American Academy of Pediatrics (AAP) Committee on Injury and Poison Prevention has issued a policy statement regarding falls from windows, roofs, and balconies (",
"    <a class=\"external\" href=\"file://aappolicy.aappublications.org/cgi/content/full/pediatrics;107/5/1188\">",
"     file://aappolicy.aappublications.org/cgi/content/full/pediatrics;107/5/1188",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/20\">",
"     20",
"    </a>",
"    ]. Recommended strategies to prevent such falls include the installation of window guards or stops on all multistory housing. The window guards or stops should have simple emergency release mechanisms in case of fire if they are to be used on the sixth or lower stories [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/43\">",
"     43",
"    </a>",
"    ]. Guards for use on the seventh floor and above should be permanently affixed [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other important strategies to prevent falls from windows include the following [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/20\">",
"     20",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Open double-hung windows from the top only",
"     </li>",
"     <li>",
"      Avoid the placement of furniture under or near windows",
"     </li>",
"     <li>",
"      Supervise young children, particularly near open windows",
"     </li>",
"     <li>",
"      Plant shrubbery at the base of tall buildings to soften the impact surface",
"     </li>",
"     <li>",
"      Close windows in rooms where children play",
"     </li>",
"     <li>",
"      Do not rely on window screens to prevent falls [",
"      <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/45\">",
"       45",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Other heights",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to falling from windows, children can fall from a variety of other heights, including rooftops, fire escapes, and balconies [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/3,20,37,46\">",
"     3,20,37,46",
"    </a>",
"    ]. Falls from these locations typically occur in older boys. Falls from stairs occur most frequently between the ages of 6 and 11 months [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/17,47\">",
"     17,47",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Prevention",
"    </span>",
"    &nbsp;&mdash;&nbsp;The building codes in many communities require that railings be placed on balconies and fire escapes to prevent a child from passing through them [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/20\">",
"     20",
"    </a>",
"    ]. National building codes for all newly constructed buildings specify that vertical railing bars must be placed no more than 4 inches apart, and most codes specify railing heights of 36 inches. The retrofitting of older dwellings with railings would help to prevent additional falls from heights. In addition, the provision of safe ground-level playing areas may prevent children from playing in dangerous areas, such as fire escapes and roofs [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The use of stair gates in the home may prevent falls from stairs in young children. Meta-analyses have shown safety interventions that provide free or reduced-cost stair gates are effective in increasing stair gate use [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/48\">",
"     48",
"    </a>",
"    ]",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     BABY WALKERS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In 2008, 3298 children under 24 months of age were treated in emergency departments for injuries associated with baby walkers [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/49\">",
"     49",
"    </a>",
"    ]. Data from the National Electronic Injury Surveillance System (NEISS) of the Consumer Product Safety Commission (CPSC) indicate that emergency department visits by children younger than 15 months for injuries related to baby walkers decreased by 76 percent (from 20,900 to 5100) between 1990 and 2001 [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/50\">",
"     50",
"    </a>",
"    ]. It is not clear if this decrease is the result of educational efforts or due to the walker safety standards that were adopted in 1997, or perhaps a combination of both. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Prevention'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Use of baby walkers is common in households with small children. A survey of more than 1500 parents of children between 3 and 12 months of age in the United Kingdom revealed that 50 percent used baby walkers [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/51\">",
"     51",
"    </a>",
"    ]. The use of walkers was associated with other unsafe practices (eg, lack of stair gates). Twelve to 40 percent of infants who use walkers sustain an injury that is related to walker use [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/49,52\">",
"     49,52",
"    </a>",
"    ], yet nearly 80 percent of these children are supervised at the time of injury [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most children younger than 15 months of age who sustain injuries related to baby walkers do so by falling down stairs (74 to 96 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/17,49,50\">",
"     17,49,50",
"    </a>",
"    ]. Children in walkers also can be injured if the walker tips over or from pinching of fingers or toes. In addition, walkers may provide increased access to other safety hazards (eg, hot surfaces or containers, pools, poisons) that can cause injury and, rarely, death [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/49,54,55\">",
"     49,54,55",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Prevention",
"    </span>",
"    &nbsp;&mdash;&nbsp;Individualized educational programs to decrease parental use of walkers have not been evaluated. However, the use of warning labels, stair gates, adult supervision, and public education appear to have little effect on the prevention of injuries related to baby walkers [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/49\">",
"     49",
"    </a>",
"    ], as illustrated by the following reports:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one prospective study of 139 infants who were treated for injuries related to baby walkers, 88 percent of the injuries were caused by falls down stairs, yet stair gates were present in one-third of the falls [",
"      <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/56\">",
"       56",
"      </a>",
"      ]. At follow-up two months after the injury event, two-thirds of the families reported that the child had used the walker since the injury event. Fewer than one-half of the families that did not have a stair gate at the time of the injury had acquired one two months later.",
"     </li>",
"     <li>",
"      In a study of 271 children treated for injuries related to baby walkers, 96 percent of the injuries were caused by falls down stairs. Adult supervision was present in 69 percent of the falls; 59 percent of the parents acknowledged that they were aware of the dangers associated with use of walkers [",
"      <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/53\">",
"       53",
"      </a>",
"      ]. One-third of the families that were contacted approximately two months after the emergency department visit continued to use the walker after the injury event.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Community-wide educational interventions may be more successful. In one community, a multifaceted intervention addressing the dangers of infant walkers was implemented. After the intervention, there was a 28 percent decrease in the number of children treated in local emergency departments for walker-related falls down stairs compared with the 30 months prior [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/57\">",
"     57",
"    </a>",
"    ]. However, a causal relationship between the intervention and the decrease in injuries could not be established.",
"   </p>",
"   <p>",
"    The lack of efficacy of educational efforts concerning baby walkers prompted the AAP Committee on Injury and Poison Prevention to issue a statement calling for a ban on the manufacture and sale of mobile baby walkers [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/49\">",
"     49",
"    </a>",
"    ]. To date, no such ban exists in the United States, although walkers have been banned in Canada since 2004 [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The American Academy of Pediatrics (AAP) recommends that if parents insist on using baby walkers, they choose one that meets American Society for Testing and Materials (ASTM F977-00) standards for safety. The standards require all baby walkers manufactured after 1997 to be wider than a 36-inch doorway and to have a braking mechanism to stop the walker if one or more wheels drop off the riding surface, thus preventing a fall [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/59\">",
"     59",
"    </a>",
"    ]. When using a baby walker or activity center, the following safety tips should be followed [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/60\">",
"     60",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Close the door or gate at the top of the stairs",
"     </li>",
"     <li>",
"      Keep children within view",
"     </li>",
"     <li>",
"      Keep children away from hot surfaces and containers",
"     </li>",
"     <li>",
"      Beware of dangling appliance cords",
"     </li>",
"     <li>",
"      Keep children away from toilets, swimming pools, and other sources of water",
"     </li>",
"     <li>",
"      Stationary activity centers provide a safer alternative to baby walkers",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     INFANT CARRIERS",
"    </span>",
"    &nbsp;&mdash;&nbsp;According to the US Consumer Product Safety Commission, approximately 2212 children suffered infant-carrier-related injuries in 2008 [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/61\">",
"     61",
"    </a>",
"    ]. Many of these injuries were the result of falls. One study reported that 87 percent of the children that sustained an infant-carrier-related injury were not buckled into their seats when they fell [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/62\">",
"     62",
"    </a>",
"    ]. Prevention of infant carrier falls should include family counseling and the use of warning labels.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     FURNITURE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Injuries related to nursery products and furniture occur commonly in children younger than five years of age, particularly those who are younger than one year [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/14,16,63-65\">",
"     14,16,63-65",
"    </a>",
"    ]. Most of these injuries are caused by falls [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/14,64\">",
"     14,64",
"    </a>",
"    ]. Falls from furniture are the most frequent type of fall among children between 3 and 47 months of age [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/47\">",
"     47",
"    </a>",
"    ]. Falls from highchairs tend to occur when an unrestrained child tries to stand in the chair or when the chair tips over [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/66,67\">",
"     66,67",
"    </a>",
"    ]. One-third of falls related to car seats or infant carriers are attributed to the seats having been placed on an elevated surface (eg, table or counter top) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/68\">",
"     68",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Severe injuries sustained in falls from less than 3 feet are extremely rare [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/3,26,35,69,70\">",
"     3,26,35,69,70",
"    </a>",
"    ]. In one retrospective study, the hospital records of 207 children younger than six years of age with documented falls of 25 to 54 inches from cribs or beds were reviewed [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/71\">",
"     71",
"    </a>",
"    ]. Only 15 percent of the children had visible trauma (contusions, minor lacerations); one child had a simple skull fracture, and one had a clavicle fracture; and none of the children had serious, multiple, visceral, or life-threatening injuries. The authors concluded that falling out of bed usually is a benign occurrence and that the history should be questioned in those children who present with severe injuries from a minor fall.",
"   </p>",
"   <p>",
"    In another review of 85 children (66 of whom were younger than six years) presenting to a pediatric emergency department for injury sustained from falling from a bed or a top bunk, most were reported to have fallen out of bed while sleeping. Thirty-three sustained lacerations or soft-tissue injury to a limb, 25 had fractures, 27 had head injuries, and 14 required admission [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/72\">",
"     72",
"    </a>",
"    ]. Twenty-two percent of the children who had significant injuries fell from the top bunk. The authors suggest that children younger than six years of age should not sleep in upper bunks.",
"   </p>",
"   <p>",
"    The condition of the contact surface may influence the risk of injury in falls from less than 4 feet. In simulations of feet-first free falls from low heights (&le;47 inches) using a three-year-old test dummy, head injuries were more likely when the linoleum contact surface was dry than when it was wet [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/73\">",
"     73",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Prevention",
"    </span>",
"    &nbsp;&mdash;&nbsp;Recommendations to prevent furniture-related fall injuries include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Using preinstalled restraints on high chairs and increasing high chair stability [",
"      <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/66\">",
"       66",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Never leaving babies alone on any furniture, even if they have not yet begun to roll over",
"     </li>",
"     <li>",
"      Using guard rails on cribs and changing tables",
"     </li>",
"     <li>",
"      Placing infant seats on the floor, rather than on tables or counters",
"     </li>",
"     <li>",
"      Lowering the mattress in the crib as the infant learns to sit and pull to stand, and discontinuing the use of the crib when the top rails are less than three-quarters of the child's height",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition, mandatory federal standards for bunk beds and any bed manufactured in the United States in which the underside foundation is more than 30 inches from the floor (effective since June 2000) include the following [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/74\">",
"     74",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The upper bunk must have guardrails on both sides; the wall-side rail must be continuous.",
"     </li>",
"     <li>",
"      Openings in the upper bunk structure must be small enough to prevent the passage of a child's torso (less than 3.5 inches).",
"     </li>",
"     <li>",
"      A label must be affixed to the bed that warns not to place children younger than six years of age on the upper bunk. Instructions that accompany the bed must contain the same information and warning.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     BATHTUBS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Falls in the bath are the most common cause of bathtub-related injuries. In one review of 204 children (4 months to 16 years, mean age 3.1 years) who were treated for bathtub-related injuries, the following findings were noted [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/75\">",
"     75",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Lacerations were the most common injury (67 percent)",
"     </li>",
"     <li>",
"      The head and face were involved in 68 percent of cases",
"     </li>",
"     <li>",
"      Adult supervision was present in 85 percent of the injuries to children younger than five years of age",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Prevention",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because adult supervision was present in most cases of bathtub falls, other passive methods of prevention, such as the addition of slip-resistant devices to increase surface friction, are recommended [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/75\">",
"     75",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     PLAYGROUND EQUIPMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Each year, approximately 17 children younger than 14 years of age die from injuries related to playground equipment [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/76,77\">",
"     76,77",
"    </a>",
"    ]. More than one-half of these deaths occur in home locations, and between one-half and three-quarters of the deaths are caused by strangulation (eg, in ropes, cords, rope swings, etc) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/77,78\">",
"     77,78",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Data from the emergency subset of the National Hospital Ambulatory Medical Care Survey indicate that an average of 153,425 children younger than 20 years of age in the United States visit emergency departments for injuries sustained in playground falls [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/79\">",
"     79",
"    </a>",
"    ]. The rate of falls from playground equipment was greatest among five- to nine-year-olds. Playground falls were more likely to occur at school or day care compared with home, public, and other locations (40, 25, 9, and 15 percent, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/79\">",
"     79",
"    </a>",
"    ]. Another study found that being male and engaging in sports was also associated with falls that occurred at schools [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/80\">",
"     80",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Falls from playground equipment, such as swings, climbing equipment, and slides, are the leading cause of playground injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/77,81\">",
"     77,81",
"    </a>",
"    ]. More than 70 percent of playground-related injuries involve falls to the undersurface, whereas approximately 10 percent involve falls onto equipment [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/27,78\">",
"     27,78",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/53/35669?source=see_link\">",
"     \"Straddle injuries\"",
"    </a>",
"    .) The activity most often associated with falls on home equipment was intentional jumping or dismounting from equipment, primarily swings.",
"   </p>",
"   <p>",
"    Playground injuries in children younger than five years of age involve the head and face more often than in older children (49 versus 28 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/78\">",
"     78",
"    </a>",
"    ]. Fractures, usually of the wrist, lower arm, and elbow, are the injuries most commonly reported in all ages. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/46/32489?source=see_link\">",
"     \"Evaluation and management of dental injuries in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/50/33575?source=see_link\">",
"     \"Nasal trauma and fractures in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The risk of incurring injury is related directly to the height of the equipment [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/82-84\">",
"     82-84",
"    </a>",
"    ], with an increased rate of injury from falls from equipment that is more than 5 to 6 feet above ground [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/82,83,85,86\">",
"     82,83,85,86",
"    </a>",
"    ]. The odds of a major fracture are almost four times greater when falling from a piece of playground equipment compared with a standing fall [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/87\">",
"     87",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The risk of incurring injury also is related to the energy-absorbing potential of the undersurface, which can vary substantially depending upon its composition [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/84-86,88-92\">",
"     84-86,88-92",
"    </a>",
"    ]. As an example, in one study of 930 children who presented to an urban pediatric emergency department for injuries related to falls from playground equipment, children were more likely to sustain a head injury or fracture when falling onto grass compared with sand (75 versus 61 percent, odds ratio 1.74, 95% CI 1.21-2.52) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/93\">",
"     93",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Safe playground surfaces include loose fill materials and synthetic rubber mats. Among loose fill materials, wood chips have better energy-absorbing potential than does sand or gravel [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/89,94\">",
"     89,94",
"    </a>",
"    ]. The absorption potential is dependent upon the depth of the material [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/94\">",
"     94",
"    </a>",
"    ]. Synthetic rubber mats also may have acceptable energy-absorbing potential [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/89\">",
"     89",
"    </a>",
"    ], but the potential varies depending upon the manufacturer and the material from which the mat is made; individuals who wish to use synthetic mats as the undersurface should request data from the supplier to ensure that it is safe for the intended equipment [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/94\">",
"     94",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Prevention",
"    </span>",
"    &nbsp;&mdash;&nbsp;Strategies for preventing playground injuries have included adding energy-absorbing surfacing materials, decreasing the height of playground equipment, performing regular playground inspections, and supervising children on playgrounds. In the Consumer Product Safety Commission (CPSC) study of home playground-related deaths and injuries, only 9 percent of home playgrounds had proper protective surfacing (compared with 80 percent of public playgrounds) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/78\">",
"     78",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Guidelines to ensure the safety of playground equipment have been developed by the CPSC [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/94\">",
"     94",
"    </a>",
"    ], the American Society for Testing and Materials (ASTM) International, and the Consumer Federation of America [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/27\">",
"     27",
"    </a>",
"    ]. The CPSC and ASTM International standards for home playgrounds include the following recommendations (",
"    <a class=\"graphic graphic_table graphicRef50855 \" href=\"UTD.htm?3/61/4060\">",
"     table 2",
"    </a>",
"    ) and requirements [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/78\">",
"     78",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Ropes must be secured at",
"      <strong>",
"       both",
"      </strong>",
"      ends to prevent the formation of a loop that could create a strangulation hazard",
"     </li>",
"     <li>",
"      Play-set instructions must include a warning against attaching items that can cause a strangulation hazard (eg, jump ropes, clotheslines, pet leashes, cables, and chains)",
"     </li>",
"     <li>",
"      Guardrails must be placed on platforms higher than 30 inches and protective barriers around platforms higher than 48 inches",
"     </li>",
"     <li>",
"      A CPSC consumer information sheet for playground surfacing material should accompany the play-set",
"      <span class=\"nowrap\">",
"       manual/instructions",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition, the CPSC handbook for public playground safety makes the following recommendations to prevent fall injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/94\">",
"     94",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Avoid using asphalt, concrete, grass, and soil surfaces under playground equipment. Acceptable loose fill materials include shredded rubber; hardwood fiber, mulch, or chips; and fine sand. Loose fill materials should not be installed over existing hard surfaces.",
"     </li>",
"     <li>",
"      Surfacing should be maintained at a depth of 12 inches and should extend a minimum of 6 feet in all directions around stationary equipment. Depending on the height of the equipment, surfacing may need to extend further than 6 feet.",
"     </li>",
"     <li>",
"      Play structures more than 30 inches high should be spaced at least 9 feet apart.",
"     </li>",
"     <li>",
"      Appropriate guidelines should be followed for access slope; tread or rung width; tread depth; rung diameter; and vertical rise for rung ladders, stepladders, stairways, and ramps (",
"      <a class=\"graphic graphic_table graphicRef61516 \" href=\"UTD.htm?21/2/21549\">",
"       table 3",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Continuous handrails extending the full length of the access should be provided on both sides of all stairways and stepladders.",
"     </li>",
"     <li>",
"      Guardrails or protective barriers should be provided for all elevated surfaces; openings in guardrails or between ladder rungs should measure less than 3.5 inches or more than 9 inches to prevent entrapment injuries.",
"     </li>",
"     <li>",
"      Hazardous hardware (eg, open \"S\" hooks, protruding bolt ends, sharp points or edges) should be repaired, replaced, or removed.",
"     </li>",
"     <li>",
"      Tripping hazards (eg, exposed concrete footings, tree stumps, and rocks) should be removed.",
"     </li>",
"     <li>",
"      Play equipment and surfacing should be regularly checked to make sure they are in good condition.",
"     </li>",
"     <li>",
"      Children on play equipment should be supervised at all times.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     SHOPPING CARTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The United States Consumer Product Safety Commission (CPSC) estimates that each year approximately 20,000 children younger than five years of age are treated in hospital emergency departments for injuries associated with falls from shopping carts [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/95\">",
"     95",
"    </a>",
"    ]. Children are injured in shopping carts when they fall out or get pinched in the folding mechanism, or when the shopping carts tip over or strike against an object [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/96,97\">",
"     96,97",
"    </a>",
"    ]. Shopping carts are prone to tipping over because they have a high center of gravity and a narrow wheel base.",
"   </p>",
"   <p>",
"    Injuries caused by falls are the most common [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/98\">",
"     98",
"    </a>",
"    ]; injuries related to falls from shopping carts decreased from 2003-2008 [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/95\">",
"     95",
"    </a>",
"    ]. Falls from the seat and falls from the basket of the shopping cart occur with equal frequency [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/99\">",
"     99",
"    </a>",
"    ]. Head injuries account for between one-half and two-thirds of the injuries; between one-quarter and one-half of these are considered serious (eg, fracture, concussion) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/95,100,101\">",
"     95,100,101",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/38/12906?source=see_link\">",
"     \"Minor head trauma in infants and children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/24/13704?source=see_link\">",
"     \"Skull fractures in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Prevention",
"    </span>",
"    &nbsp;&mdash;&nbsp;The American Academy of Pediatrics (AAP) policy statement on shopping-cart-related injuries calls for clear and effective performance standards to prevent falls and tip-overs [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/102,103\">",
"     102,103",
"    </a>",
"    ]. The AAP further advises parents to use other methods for transporting their children while shopping until safety standards for carts are implemented in the United States. If parents choose to use a shopping cart, they should follow CPSC recommendations to prevent injuries related to shopping carts [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/95\">",
"     95",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Children riding in the seat of the cart should wear a seatbelt",
"     </li>",
"     <li>",
"      Children should not ride in the cart basket, stand in the cart, or climb on the sides of the cart",
"     </li>",
"     <li>",
"      Adults should push shopping carts in which children are seated",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Two states, Texas and New York, require manufacturers of shopping carts to equip every new cart sold and distributed in their state with a safety strap [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/99\">",
"     99",
"    </a>",
"    ]. However, the use of infant seats and restraining belts may not prevent injuries related to shopping carts in children younger than one year of age because tip-over of shopping carts is an important mechanism of injury for this age group [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/97\">",
"     97",
"    </a>",
"    ]. Some authors suggest that children should not be transported in shopping carts unless the carts have been redesigned to prevent tip-over (eg, with a wider wheel base and outrigger-type wheels) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/97\">",
"     97",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     PICKUP TRUCKS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although falls from pickup trucks are not a common occurrence, each year approximately 200 deaths occur to passengers in truck cargo areas; approximately one-half of these deaths occur in children [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/104-106\">",
"     104-106",
"    </a>",
"    ]. Ejection from the cargo area is the most common cause of death and injury [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/107\">",
"     107",
"    </a>",
"    ]. Enclosure of the cargo area (eg, with a camper shell) does not provide adequate protection from injury. In one study of 161 fatalities in occupants of cargo areas of pickup trucks, 16 percent of the victims were riding in enclosed cargo beds [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/108\">",
"     108",
"    </a>",
"    ]. Occupants of the cargo area are more likely to sustain multiple and severe injuries than are occupants of the cab [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/104,109,110\">",
"     104,109,110",
"    </a>",
"    ] and are eight times more likely to die in a collision than are restrained occupants in the cab of the truck [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/108\">",
"     108",
"    </a>",
"    ]. Even without a collision, children could fall from cargo beds should rapid braking occur or if traveling on an uneven road surface [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/108,111,112\">",
"     108,111,112",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Prevention",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cargo areas of pickup trucks are neither required nor designed to meet occupant safety standards because they are not intended for passenger use. The American Academy of Pediatrics (AAP) Committee on Injury and Poison Prevention has issued the following recommendations regarding children in pickup trucks [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/104\">",
"     104",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Travel in the cargo area of pickup trucks should be prohibited; teenagers should agree that they will neither ride nor transport others in the cargo area of pickup trucks",
"     </li>",
"     <li>",
"      Age-appropriate restraint devices should be used for travel within the cabs of pickup trucks",
"     </li>",
"     <li>",
"      Trips should be planned in advance so that an appropriate seat position and restraint device are used for each passenger",
"     </li>",
"     <li>",
"      Injuries that occur during travel in the cargo area should be recorded and reported appropriately [",
"      <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/113\">",
"       113",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Clinicians should advocate for more stringent and comprehensive state legislation that would prohibit any occupant from traveling in the cargo area of a pickup truck and urge law enforcement agencies to enforce laws related to occupant travel",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     RECREATIONAL ACTIVITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to the types of falls described above (see",
"    <a class=\"local\" href=\"#H2\">",
"     'Falls from height'",
"    </a>",
"    above), children are injured in falls during recreational activities, including inline skating and riding skateboards and nonmotorized scooters [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/114-119\">",
"     114-119",
"    </a>",
"    ]. Data from the National Electronic Injury Surveillance System (NEISS) of the United States Consumer Product Safety Commission (CPSC) indicate that in 2010, nearly 3,500children younger than 15 years of age were treated in hospital emergency departments for injuries related to inline skating;60,000- for injuries related to skateboards; and 42,000or injuries related to nonmotorized scooters [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/120\">",
"     120",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Injuries to inline skaters are particularly common for novice skaters, roller hockey players, and those who perform tricks. Most injuries occur because of loss of balance secondary to road defects or debris; being unable to stop; speeding out of control; or doing a trick [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/121\">",
"     121",
"    </a>",
"    ]. The same probably is true for skateboard and scooter injuries. Two-thirds of inline-skating-related injuries are fractures; the wrist is the most common site of injury, accounting for 37 percent of all injuries. Two cases of severe perineal lacerations have been reported in girls whose legs were rapidly abducted (ie, a \"splits\" type maneuver) during a fall [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/122\">",
"     122",
"    </a>",
"    ]. Death caused by injuries related to inline skating rarely occurs (36 deaths reported to the CPSC between 1992 and 1998) and usually is caused by collision with a motor vehicle [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/123\">",
"     123",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Similar to inline skates, athletic shoes with a single removable wheel located in the heel (Heelys or inline gliders) are adding to the burden of injuries from falls [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/102,124-126\">",
"     102,124-126",
"    </a>",
"    ]. Upper-body orthopedic injuries are the most common injury associated with inline gliders.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Prevention",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of protective equipment (eg, helmets, knee and elbow pads, and wrist guards) during these activities can prevent injury [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/121\">",
"     121",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Inline skating",
"    </span>",
"    &nbsp;&mdash;&nbsp;The effectiveness of various types of safety gear in preventing injury of inline skaters was evaluated in a case-control study [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/121\">",
"     121",
"    </a>",
"    ]. The age- and sex-adjusted odds ratio (OR) for wrist injury in those not wearing wrist guards, compared with those who were, was 10.4 (95% CI 2.9-36.9); the OR for elbow injury in those who did not wear elbow pads (adjusted for the number of lessons skaters had had and whether or not they performed trick skating) was 9.5 (95% CI 2.6-34.4). Not wearing knee pads was associated with a nonsignificant increase in the risk of incurring knee injury (crude odds ratio, 2.2; 95% CI 0.7-7.2). The effectiveness of helmets could not be assessed.",
"   </p>",
"   <p>",
"    The AAP Committees on Injury and Poison Prevention and Sports Medicine and Fitness make the following recommendations to prevent injury to children during inline skating activity [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/114\">",
"     114",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A helmet, wrist guards, knee pads, and elbow pads should be worn at all times. The helmet should be certified by the American National Standards Institute (ANSI), the American Society for Testing and Materials (ASTM), the Snell Memorial Foundation, or the CPSC. Skaters who perform tricks need special protective gear, including well-constructed wrist guards, knee and elbow pads, and a full-head helmet that covers the ears.",
"     </li>",
"     <li>",
"      Novice skaters should practice on a rink before attempting to skate on a path or the street.",
"     </li>",
"     <li>",
"      Skating should take place only on streets that are blocked off or closed to through-traffic (eg, dead end streets or cul-de-sacs).",
"     </li>",
"     <li>",
"      Skating while holding onto a moving vehicle (\"truck-surfing\" or \"skitching\") should be prohibited for all skaters.",
"     </li>",
"     <li>",
"      Skates should fit properly; the type of skate should be appropriate for the child's size, skill level, and purpose.",
"     </li>",
"     <li>",
"      Skaters should learn to stop quickly and fall safely; receiving instruction by a teacher certified by the International Inline Skate Association is recommended.",
"     </li>",
"     <li>",
"      Children with hearing or vision deficits and those with problems of large-muscle motor skill or balance should skate only in a protected environment.",
"     </li>",
"     <li>",
"      State legislation that requires use of a helmet while skating should be encouraged; helmets are required for children and adolescent skaters in some states.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     Skateboards",
"    </span>",
"    &nbsp;&mdash;&nbsp;The AAP Committees on Injury and Poison Prevention and Sports Medicine and Fitness make the following recommendations to prevent injury to children during skateboarding [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/123\">",
"     123",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Children younger than five years of age should not be allowed to ride skateboards [",
"      <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/123,127\">",
"       123,127",
"      </a>",
"      ]. They are more susceptible to incurring injury because they have a high center of mass, immature skeletal development, an undeveloped neuromuscular system, and lack of judgment of their own skills and strength.",
"     </li>",
"     <li>",
"      Children younger than 10 years of age should not use skateboards without close supervision by an adult or responsible adolescent [",
"      <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/118\">",
"       118",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Skateboards must",
"      <strong>",
"       never",
"      </strong>",
"      be ridden in or near traffic.",
"     </li>",
"     <li>",
"      Children should",
"      <strong>",
"       never",
"      </strong>",
"      hold onto the side or rear of a moving vehicle while riding a skateboard (\"skitching a ride\").",
"     </li>",
"     <li>",
"      All skateboarders should wear a helmet and other protective gear (including wrist guards, elbow pads, and knee pads) to prevent the occurrence or reduce the severity of injuries resulting from falls [",
"      <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/128\">",
"       128",
"      </a>",
"      ]. The helmet should be a bicycle helmet or a multisport helmet that complies with the CPSC standard or the N-94 standard established by the Snell Memorial Foundation [",
"      <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/129\">",
"       129",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h3\">",
"     Scooters",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nonmotorized scooters are becoming increasingly popular among young children. Falls are the most common cause of scooter-related injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/130,131\">",
"     130,131",
"    </a>",
"    ]. Head injuries occur most frequently when children fall forward or to the side after losing control of the scooter or colliding with another object [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/130\">",
"     130",
"    </a>",
"    ]. Distal radial fractures are associated with holding onto the handle of the scooter while falling [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/132\">",
"     132",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The AAP recommends that pediatric healthcare providers counsel parents regarding nonmotorized scooters according to the CPSC recommendations [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/123,133\">",
"     123,133",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Children younger than eight years of age should not ride scooters without close adult supervision",
"     </li>",
"     <li>",
"      Children should not ride scooters in streets, in traffic, or at night",
"     </li>",
"     <li>",
"      Children should wear helmets, knee pads, and elbow pads while using scooters",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     INJURY REPORTING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Full, accurate documentation of injury events, including the \"who, what, when, where, why, and how\" of the injury occurrence and whether protective equipment (eg, a safety helmet) was used, is an essential step in injury prevention [",
"    <a class=\"abstract\" href=\"UTD.htm?11/52/12106/abstract/113\">",
"     113",
"    </a>",
"    ]. Such information defines the extent of the problem and provides the basis for preventive counseling and development of possible prevention strategies.",
"   </p>",
"   <p>",
"    The United States",
"    <a class=\"external\" href=\"https://www.saferproducts.gov/CPSRMSPublic/Incidents/ReportIncident.aspx\">",
"     Consumer Product Safety Commission",
"    </a>",
"    should be contacted for any injury or death involving consumer products",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?13/44/14020?source=see_link\">",
"       \"Patient information: Head injury in children and adolescents (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Unintentional falls are the leading cause of nonfatal injury in children younger than 14 years of age in the United States. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The severity of fall-related injuries is related to the height of the fall. Intentional injury should be considered in children with serious injuries from falls that were reported to be less than two stories and in all unwitnessed falls. Window guards or stops can be used to prevent falls through open windows. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Falls from height'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most children younger than 15 months of age who sustain injuries related to baby walkers are injured by falling down stairs. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Baby walkers'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Falls from furniture may be prevented through use of preinstalled restraints and guardrails; supervising infants who are placed on furniture (eg, changing tables, sofas, beds, etc), even if the infant cannot roll over; not placing infant seats on tables or counters; and lowering the mattress in the crib once the infant can pull to stand. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Furniture'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Fractures, usually of the arm, are the most common injury related to falls from playground equipment. The risk of injury is related to the height of the equipment and the energy-absorbing potential of the undersurface. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Playground equipment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Head injuries are the most common injury related to falls from shopping carts, which are prone to tipping over because they have a high center of gravity and a narrow wheel base. If parents choose to place their child in a shopping cart, the child should ride in the seat and wear a seat belt, and the cart should be pushed by an adult. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Shopping carts'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The use of protective equipment (eg, helmets, knee and elbow pads, and wrist guards) during inline skating, skate boarding, and scooter riding can prevent fall-related injuries. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Recreational activity'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In the United States, injuries related to consumer products should be reported to the US",
"      <a class=\"external\" href=\"https://www.saferproducts.gov/CPSRMSPublic/Incidents/ReportIncident.aspx\">",
"       Consumer Product Safety Commission",
"      </a>",
"      . (See",
"      <a class=\"local\" href=\"#H27\">",
"       'Injury reporting'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Centers for Disease Control and Prevention. Leading Causes of Nonfatal Injury Reports. Available at: webapp.cdc.gov/sasweb/ncipc/nfilead.html (Accessed on March 18, 2012).",
"    </li>",
"    <li>",
"     Centers for Disease Control and Prevention. Injury Mortality Reports. Available at: webappa.cdc.gov/sasweb/ncipc/mortrate10_sy.html (Accessed on March 18, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/3\">",
"      Garrettson LK, Gallagher SS. Falls in children and youth. Pediatr Clin North Am 1985; 32:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/4\">",
"      Lallier M, Bouchard S, St-Vil D, et al. Falls from heights among children: a retrospective review. J Pediatr Surg 1999; 34:1060.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/5\">",
"      Hambidge SJ, Davidson AJ, Gonzales R, Steiner JF. Epidemiology of pediatric injury-related primary care office visits in the United States. Pediatrics 2002; 109:559.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/6\">",
"      Zuckerbraun NS, Powell EC, Sheehan KM, et al. Community childhood injury surveillance: an emergency department-based model. Pediatr Emerg Care 2004; 20:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/7\">",
"      Mathers LJ, Weiss HB. Incidence and characteristics of fall-related emergency department visits. Acad Emerg Med 1998; 5:1064.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/8\">",
"      Simon TD, Bublitz C, Hambidge SJ. External causes of pediatric injury-related emergency department visits in the United States. Acad Emerg Med 2004; 11:1042.",
"     </a>",
"    </li>",
"    <li>",
"     National Center for Injury Prevention and Control. WISQARS Leading Causes of Nonfatal Injury Reports. Available at: webappa.cdc.gov/sasweb/ncipc/nfilead2001.html (Accessed on March 04, 2010).",
"    </li>",
"    <li>",
"     National Center for Injury Prevention and Control. WISQARS Leading Causes of Death Reports, 1999-2006. Available at: webappa.cdc.gov/sasweb/ncipc/leadcaus10.html (Accessed on March 04, 2010).",
"    </li>",
"    <li>",
"     Centers for Disease Control and Prevention. Protect the Ones You Love: Falls. www.cdc.gov/safechild/Falls/index.html (Accessed on March 18, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/12\">",
"      Powell EC, Tanz RR. Adjusting our view of injury risk: the burden of nonfatal injuries in infancy. Pediatrics 2002; 110:792.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/13\">",
"      Mamdani MM, Upshur RE. Fall-related hospitalizations: what's in season? Can J Public Health 2001; 92:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/14\">",
"      Agran PF, Winn D, Anderson C, et al. Rates of pediatric and adolescent injuries by year of age. Pediatrics 2001; 108:E45.",
"     </a>",
"    </li>",
"    <li>",
"     Falls from Windows: Preventing a Warm Weather Tragedy. Harborview Injury Prevention &amp; Research Center. Available at: file://depts.washington.edu/hiprc/Newsroom/2006/0506newsrelease.html (Accessed on March 18, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/16\">",
"      Mack KA, Gilchrist J, Ballesteros MF. Injuries among infants treated in emergency departments in the United States, 2001-2004. Pediatrics 2008; 121:930.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/17\">",
"      Zielinski AE, Rochette LM, Smith GA. Stair-Related Injuries to Young Children Treated in US Emergency Departments, 1999-2008. Pediatrics 2012; 129:721.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/18\">",
"      Mosenthal AC, Livingston DH, Elcavage J, et al. Falls: epidemiology and strategies for prevention. J Trauma 1995; 38:753.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/19\">",
"      Hong J, Lee B, Ha EH, Park H. Parental socioeconomic status and unintentional injury deaths in early childhood: consideration of injury mechanisms, age at death, and gender. Accid Anal Prev 2010; 42:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/20\">",
"      Committee on Injury and Poison Prevention. American Academy of Pediatrics: Falls from heights: windows, roofs, and balconies. Pediatrics 2001; 107:1188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/21\">",
"      Bergner L, Mayer S, Harris D. Falls from heights: a childhood epidemic in an urban area. Am J Public Health 1971; 61:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/22\">",
"      Musemeche CA, Barthel M, Cosentino C, Reynolds M. Pediatric falls from heights. J Trauma 1991; 31:1347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/23\">",
"      Sieben RL, Leavitt JD, French JH. Falls as childhood accidents: an increasing urban risk. Pediatrics 1971; 47:886.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/24\">",
"      Wang MY, Kim KA, Griffith PM, et al. Injuries from falls in the pediatric population: an analysis of 729 cases. J Pediatr Surg 2001; 36:1528.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/25\">",
"      Demetriades D, Murray J, Brown C, et al. High-level falls: type and severity of injuries and survival outcome according to age. J Trauma 2005; 58:342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/26\">",
"      Chadwick DL, Bertocci G, Castillo E, et al. Annual risk of death resulting from short falls among young children: less than 1 in 1 million. Pediatrics 2008; 121:1213.",
"     </a>",
"    </li>",
"    <li>",
"     National Safe Kids Campaign. Injury Facts: Falls. Available at: www.safekids.org/our-work/research/fact-sheets/falls-prevention-fact-sheet.html (Accessed on March 18, 2012).",
"    </li>",
"    <li>",
"     Adler P, Kyle S. Window falls. Consumer Product Safety Review 2000; 5:5. www.cpsc.gov/cpscpub/pubs/cpsr_nws17.pdf (Accessed on March 19, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/29\">",
"      Harris VA, Rochette LM, Smith GA. Pediatric injuries attributable to falls from windows in the United States in 1990-2008. Pediatrics 2011; 128:455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/30\">",
"      Williams RA. Injuries in infants and small children resulting from witnessed and corroborated free falls. J Trauma 1991; 31:1350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/31\">",
"      Chadwick DL, Chin S, Salerno C, et al. Deaths from falls in children: how far is fatal? J Trauma 1991; 31:1353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/32\">",
"      Murray JA, Chen D, Velmahos GC, et al. Pediatric falls: is height a predictor of injury and outcome? Am Surg 2000; 66:863.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/33\">",
"      Goodacre S, Than M, Goyder EC, Joseph AP. Can the distance fallen predict serious injury after a fall from a height? J Trauma 1999; 46:1055.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/34\">",
"      Reiber GD. Fatal falls in childhood. How far must children fall to sustain fatal head injury? Report of cases and review of the literature. Am J Forensic Med Pathol 1993; 14:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/35\">",
"      Helfer RE, Slovis TL, Black M. Injuries resulting when small children fall out of bed. Pediatrics 1977; 60:533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/36\">",
"      Barlow B, Niemirska M, Gandhi RP, Leblanc W. Ten years of experience with falls from a height in children. J Pediatr Surg 1983; 18:509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/37\">",
"      Spiegel CN, Lindaman FC. Children can't fly: a program to prevent childhood morbidity and mortality from window falls. Am J Public Health 1977; 67:1143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/38\">",
"      Hussain N, Mewasingh L, Gosalakkal J. Is the heat wave increasing the number of falls from open windows among children? Arch Dis Child 2007; 92:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/39\">",
"      Benoit R, Watts DD, Dwyer K, et al. Windows 99: a source of suburban pediatric trauma. J Trauma 2000; 49:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/40\">",
"      Lehman D, Schonfeld N. Falls from heights: a problem not just in the northeast. Pediatrics 1993; 92:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/41\">",
"      Keogh S, Gray JS, Kirk CJ, et al. Children falling from a height in London. Inj Prev 1996; 2:188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/42\">",
"      Spiegel CN, Lindaman FC. Children can't fly: a program to prevent childhood morbidity and mortality from window falls. 1977. Inj Prev 1995; 1:194.",
"     </a>",
"    </li>",
"    <li>",
"     ASTM F2090-01a. Specification for window fall prevention devices with emergency escape (egress) release mechanisms. Available at: www.astm.org/Standards/F2090.htm (Accessed on March 18, 2012).",
"    </li>",
"    <li>",
"     ASTM F2006-00. Standard safety specification for window fall prevention devices for non-emergency escape (egress) and rescue (ingress) windows. www.astm.org/Standards/F2006.htm (Accessed on March 19, 2012).",
"    </li>",
"    <li>",
"     National Safety Council. Window Safety Checklist. Available at: www.nsc.org/get_involved/divisions/Pages/WindowSafetyChecklist.aspx (Accessed on March 19, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/46\">",
"      Meller JL, Shermeta DW. Falls in urban children. A problem revisited. Am J Dis Child 1987; 141:1271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/47\">",
"      Agran PF, Anderson C, Winn D, et al. Rates of pediatric injuries by 3-month intervals for children 0 to 3 years of age. Pediatrics 2003; 111:e683.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/48\">",
"      Kendrick D, Watson MC, Mulvaney CA, et al. Preventing childhood falls at home: meta-analysis and meta-regression. Am J Prev Med 2008; 35:370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/49\">",
"      American Academy of Pediatrics. Committee on Injury and Poison Prevention. Injuries associated with infant walkers. Pediatrics 2001; 108:790.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/50\">",
"      Shields BJ, Smith GA. Success in the prevention of infant walker-related injuries: an analysis of national data, 1990-2001. Pediatrics 2006; 117:e452.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/51\">",
"      Kendrick D, Marsh P. Babywalkers: prevalence of use and relationship with other safety practices. Inj Prev 1998; 4:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/52\">",
"      Use of infant walkers. Board of Trustees, American Medical Association. Am J Dis Child 1991; 145:933.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/53\">",
"      Smith GA, Bowman MJ, Luria JW, Shields BJ. Babywalker-related injuries continue despite warning labels and public education. Pediatrics 1997; 100:E1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/54\">",
"      Millar R, Colville J, Hughes NC. Burns to infants using walking aids. Injury 1975; 7:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/55\">",
"      Johnson CF, Ericson AK, Caniano D. Walker-related burns in infants and toddlers. Pediatr Emerg Care 1990; 6:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/56\">",
"      Rieder MJ, Schwartz C, Newman J. Patterns of walker use and walker injury. Pediatrics 1986; 78:488.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/57\">",
"      Conners GP, Veenema TG, Kavanagh CA, et al. Still falling: a community-wide infant walker injury prevention initiative. Patient Educ Couns 2002; 46:169.",
"     </a>",
"    </li>",
"    <li>",
"     Baby Walkers (Banned) and Stationary Activity Centres. Available at: www.hc-sc.gc.ca/cps-spc/child-enfant/equip/walk-marche-eng.php (Accessed on March 19, 2012).",
"    </li>",
"    <li>",
"     ASTM F977-11b. Standard consumer safety specifications for infant walkers. West Conshohocken, PA. Availabe at: www.astm.org/Standards/F977.htm (Accessed on March 19, 2012).",
"    </li>",
"    <li>",
"     Consumer Product Safety Commission. CPSC gets new, safer baby walkers on the market. Release #98-142. Available at: www.cpsc.gov/cpscpub/prerel/prhtml98/98142.html (Accessed on March 19, 2012).",
"    </li>",
"    <li>",
"     U.S. Consumer Product Safety Commission. National Electronic Injury Surveillance System (NEISS) Online. www.cpsc.gov/library/neiss.html (Accessed on March 19, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/62\">",
"      Greenberg RA, Bolte RG, Schunk JE. Infant carrier-related falls: an unrecognized danger. Pediatr Emerg Care 2009; 25:66.",
"     </a>",
"    </li>",
"    <li>",
"     McDonald J. Children's products. Consumer Product Safety Review 2002; 6:1. www.cpsc.gov/cpscpub/pubs/cpsr_nws23.pdf (Accessed on March 20, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/64\">",
"      Powell EC, Jovtis E, Tanz RR. Incidence and description of high chair-related injuries to children. Ambul Pediatr 2002; 2:276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/65\">",
"      Yeh ES, Rochette LM, McKenzie LB, Smith GA. Injuries associated with cribs, playpens, and bassinets among young children in the US, 1990-2008. Pediatrics 2011; 127:479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/66\">",
"      Mayr JM, Seebacher U, Schimpl G, Fiala F. Highchair accidents. Acta Paediatr 1999; 88:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/67\">",
"      Schalamon J, Ainoedhofer H, Saxena AK, et al. Falls from highchairs. Eur J Pediatr 2006; 165:732.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/68\">",
"      Pollack-Nelson C. Fall and suffocation injuries associated with in-home use of car seats and baby carriers. Pediatr Emerg Care 2000; 16:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/69\">",
"      Nimityongskul P, Anderson LD. The likelihood of injuries when children fall out of bed. J Pediatr Orthop 1987; 7:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/70\">",
"      Duhaime AC, Alario AJ, Lewander WJ, et al. Head injury in very young children: mechanisms, injury types, and ophthalmologic findings in 100 hospitalized patients younger than 2 years of age. Pediatrics 1992; 90:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/71\">",
"      Lyons TJ, Oates RK. Falling out of bed: a relatively benign occurrence. Pediatrics 1993; 92:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/72\">",
"      Macgregor DM. Injuries associated with falls from beds. Inj Prev 2000; 6:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/73\">",
"      Deemer E, Bertocci G, Pierce MC, et al. Influence of wet surfaces and fall height on pediatric injury risk in feet-first freefalls as predicted using a test dummy. Med Eng Phys 2005; 27:31.",
"     </a>",
"    </li>",
"    <li>",
"     Heh S. Safer bunkbeds. Consumer Product Safety Review 2000; 4:6. www.cpsc.gov/cpscpub/pubs/cpsr_nws15.pdf (Accessed on March 20, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/75\">",
"      Spencer SP, Shields BJ, Smith GA. Childhood bathtub-related injuries: slip and fall prevalence and prevention. Clin Pediatr (Phila) 2005; 44:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/76\">",
"      Mack MG, Hudson S, Thompson D. A descriptive analysis of children's playground injuries in the United States 1990-4. Inj Prev 1997; 3:100.",
"     </a>",
"    </li>",
"    <li>",
"     Centers for Disease Control and Prevention. Playground Injuries Fact Sheet. Available at: www.cdc.gov/HomeandRecreationalSafety/Playground-Injuries/playgroundinjuries-factsheet.htm (Accessed on March 20, 2012).",
"    </li>",
"    <li>",
"     Consumer Product Safety Commission. Home Playground Equipment-Related deaths and injuries. CPSC Document. Available at: www.cpsc.gov/library/playground.pdf (Accessed on March 19, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/79\">",
"      Phelan KJ, Khoury J, Kalkwarf HJ, Lanphear BP. Trends and patterns of playground injuries in United States children and adolescents. Ambul Pediatr 2001; 1:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/80\">",
"      Gore GC, Magdalinos H, Pless IB. School injuries and preventive policies and programs. Can J Public Health 2004; 95:424.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/81\">",
"      Vollman D, Witsaman R, Comstock RD, Smith GA. Epidemiology of playground equipment-related injuries to children in the United States, 1996-2005. Clin Pediatr (Phila) 2009; 48:66.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/82\">",
"      Sacks JJ, Holt KW, Holmgreen P, et al. Playground hazards in Atlanta child care centers. Am J Public Health 1990; 80:986.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/83\">",
"      Chalmers DJ, Marshall SW, Langley JD, et al. Height and surfacing as risk factors for injury in falls from playground equipment: a case-control study. Inj Prev 1996; 2:98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/84\">",
"      Laforest S, Robitaille Y, Lesage D, Dorval D. Surface characteristics, equipment height, and the occurrence and severity of playground injuries. Inj Prev 2001; 7:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/85\">",
"      Macarthur C, Hu X, Wesson DE, Parkin PC. Risk factors for severe injuries associated with falls from playground equipment. Accid Anal Prev 2000; 32:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/86\">",
"      Mott A, Rolfe K, James R, et al. Safety of surfaces and equipment for children in playgrounds. Lancet 1997; 349:1874.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/87\">",
"      Fiissel D, Pattison G, Howard A. Severity of playground fractures: play equipment versus standing height falls. Inj Prev 2005; 11:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/88\">",
"      Lewis LM, Naunheim R, Standeven J, Naunheim KS. Quantitation of impact attenuation of different playground surfaces under various environmental conditions using a tri-axial accelerometer. J Trauma 1993; 35:932.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/89\">",
"      Mack MG, Sacks JJ, Thompson D. Testing the impact attenuation of loose-fill playground surfaces. Inj Prev 2000; 6:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/90\">",
"      Sosin DM, Keller P, Sacks JJ, et al. Surface-specific fall injury rates on Utah school playgrounds. Am J Public Health 1993; 83:733.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/91\">",
"      Mack MG, Thompson D, Hudson S. An analysis of playground surface injuries. Res Q Exerc Sport 1997; 68:368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/92\">",
"      Howard AW, Macarthur C, Rothman L, et al. School playground surfacing and arm fractures in children: a cluster randomized trial comparing sand to wood chip surfaces. PLoS Med 2009; 6:e1000195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/93\">",
"      Laforest S, Robitaille Y, Dorval D, et al. Severity of fall injuries on sand or grass in playgrounds. J Epidemiol Community Health 2000; 54:475.",
"     </a>",
"    </li>",
"    <li>",
"     US Consumer Product Safety Commission. Handbook for public playground safety. U.S. Government Printing Office, Washington, DC, 1997. www.hdfs.hs.iastate.edu/research/pdfs/CPSC_Handbook_for_Public_Playgrounds.pdf (Accessed on March 19, 2012).",
"    </li>",
"    <li>",
"     Consumer Product Safety Commission. Shopping Cart Injuries to Children Under Five. Available at: www.cpsc.gov/library/foia/foia10/os/shopcart2008.pdf (Accessed on March 20, 2012).",
"    </li>",
"    <li>",
"     Friedman J. Reported shopping cart accidents: data from 1979-1985. U.S. Consumer Product Safety Commission, Washington, DC, October 1986.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/97\">",
"      Smith GA, Dietrich AM, Garcia CT, Shields BJ. Injuries to children related to shopping carts. Pediatrics 1996; 97:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/98\">",
"      Vilke GM, Stepanski BM, Ray LU, et al. 9-1-1 responses for shopping cart and stroller injuries. Pediatr Emerg Care 2004; 20:660.",
"     </a>",
"    </li>",
"    <li>",
"     Elder J. Shopping carts: buckle up. Consumer Product Safety Review 1997; 2:6. Available at: www.cpsc.gov/cpscpub/pubs/cpsr_nws05.pdf (Accessed on March 21, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/100\">",
"      Smith GA, Dietrich AM, Garcia CT, Shields BJ. Epidemiology of shopping cart-related injuries to children. An analysis of national data for 1990 to 1992. Arch Pediatr Adolesc Med 1995; 149:1207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/101\">",
"      Parry ML, Morrison LG, Chalmers DJ, Wright CS. Shopping trolley-related injuries to children in New Zealand, 1988-97. J Paediatr Child Health 2002; 38:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/102\">",
"      Smith GA, Committee on Injury, Violence, and Poison Prevention, American Academy of Pediatrics. Shopping-cart-related injuries to children. Pediatrics 2006; 118:e540.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/103\">",
"      Committee on Injury, Violence, and Poison Prevention, American Academy of Pediatrics. Shopping-cart-related injuries to children. Committee on Injury, Violence, and Poison Prevention, American Academy of Pediatrics. Pediatrics 2006; 118:825.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/104\">",
"      American Academy of Pediatrics Committee on Injury and Poison Prevention. Children in pickup trucks. American Academy of Pediatrics. Committee on Injury and Poison Prevention. Pediatrics 2000; 106:857.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/105\">",
"      Christoffel T, Agran P, Winn D, et al. Developing a model law restricting the transporting of passengers in the cargo areas of pickup trucks. J Public Health Policy 2000; 21:61.",
"     </a>",
"    </li>",
"    <li>",
"     U.S. Department of Transportation, National Highway Traffic Safety Administration, National Center for Statistics and Analysis. Fatality Analysis Reporting System. U.S. Department of Transportation, Washington, DC 1998.",
"    </li>",
"    <li>",
"     National Highway Traffic Safety Administration. Occupants of pickups involved in fatal crashes by state and age group.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/108\">",
"      Anderson CL, Agran PF, Winn DG, Greenland S. Fatalities to occupants of cargo areas of pickup trucks. Accid Anal Prev 2000; 32:533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/109\">",
"      Agran PF, Winn DG, Castillo DN. Pediatric injuries in the back of pickup trucks. JAMA 1990; 264:712.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/110\">",
"      Agran P, Winn D, Anderson C. Injuries to occupants in cargo areas of pickup trucks. West J Med 1994; 161:479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/111\">",
"      Bucklew PA, Osler TM, Eidson JJ, et al. Falls and ejections from pickup trucks. J Trauma 1992; 32:468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/112\">",
"      Fallat ME, Svenson JE, Roussell SS, Hardwick VG. Hazards to children riding in the back of pickup trucks. J Ky Med Assoc 1995; 93:515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/113\">",
"      Katcher ML, Agran P, Laraque D, et al. The hospital record of the injured child and the need for external cause-of-injury codes. American Academy of Pediatrics. Committee on Injury and Poison Prevention, 1998-1999. Pediatrics 1999; 103:524.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/114\">",
"      In-line skating injuries in children and adolescents. American Academy of Pediatrics. Committee on Injury and Poison Prevention and Committee on Sports Medicine and Fitness. Pediatrics 1998; 101:720.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/115\">",
"      Forsman L, Eriksson A. Skateboarding injuries of today. Br J Sports Med 2001; 35:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/116\">",
"      Osberg JS, Schneps SE, Di Scala C, Li G. Skateboarding: more dangerous than roller skating or in-line skating. Arch Pediatr Adolesc Med 1998; 152:985.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/117\">",
"      Levine DA, Platt SL, Foltin GL. Scooter injuries in children. Pediatrics 2001; 107:E64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/118\">",
"      Cass DT, Ross F. Skateboard injuries. Med J Aust 1990; 153:140, 143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/119\">",
"      Fountain JL, Meyers MC. Skateboarding injuries. Sports Med 1996; 22:360.",
"     </a>",
"    </li>",
"    <li>",
"     U.S. Consumer Product Safety Commission. National Electronic Injury Surveillance System (NEISS) Online. Available at: www.cpsc.gov/library/neiss.html (Accessed on March 21, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/121\">",
"      Schieber RA, Branche-Dorsey CM, Ryan GW, et al. Risk factors for injuries from in-line skating and the effectiveness of safety gear. N Engl J Med 1996; 335:1630.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/122\">",
"      Herrmann B, Crawford J. Genital injuries in prepubertal girls from inline skating accidents. Pediatrics 2002; 110:e16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/123\">",
"      Committee on Injury and Poison Prevention, American Academy of Pediatrics. Skateboard and scooter injuries. Pediatrics 2002; 109:542.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/124\">",
"      Vioreanu M, Sheehan E, Glynn A, et al. Heelys and street gliders injuries: a new type of pediatric injury. Pediatrics 2007; 119:e1294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/125\">",
"      Lenehan B, Callender O, McIntyre A, et al. Heely injuries: a new epidemic warranting a government health warning! Injury 2007; 38:923.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/126\">",
"      Oh D, Arjandas M, Lim KB, Lee EH. Heelys injuries in children. Singapore Med J 2006; 47:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/127\">",
"      Retsky J, Jaffe D, Christoffel K. Skateboarding injuries in children. A second wave. Am J Dis Child 1991; 145:188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/128\">",
"      Schieber RA, Branche-Dorsey CM, Ryan GW. Comparison of in-line skating injuries with rollerskating and skateboarding injuries. JAMA 1994; 271:1856.",
"     </a>",
"    </li>",
"    <li>",
"     Snell Memorial Foundation. 1994 standard for protective headgear for use in non-motorized sports. Snell Memorial Foundation, North Highlands, CA, 1994. Available at: www.smf.org/stds.html (Accessed on March 21, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/130\">",
"      Kubiak R, Slongo T. Unpowered scooter injuries in children. Acta Paediatr 2003; 92:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/131\">",
"      Gaines BA, Shultz BL, Ford HR. Nonmotorized scooters: a source of significant morbidity in children. J Trauma 2004; 57:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/52/12106/abstract/132\">",
"      Brudvik C. Injuries caused by small wheel devices. Prev Sci 2006; 7:313.",
"     </a>",
"    </li>",
"    <li>",
"     U.S. Consumer Product Safety Commission. Scooter data. Available at: www.cpsc.gov/PR/prscoot.html (Accessed on March 21, 2012).",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2857 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.39.66.147-7DB0BEB7E6-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_52_12106=[""].join("\n");
var outline_f11_52_12106=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H29\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      FALLS FROM HEIGHT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Windows",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Prevention",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Other heights",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      BABY WALKERS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      INFANT CARRIERS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      FURNITURE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      BATHTUBS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      PLAYGROUND EQUIPMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      SHOPPING CARTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      PICKUP TRUCKS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      RECREATIONAL ACTIVITY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Prevention",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Inline skating",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - Skateboards",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      - Scooters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      INJURY REPORTING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/2857\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/2857|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?7/46/7918\" title=\"table 1\">",
"      Causes nonfatal injury in children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?3/61/4060\" title=\"table 2\">",
"      Home playground safety",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?21/2/21549\" title=\"table 3\">",
"      Guidelines playground equipment",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/46/32489?source=related_link\">",
"      Evaluation and management of dental injuries in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/7/32889?source=related_link\">",
"      Evaluation of cervical spine injuries in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/63/27640?source=related_link\">",
"      Initial evaluation and stabilization of children with thoracic trauma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/38/12906?source=related_link\">",
"      Minor head trauma in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/50/33575?source=related_link\">",
"      Nasal trauma and fractures in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/62/33768?source=related_link\">",
"      Overview of blunt abdominal trauma in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?13/44/14020?source=related_link\">",
"      Patient information: Head injury in children and adolescents (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/54/26473?source=related_link\">",
"      Physical abuse in children: Epidemiology and clinical manifestations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/24/13704?source=related_link\">",
"      Skull fractures in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/53/35669?source=related_link\">",
"      Straddle injuries",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_52_12107="Parinaud syndrome";
var content_f11_52_12107=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F81227&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F81227&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Ophthalmic findings in the Parinaud syndrome",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Vertical gaze abnormalities, especially upgaze",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Downward gaze preference or tonic downward deviation of the eyes (\"setting-sun sign\")",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Primary position upbeat or downbeat nystagmus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Impaired convergence and divergence",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Excessive convergence tone",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Convergence-retraction nystagmus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Skew deviation, often with the higher eye on the side of the lesion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Alternating adduction hypertropia or alternating adduction hypotropia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bilateral upper eyelid retraction (Collier \"tucked-lid\" sign)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bilateral ptosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pupillary abnormalities (large with light-near dissociation)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Modified with permission from: Lee AG, Brazis PW. Clinical Pathways in Neuro-ophthalmology: An Evidence-based Approach, Thieme, New York 1998.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_52_12107=[""].join("\n");
var outline_f11_52_12107=null;
var title_f11_52_12108="TMP SMX adverse effects";
var content_f11_52_12108=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F81921&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F81921&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Major adverse effects of trimethoprim-sulfamethoxazole",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Systemic allergic reactions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Anaphylaxis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Serum sickness",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Cutaneous reactions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rash",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stevens-Johnson syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Erythema muliforme",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Urticaria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Toxic epidermal necrolysis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Photodermatis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Gastrointestinal and hepatic reactions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nausea and vomiting",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Diarrhea",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hepatotoxicity",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Hematologic reactions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pancytopenia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Agranulocytosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Anemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Thrombocytopenia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Renal disorders",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Transient rise in creatinine due to impaired secretion by trimethoprim",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Acute interstitial nephritis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Crystalluria due to precipitation of sulfamethoxazole",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hyperkalemia due to trimethoprim-induced blockade of collecting tubule sodium channel",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Other reactions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Central nervous system - headache, confusion, aseptic meningitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fever",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Phlebitis",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_52_12108=[""].join("\n");
var outline_f11_52_12108=null;
var title_f11_52_12109="Survival by T and N stg";
var content_f11_52_12109=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F66398&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F66398&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Survival of paranasal sinus cancer according to tumor site and T and N stage",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Tumor site",
"      </td>",
"      <td class=\"subtitle1\" colspan=\"2\">",
"       Maxillary sinus",
"       <sup>",
"        [1]",
"       </sup>",
"      </td>",
"      <td class=\"subtitle1\" colspan=\"2\">",
"       Maxillary sinus",
"       <sup>",
"        [2]",
"       </sup>",
"      </td>",
"      <td class=\"subtitle1\" colspan=\"2\">",
"       Ethmoid sinus",
"       <sup>",
"        [1]",
"       </sup>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2\">",
"       Characteristic",
"      </td>",
"      <td class=\"subtitle2\">",
"       N (n = 399)",
"      </td>",
"      <td class=\"subtitle2\">",
"       5-year OS",
"      </td>",
"      <td class=\"subtitle2\">",
"       N (n = 650)",
"      </td>",
"      <td class=\"subtitle2\">",
"       5-year OS",
"      </td>",
"      <td class=\"subtitle2\">",
"       N (n = 704)",
"      </td>",
"      <td class=\"subtitle2\">",
"       5-year OS",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle3_left\" colspan=\"7\">",
"       AJCC-UICC 2002 classification",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent2\">",
"       T1",
"      </td>",
"      <td>",
"       0",
"      </td>",
"      <td>",
"       NE",
"      </td>",
"      <td>",
"       80",
"      </td>",
"      <td>",
"       51.6",
"      </td>",
"      <td>",
"       27",
"      </td>",
"      <td>",
"       53.2",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent2\">",
"       T2",
"      </td>",
"      <td>",
"       156",
"      </td>",
"      <td>",
"       61.7",
"      </td>",
"      <td>",
"       63",
"      </td>",
"      <td>",
"       41.8",
"      </td>",
"      <td>",
"       46",
"      </td>",
"      <td>",
"       60.3",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent2\">",
"       T3",
"      </td>",
"      <td>",
"       37",
"      </td>",
"      <td>",
"       50.5",
"      </td>",
"      <td>",
"       169",
"      </td>",
"      <td>",
"       39.8",
"      </td>",
"      <td>",
"       85",
"      </td>",
"      <td>",
"       48.2",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent2\">",
"       T4a/b",
"      </td>",
"      <td>",
"       206",
"      </td>",
"      <td>",
"       35.9",
"      </td>",
"      <td>",
"       335",
"      </td>",
"      <td>",
"       28.9",
"      </td>",
"      <td>",
"       147",
"      </td>",
"      <td>",
"       35.4",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent2\">",
"       Not assigned",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       3",
"      </td>",
"      <td>",
"       NE",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle3_left\" colspan=\"7\">",
"       Nodal status",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent2\">",
"       N0",
"      </td>",
"      <td>",
"       366",
"      </td>",
"      <td>",
"       50.6",
"      </td>",
"      <td>",
"       323",
"      </td>",
"      <td>",
"       40.1",
"      </td>",
"      <td>",
"       300",
"      </td>",
"      <td>",
"       45.3",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent2\">",
"       N+",
"      </td>",
"      <td>",
"       33",
"      </td>",
"      <td>",
"       16.8",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       5",
"      </td>",
"      <td>",
"       0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent2\">",
"       N1",
"      </td>",
"      <td>",
"       23",
"      </td>",
"      <td>",
"       NE",
"      </td>",
"      <td>",
"       16",
"      </td>",
"      <td>",
"       35.7",
"      </td>",
"      <td>",
"       3",
"      </td>",
"      <td>",
"       NE",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent2\">",
"       N2",
"      </td>",
"      <td>",
"       9",
"      </td>",
"      <td>",
"       NE",
"      </td>",
"      <td>",
"       31",
"      </td>",
"      <td>",
"       0",
"      </td>",
"      <td>",
"       2",
"      </td>",
"      <td>",
"       NE",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent2\">",
"       N3",
"      </td>",
"      <td>",
"       1",
"      </td>",
"      <td>",
"       NE",
"      </td>",
"      <td>",
"       1",
"      </td>",
"      <td>",
"       NE",
"      </td>",
"      <td>",
"       0",
"      </td>",
"      <td>",
"       NE",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent2\">",
"       Not assigned",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       279",
"      </td>",
"      <td>",
"       NE",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     N: number of patients; NE: not estimated; OS: overall survival; PNS: paranasal sinuses (including maxillary, ethmoid, sphenoid, and frontal sinuses; esthesioneuroblastoma excluded).",
"    </div>",
"    <div class=\"reference\">",
"     Data from:",
"     <br>",
"      1. Cantu, G, et al. Arch Otolaryngol Head Neck Surg 2008; 134:170.",
"      <br>",
"       2. Bhattacharyya, N. J Oral Maxillofac Surg 2003; 61:1016.",
"      </br>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_52_12109=[""].join("\n");
var outline_f11_52_12109=null;
var title_f11_52_12110="Dressings for EB simplex";
var content_f11_52_12110=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F87148%7EDERM%2F87149%7EDERM%2F87150&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F87148%7EDERM%2F87149%7EDERM%2F87150&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Dressings for epidermolysis bullosa (EB) simplex",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"3\" width=\"20%\">",
"     </colgroup>",
"     <colgroup width=\"40%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Type",
"       </td>",
"       <td class=\"subtitle1\">",
"        Brand",
"       </td>",
"       <td class=\"subtitle1\">",
"        Indication",
"       </td>",
"       <td class=\"subtitle1\">",
"        Contraindications/comments",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Primary",
"       </td>",
"       <td>",
"        <p>",
"         Mepitel",
"        </p>",
"        Urgotul",
"       </td>",
"       <td>",
"        Wound",
"       </td>",
"       <td>",
"        Dowling-Meara",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Foam",
"       </td>",
"       <td>",
"        <p>",
"         Mepilex",
"        </p>",
"        <p>",
"         Mepilex Lite",
"        </p>",
"        Mepilex Transfer",
"       </td>",
"       <td>",
"        Protection",
"       </td>",
"       <td>",
"        May induce heat-related blistering",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Hydrogel",
"       </td>",
"       <td>",
"        <p>",
"         IntraSite",
"        </p>",
"        Conformable",
"       </td>",
"       <td>",
"        <p>",
"         Cooling",
"        </p>",
"        Pain reduction",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Biosynthetic cellulose",
"       </td>",
"       <td>",
"        Suprasorb X",
"       </td>",
"       <td>",
"        <p>",
"         Cooling",
"        </p>",
"        Pain reduction",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Bordered dressings",
"       </td>",
"       <td>",
"        <p>",
"         Mepilex Border",
"        </p>",
"        <p>",
"         Mepilex Border Lite",
"        </p>",
"        <p>",
"         Alleyvn Gentle Border",
"        </p>",
"        Urgotul Duo Border",
"       </td>",
"       <td>",
"        Protection",
"       </td>",
"       <td>",
"        Use silicone medical removers to avoid skin stripping",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Hydrofiber",
"       </td>",
"       <td>",
"        Aquacel",
"       </td>",
"       <td>",
"        Dowling-Meara",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Powder",
"       </td>",
"       <td>",
"        <p>",
"         Cornflour",
"        </p>",
"        Catrix",
"       </td>",
"       <td>",
"        Apply after lancing blisters",
"       </td>",
"       <td>",
"        Diaper area",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Original figure modified for this publication. Denyer JE. Wound management for children with epidermolysis bullosa. Dermatol Clin 2010; 28:257. Table used with the permission of Elsevier Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Dressings for junctional epidermolysis bullosa (EB)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"2\" width=\"15%\">",
"     </colgroup>",
"     <colgroup span=\"3\" width=\"23%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Type",
"       </td>",
"       <td class=\"subtitle1\">",
"        Brand",
"       </td>",
"       <td class=\"subtitle1\">",
"        Indication",
"       </td>",
"       <td class=\"subtitle1\">",
"        Contraindication",
"       </td>",
"       <td class=\"subtitle1\">",
"        Wear time",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Primary",
"       </td>",
"       <td>",
"        Urgotul",
"       </td>",
"       <td>",
"        Primary dressing",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        Change every three to four days",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Hydrogel",
"       </td>",
"       <td>",
"        <p>",
"         IntraSite",
"        </p>",
"        Conformable",
"       </td>",
"       <td>",
"        Infant JEB-Herlitz",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        Change daily",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Hydrofiber",
"       </td>",
"       <td>",
"        Aquacel",
"       </td>",
"       <td>",
"        Very moist wounds",
"       </td>",
"       <td>",
"        Lightly exuding or dry wounds",
"       </td>",
"       <td>",
"        Change every three to four days",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Soft silicone foam",
"       </td>",
"       <td>",
"        <p>",
"         Mepilex",
"        </p>",
"        <p>",
"         Mepilex Lite",
"        </p>",
"        Mepilex Transfer",
"       </td>",
"       <td>",
"        <p>",
"         Protection",
"        </p>",
"        Absorption",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        As determined by level of exudate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Polymeric membrane",
"       </td>",
"       <td>",
"        PolyMem",
"       </td>",
"       <td>",
"        <p>",
"         Chronic wounds",
"        </p>",
"        Critical colonization or infection",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        As determined by level of exudate",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Original figure modified for this publication. Denyer JE. Wound management for children with epidermolysis bullosa. Dermatol Clin 2010; 28:257. Table used with the permission of Elsevier Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Dressings for dystrophic epidermolysis bullosa",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Type",
"       </td>",
"       <td class=\"subtitle1\">",
"        Brand",
"       </td>",
"       <td class=\"subtitle1\">",
"        Indication",
"       </td>",
"       <td class=\"subtitle1\">",
"        Contraindication",
"       </td>",
"       <td class=\"subtitle1\">",
"        Wear time",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Soft silicone primary dressings",
"       </td>",
"       <td>",
"        <p>",
"         Mepitel",
"        </p>",
"        Silflex",
"       </td>",
"       <td>",
"        Moist wound",
"       </td>",
"       <td>",
"        Silicone sensitivity",
"       </td>",
"       <td>",
"        Change every three to four days",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Lipidocolloid primary dressings",
"       </td>",
"       <td>",
"        Urgotul",
"       </td>",
"       <td>",
"        Moist wounds, drier wounds, protection of vulnerable skin",
"       </td>",
"       <td>",
"        Where retention difficult",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Soft silicone foam dressings",
"       </td>",
"       <td>",
"        <p>",
"         Mepilex",
"        </p>",
"        <p>",
"         Mepilex Lite",
"        </p>",
"        Mepilex Transfer",
"       </td>",
"       <td>",
"        <p>",
"         Absorption of exudate",
"        </p>",
"        <p>",
"         Protection",
"        </p>",
"        <p>",
"         Lightly exuding wounds",
"        </p>",
"        Where conformability required &ndash; digits and axillae",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        Change every three to four days",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Foam dressings",
"       </td>",
"       <td>",
"        <p>",
"         Alleyvn",
"        </p>",
"        Urgocell",
"       </td>",
"       <td>",
"        <p>",
"         Absorption",
"        </p>",
"        Protection",
"       </td>",
"       <td>",
"        May need to apply over primary dressings",
"       </td>",
"       <td>",
"        Change every three to four days",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Polymeric membrane",
"       </td>",
"       <td>",
"        PolyMem",
"       </td>",
"       <td>",
"        Where cleansing required",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        As determined by level of exudate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bordered dressings",
"       </td>",
"       <td>",
"        <p>",
"         Mepilex Border",
"        </p>",
"        <p>",
"         Mepilex Border Lite",
"        </p>",
"        Alleyvn Gentle Border",
"       </td>",
"       <td>",
"        <p>",
"         Isolated wounds",
"        </p>",
"        Dominant and mild recessive DEB",
"       </td>",
"       <td>",
"        Use silicone medical removers to avoid skin stripping",
"       </td>",
"       <td>",
"        Change every three to four days",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Original figure modified for this publication. Denyer JE. Wound management for children with epidermolysis bullosa. Dermatol Clin 2010; 28:257. Table used with the permission of Elsevier Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_52_12110=[""].join("\n");
var outline_f11_52_12110=null;
var title_f11_52_12111="Therapy approach MM I";
var content_f11_52_12111=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F73792&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F73792&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 614px\">",
"   <div class=\"ttl\">",
"    Approach to therapy in patients with multiple myeloma eligible for transplantation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 594px; height: 296px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <strong>",
"     High risk",
"    </strong>",
"    : Patients with t(14;16), t(14;20), or del17p13 by FISH or high risk gene expression profiling signature.",
"    <br>",
"     <strong>",
"      Intermediate risk",
"     </strong>",
"     : Patients with t(4;14) by FISH or deletion 13/hypodiploidy by conventional cytogenetics.",
"     <br>",
"      <strong>",
"       Standard risk",
"      </strong>",
"      : All patients with myeloma who lack any of the high or intermediate risk genetic abnormalities described above.",
"      <div class=\"footnotes\">",
"       ASCT: autologous hematopoietic stem cell transplantation; CR: complete response.",
"       <br/>",
"       * If age &gt;65 or &gt;4 cycles of Rd Consider G-CSF plus cyclophosphamide or plerixafor.",
"       <br/>",
"       <span class=\"bullet\">",
"        &bull;",
"       </span>",
"       Continuing Rd beyond one year is an option for patients responding to Rd and with low toxicities; dexamethasone is usually discontinued after first year.",
"      </div>",
"      <div class=\"reference\">",
"       Modified from: Rajkumar SV. Treatment of multiple myeloma. Nat Rev Clin Oncol 2011; 26:479.",
"      </div>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_52_12111=[""].join("\n");
var outline_f11_52_12111=null;
              